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Die	  vorliegende	  Dissertation	  ist	  in	  zwei	  Thematiken	  unterteilt:	  
	  
1.Molekulare	  Mechanismen	  der	  Segregation	  von	  Chromosomen	  
	  
Die	  Segregation	  der	  Chromosomen	  ist	  ein	  zentraler	  Prozess	  während	  der	  Zellteilung.	  Dieser	  wird	  durch	  
hierarchische	  Proteinkomplexe	  reguliert,	  die	  Kinetochore.	  Sie	  kontrollieren	  die	  synchrone	  Teilung	  der	  
Schwesterchromatiden	  in	  höheren	  Eukaryoten	  in	  einem	  Prozess,	  der	  als	  spindle	  assembly	  checkpoint	  
(SAC)	   bezeichnet	   wird.	   Der	   800	   kDa	   große	   ROD-­‐Zw10-­‐Zwilch	   (RZZ)	   Proteinkomplex	   besitzt	   eine	  
Schlüsselfunktion	  in	  der	  Formierung	  des	  SAC	  sowie	  der	  Anheftung	  der	  Mikrotubuli	  an	  die	  Kinetochore.	  
Diese	   Arbeit	   beschreibt	   die	   erste	   mittels	   Kryo-­‐Elektronenmikroskopie	   bestimmte	   hochaufgelöste	  
Struktur	   des	   RZZ	   Komplexes.	   Die	   Organisation	   der	   Bestandteile	   des	   Komplexes	   wurde	   durch	  
Einbeziehung	  diverser	  biochemischer	  Methoden	  charakterisiert.	  Diese	  Arbeit	  stellt	  den	  ersten	  Schritt	  
für	  ein	  strukturelles	  Verständnis	  des	  SAC	  dar	  und	  ermöglicht	  hierdurch	  ein	  besseres	  Verständnis	  der	  
komplexen	  Signalwege,	  welche	  die	  Zellteilung	  steuern.	  
	  
2.	  Molekulare	  Grundlagen	  der	  Batten-­‐Krankheit	  
	  
Das	   Ceroid-­‐lipofuscinosis	   neuronal-­‐3	   (cln3)	   Gen	   kodiert	   für	   ein	   Transmembranprotein	   (Cln3p).	  
Mutationen	   dieses	   Proteins	   bilden	   die	   Grundlage	   für	   die	   Batten-­‐Krankheit,	   die	   am	   weitesten	  
verbreitete	  aller	  neuronalen	  Ceroid-­‐Lipofuscinosen	  (NCL).	  Diese	  vererbbaren	  neuronalen	  Krankheiten	  
sind	   durch	   den	   Verlust	   der	   Sehkraft,	   myoklonische	   Anfälle,	   Verlust	   der	   geistigen	   Fähigkeiten	   sowie	  
Störungen	   der	  motorischen	   Fertigkeiten	   charakterisiert.	   In	   dieser	   Arbeit	   wird	   die	   erste	   erfolgreiche	  
Expression	   und	   Reinigung	   des	   humanen	   Cln3p	   mittels	   eines	   Baculovirus-­‐Insektenzellen-­‐
Expressionssystems	   beschrieben.	   Initiale	   biochemische	   Charakterisierungen	   der	   posttranslationalen	  
Modifikationen	  des	  Proteins	  wurden	  durchgeführt.	  Weiterhin	  wurden	  erste	  Versuche	  zum	  Aufklärung	  
der	  Proteinfunktion	  und	  der	  Struktur	  des	  Proteins	  begonnen.	  
	  
	   	  









The	  work	  presented	  in	  this	  thesis	  can	  be	  divided	  into	  two	  topics:	  
1.	  	  	  	  	  Molecular	  mechanism	  of	  chromosome	  segregation	  
Chromosome	   segregation	   is	   a	   central	   process	   in	   cell	   division.	   Hierarchical	   protein	   assemblies	   called	  
kinetochores	  navigate	  this	  process.	  They	  monitor	  the	  synchronous	  separation	  of	  sister	  chromatids	   in	  
higher	  eukaryotes	  by	  a	  pathway	  commonly	  referred	  to	  as	  spindle	  assembly	  checkpoint	  (SAC).	  The	  800	  
kDa	   ROD-­‐Zw10-­‐Zwilch	   (RZZ)	   complex	   is	   a	   key	   player	   both	   in	   SAC	   and	   formation	   of	   kinetochore	   –	  
microtubule	  attachments.	  This	  work	  highlights	  the	  first	  high-­‐resolution	  structure	  of	  the	  RZZ	  complex	  
determined	  by	  cryo-­‐electron	  microscopy.	  The	  organization	  of	  constituent	  proteins	  in	  the	  complex	  has	  
been	  understood	  by	  interweaving	  various	  biochemical	  methods.	  This	  study	  is	  essentially	  the	  first	  step	  
in	  understanding	  the	  SAC	  from	  a	  structural	  perspective	  and	  enables	  to	  use	  hints	  from	  the	  structure	  in	  
understanding	  the	  complex	  signaling	  process	  that	  drives	  cell	  division.	  
2.	  	  	  	  	  Molecular	  basis	  of	  the	  Batten	  disease	  
Ceroid	  –	  lipofuscinosis	  neuronal-­‐3	  (cln3)	  gene	  encodes	  a	  trans-­‐membrane	  protein	  (Cln3p)	  mutations	  in	  
which	  cause	  Batten’s	  disease.	  Batten	  disease	  is	  the	  most	  common	  of	  all	  neuronal	  ceroid-­‐lipofuscinoses	  
(NCL,	  genetically	  inherited	  neuronal	  disorders)	  characterized	  by	  loss	  of	  vision,	  myoclonic	  seizures,	  loss	  
of	   cognitive	   function,	  motor	   dysfunction.	   This	   work	   reports	   the	   first	   expression	   and	   purification	   of	  
human	   Cln3p	   from	   the	   baculovirus	   driven	   insect	   cell	   expression	   system.	   Initial	   biochemical	  
characterization	  of	  the	  protein	  is	  also	  reported.	  Efforts	  to	  understand	  the	  protein	  function	  have	  been	  
initialized	  and	  variety	  of	  techniques	  used	  to	  understand	  the	  structure	  of	  the	  protein.	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1.1 Mitosis	  	  
1.1.1 General	  principles	  	  
Cell	  cycle	  is	  the	  process	  of	  duplication	  of	  a	  cell	  into	  daughter	  cells.	  A	  cascade	  of	  indispensable	  signaling	  
events	  regulates	  this	  process,	  propelling	  it	  irreversibly	  forward.	  The	  point	  of	  cell	  division	  is	  to	  duplicate	  
and	  distribute	  the	  DNA	  (condensed	  as	  chromosomes)	  into	  the	  daughter	  cells	  precisely.	  Any	  digression	  
or	  defect	  otherwise,	  generally	   is	  of	   irreparable	  consequence	   to	   the	  cell,	  usually	   reflected	  as	  cancers	  
[1].	   Various	   proteins	   regulate	   the	   fidelity	   of	   the	   cell	   cycle;	   of	   these,	   cyclins	   are	   of	   paramount	  
importance.	  G1/S,	  S	  and	  M	  are	  three	  major	  classes	  of	  cyclins	  that	  interact	  with	  Cdk	  (cyclin	  dependent	  
kinase)	   to	   generate	   cyclin-­‐cdk	   complexes.	   Oscillations	   in	   the	   levels	   of	   these	   complexes	   control	   the	  
stages	  of	  the	  cell	  cycle	  [2,	  3].	  Mitosis,	  the	  shortest	  and	  visually	  most	  stunning	  of	  all	  the	  phases	  in	  cell	  
cycle,	  is	  responsible	  for	  the	  distribution	  of	  replicated	  DNA.	  	  
	   	  
Figure	   1.1:	   Stages	   in	  mitosis.	  Mitosis	   is	   comprised	   of	   distinct	   phases.	   The	   onset	   of	   cell	   division	   is	  marked	   by	  
duplication	  and	  condensation	  of	  genetic	  material	  into	  chromosomes.	  In	  prophase	  chromosomes	  become	  highly	  
condensed	  and	  the	  centrosomes	  begin	  to	  drift	  apart.	  Nuclear	  envelope	  breakdown	  (NEBD)	  marks	  the	  transition	  
from	   prophase	   to	   prometaphase	   making	   chromosomes	   not	   bound	   to	   the	   nuclear	   periphery.	   During	  
prometaphase	  the	  spindle	  microtubules	  connect	  with	  kinetochores	  on	  the	  chromosomes,	  so	  that	  they	  can	  align	  
at	   the	   spindle	   equator,	   a	   process,	   which	   outlines	   metaphase.	   Microtubules	   are	   indispensible	   to	   the	   whole	  
process.	  They	  are	  bipolar,	  with	   their	   ‘minus’	  end	  at	   the	  centrosomes	  and	   ‘plus’	  end	  engaging	  either,	  with	   the	  
chromosomes	  (spindle	  microtubules)	  or	  the	  cell	  cortex	  (astral	  microtubules).	  Anaphase	  is	  defined	  by	  separation	  
of	  the	  sister	  chromatids	  towards	  opposite	  ends	  of	  the	  cell.	  The	  nuclear	  envelope	  starts	  to	  re-­‐appear	  and	  the	  DNA	  
starts	  to	  unwind,	  marking	  the	  penultimate	  stage	  of	  mitosis.	  Mitosis	  culminates	  when	  the	  cell	  divides,	  with	  two	  
daughter	  nuclei	  segregated	  into	  different	  cells,	  which	  are	  ready	  to	  re-­‐start	  the	  process.	  Source:	  [4]	  
	  
Decades	   of	   research	   have	   led	   us	   to	   a	   standpoint	   where	   the	   key	   players	   have	   been	   identified	   and	  
crucial	   events	   outlined.	   Briefly,	  mitosis	   constitutes	   of	   five	   distinct	   phases,	   defined	   primarily	   on	   the	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spatial	   organization	   of	   chromosomes	   (Figure	   1.1)[4].	   At	   the	   heart	   of	   the	   process	   lies	  what	   is	   called	  
chromosome	   segregation,	   where	   Cohesin	   (a	   multi-­‐protein	   complex	   that	   binds	   sister	   chromatids)	   is	  
cleaved	   leading	   to	   concomitant	   release	   of	   sister	   chromatids	   that	   are	   subsequently	   driven	   towards	  
opposite	  spindle	  poles	  [5].	  
1.1.2 Kinetochores	  -­‐	  molecular	  assemblies	  at	  the	  helm	  of	  chromosome	  segregation	  
Kinetochores	   are	   macromolecular	   protein	   assemblies,	   which	   are	   at	   the	   helm	   of	   chromosome	  
segregation.	   These	   protein	   assemblies,	   with	   loci	   at	   the	   chromosomes,	   engage	   primarily	   in	   forming	  
stable	   load	   bearing	   attachments	   to	   the	   dynamic	   ends	   of	   microtubules	   (dynamic	   polymers	   of	   α,	   β-­‐
tubulin).	   Such	   attachments	   underline	   the	   process	   of	   correct	   sister	   chromatid	   separation	   [6].	  
Saccharomyces	   cerevisiae	   bears	   the	   simplest	   known	   kinetochore	   (binds	   a	   single	   microtubule)	   and	  
contains	   approximately	   40	   proteins,	   which	   are	   grouped	   into	   7	   different	   complexes	   [7,	   8].	   The	  
kinetochore	  organization	  of	   higher	   eukaryotes	   (which	   contain	   up	   to	   100	  proteins	   and	  bind	  multiple	  
microtubules)	   has	   remained	   widely	   speculative.	   On	   one	   hand	   constitutive	   protein	   complexes	   are	  
conserved	   from	   yeast	   to	   higher	   eukaryotes,	   hinting	   at	   the	   fact	   that	   eukaryotic	   kinetochores	   are	  
possibly	  multimeric	   assemblies	  of	   yeast	   constituents	   [9,	   10]	   and	  on	   the	  other,	   electron	   tomography	  
studies	   on	   the	   kinetochores	   from	   PtK1	   cells	   show	   that	   the	   outer	   plate	   is	   protein	   meshwork	   which	  
seemed	   to	   not	   exhibit	   any	   definite	   architecture	   [11].	   Single	   particles	   of	   purified	   yeast	   kinetochores	  
observed	  by	  negative	  stain	  electron	  microscopy	  revealed	  a	  central	  hub	  surrounded	  by	  several	  domains	  
[12].	  Complete	  architecture	  of	  eukaryotic	  kinetochore,	  however,	  is	  still	  obscure.	  	  
On	  organizational	   level	  kinetochores	  are	  thought	  to	  be	  made	  up	  of	  the	   inner	  kinetochore,	   the	  outer	  
kinetochore	   and	   the	   corona	   (Figure	   1.2).	   Kinetochores	   are	   built	   up	   on	   a	   homologue	   of	   the	   H3	  
nucleosome	  called	  CENP-­‐A	  (Centromeric	  protein-­‐A).	  CENP-­‐A	  interacts	  with	  various	  other	  centromeric	  
proteins	  such	  as	  CENP-­‐C,	  H,	  I,	  K,	  L,	  M,	  O,	  P,	  Q,	  R,	  S,	  T,	  U	  and	  W	  to	  form	  what	  is	  known	  as	  constitutive	  
centromere-­‐associated	   network	   complex	   (CCAN,	   Figure	   1.2)[13-­‐15].	   The	   CCAN	   network	   constitutes	  
the	   inner	   kinetochore	   region	  and	  primarily	   interacts	  with	   the	   centromeric	  DNA.	  The	   components	  of	  
CCAN	   network	   can	   be	   further	   sub	   classified,	   supported	   by	   biochemical	   and	   functional	   analysis,	   to	  
CENP-­‐T/W,	   CENP-­‐H/I/K	   and	   CENP-­‐O/P/Q/R/U	   complexes.	   The	   sub-­‐units	   of	   CCAN	   network	   are	  
interdependent	   on	   each	   other	   for	   their	   localization	   at	   the	   kinetochore	   and	   serve	   as	   a	   platform	   for	  

















Figure	  1.2:	  Organization	  of	  the	  kinetochore.	  (a)	  Eukaryotic	  kinetochores	  are	  hierarchical	  assemblies	  consisting	  of	  
up	  to	  100	  proteins	  and	  can	  be	  segmented	  into	  regions	  called	  inner	  kinetochore,	  outer	  kinetochore	  and	  corona.	  
The	   Histone	   H3	   homologue,	   CENP-­‐A	   is	   central	   to	   the	   assembly	   of	   all	   kinetochore	   proteins.	   It	   interacts	   and	  
underlines	  the	  assembly	  of	  other	  members	  of	  inner	  kinetochore	  (highlighted	  in	  purple	  and	  light	  blue)	  ,	  which	  are	  
collectively	  known	  as	  the	  CCAN	  (constitutive	  centromere	  associated	  network).	  Most	  of	  the	  components	  of	  CCAN	  
network,	   inner	   kinetochore,	   remain	   associated	   with	   the	   kinetochore	   throughout	   the	   cell	   cycle.	   The	   outer	  
kinetochore	   forms	   a	   chassis	   for	   assembly	   of	   universally	   conserved	   complexes	   and	   is	   commonly	   known	   as	   the	  
KMN	  network.	  Most	  of	  the	  proteins	  of	  the	  outer	  kinetochore	  are	  recruited	  during	  mitosis.	  Proteins	  of	  the	  outer	  
kinetochore	   are	   responsible	   for	   primary	   kinetochore-­‐microtubule	   interactions	   and	   also	   help	   recruiting	   the	  
proteins	   that	   form	   the	   corona.	   The	   proteins	   of	   corona	   encompass	   diverse	   roles	   including	   spindle	   assembly	  
checkpoint,	   (RZZ	  complex,	  Cdc20,	  BubR1,	  Bub3,	  Bub1)	   regulating	  microtubule	  binding,	  motor	  proteins	   (dynein-­‐
dynactin,	   CENP-­‐F)	   etc.	   The	   kinetochore	   centromere	   interface	   is	   populated	   by	   the	   chromosomal	   passenger	  
complex,	   with	   primary	   kinase	   functionality,	   involved	   in	   correcting	   faulty	   attachments	   Source:	   [17]	   (b)	  
organization	  of	  the	  kinetochore	  at	  a	  very	  rudimentary	  functional	  level.	  	  
	  
The	  outer	  kinetochore	  region	  is	  comprised	  of	  the	  highly	  conserved	  KMN	  network	  (discussion	  follows	  in	  
section	  1.1.3),	  which	  mediates	  the	  interactions	  with	  microtubules,	  and	  provides	  a	  platform	  for	  most	  of	  
the	  proteins	   that	  populate	   the	  corona	   [18].	  The	  corona	   is	   the	  outermost	   region	  of	   kinetochore	   that	  
hosts	   proteins	   and	   protein	   complexes	   which	   are	   primarily	   involved	   in	   the	   checkpoint	   activity	   and	  
feedback	   mechanisms,	   it	   also	   hosts	   proteins	   which	   bind	   and	   regulate	   microtubules	   [17].	   A	   very	  
important	   region	   is	   also	   the	   centromere-­‐kinetochore	   interface.	   This	   space	   is	   pervaded	   by	   what	   is	  
known	  as	   the	  chromosome	  passenger	  complex	   (CPC,	  Aurora-­‐B	  protein	  kinase,	   the	   inner	  centromere	  
protein	  INCENP,	  Survivin	  and	  Borealin),	  a	  complex	  that	  is	  critical	  for	  correction	  of	  faulty	  kinetochore-­‐
microtubule	  attachments	   [19].	  Recent	   technological	  advances	   in	   single	  molecule	   studies	  have	   led	   to	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developments	   of	   methods	   such	   as	   ‘kinetochore-­‐speckle	   high	   resolution	   co-­‐localization’	   (K-­‐SHREC)	  
which	   allows	   to	   determine	   the	   average	   separation	   between	   the	   centroids	   of	   two	   different	   colored	  
fluorescent	   probes	   that	   label	   different	   protein	   domains	   within	   the	   kinetochores	   of	   human	   cells.	   K-­‐
SHREC	   analysis	   applied	   to	   cells	   in	   metaphase	   where	   the	   sister	   chromatids	   are	   aligned	   in	   opposite	  
directions	   led	   to	   the	  mapping	   of	   positions	   of	   various	   proteins	   along	   the	   kinetochore	   axis[20].	   Such	  
studies	   have	   unveiled	   spatial	   organization	   of	   kinetochores	   to	   a	   certain	   extent.	  One	   such	   analysis	   of	  
cells	   in	   metaphase	   with	   and	   without	   taxol	   treatment	   is	   highlighted	   in	   Figure	   1.3	   [21].	   Cellular	  
complexes	   seldom	   come	  without	   any	   critical	   functional	   roles.	   The	   function	   of	   kinetochores	   is,	   very	  





Figure	   1.3:	   Delta	   measurements	   in	   control	  
and	  taxol-­‐treated	  HeLa	  cells.	  	  
‘kinetochore-­‐speckle	   high	   resolution	   co-­‐
localization’	   (K-­‐SHREC)	   analysis	   is	   a	  
fluorescence	   based	   method,	   where	   one	  
measures	  average	  separation,	  Delta,	  between	  
proteins	   labeled	   with	   two	   fluorophores	   at	   a	  
single	   molecule	   level.	   The	   figure	   highlights	  
delta	   measurements	   for	   19	   epitopes	   in	   16	  
kinetochore	  proteins	  in	  control	  cells	  (left)	  and	  
in	   taxol-­‐treated	   (right)	   cells.	   The	   scale	   is	  
calibrated	   to	   zero	   at	   the	  N-­‐terminus	  of	  Hec1	  
(Ndc80)	   centroid,	   where	   positive	   values	  
indicate	   distances	   outward	   (away	   from	   the	  
kinetochore	   and	   towards	   the	   spindle).	  While	  
negative	   values	   are	   inward	   (towards	   the	  
centromeric	   chromatin).	   Color-­‐coded	   boxes	  
highlight	   specific	   complex.	   Such	   analysis	  
predict	   the	   position	   of	   epitope	   within	   an	  
accuracy	  limit	  of	  <5	  nm.	  Source:	  [20]	  
	  
Before	  continuing	  any	  further,	  two	  things	  need	  to	  be	  clarified:	  One,	  since	  ROD	  and	  Zwilch	  (the	  subjects	  
of	   this	   study)	  are	   found	  only	   in	  metazoans	  and	  higher	  eukaryotes,	  most	  of	   the	  concepts	   introduced	  
and	  discussions	   led	  will	  be	  keeping	  higher	  eukaryotes	   in	  mind.	  Two,	  a	   lot	  of	  the	  current	  chapter	  will	  
deal	  with	  term	  ‘recruitment’.	  Recruitment	  here	   is	  referred	  to	   in	  a	  much	  broader	  sense.	  The	  proteins	  
that	  make	  up	  and/or	  associate	  with	  the	  kinetochore	  do	  not	  have	  any	   localization	  sequences/signals.	  
When	  a	  protein	  A	  is	  referred	  to	  recruit	  another	  protein	  B,	  it	  generally	  refers	  to	  the	  fact	  that	  A	  is	  at	  a	  
certain	  locus	  (kinetochore)	  before	  B	  and	  is	  absolutely	  necessary	  for	  the	  localization	  of	  B.	  Also,	  in	  most	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of	   the	  cases,	   the	  quintessential	  dependence	  highlighted	   in	   recruitment	  has	  not	  been	  translated	   into	  
biochemical	  interaction.	  	  
1.1.3 Kinetochore-­‐microtubule	  interaction:	  KMN	  network	  
Microtubules	   are	   polymers	   of	   α/β-­‐tubulin	   dimers,	   which	   shuttle	   stochastically	   between	  
polymerization	   (growth	   phase)	   and	   catastrophe	   (de-­‐polymerization).	   They	   are	   versatile	   in	   their	  
interactions,	   engaging	  a	  diverse	   spectrum	  of	   functionally	   variant	  proteins,	   crucial	   for	   a	  multitude	  of	  
cellular	  processes	  including	  cell	  division,	  migration	  and	  differentiation	  [22,	  23].	  The	  following	  section	  
deals	  with	  a	  subset	  of	  such	  microtubule	  binding	  proteins	  essential	  for	  cell	  division.	  
Using	   a	   synergistic	   approach	   of	   biochemistry	   and	   RNAi	   screening	   (functional	   genomics)	   the	   KMN	  
protein	  network	  was	  discovered	  in	  C.elegans	  [24,	  25].	  This	  extremely	  conserved	  ten-­‐protein	  network	  is	  
what	   links	  centromeric	  DNA	  to	   the	  plus	  end	  of	  bipolar	  spindle	  microtubules	  and	  regulates	   functions	  
such	   as:	   formation	   and	   correction	   of	   load	   bearing	   kinetochore-­‐microtubule	   attachments,	   recruiting	  
and	  hence	  controlling	   the	  proteins	   involved	   in	   the	  spindle	  assembly	  checkpoint	   (Figure	   1.4)	   [18,	  26,	  
27].	   Depletion	   of	   the	   KMN	   network	   results	   in	   a	   kinetochore-­‐null	   phenotype	   (no	   load	   bearing	  
kinetochore-­‐microtubule	  attachments	  can	  be	  formed)	  [18,	  24,	  25,	  28,	  29].	  The	  network	  comprises	  of	  
three	   sub-­‐complexes:	   the	   KNL1	   complex	   (KNL1-­‐C),	   which	   is	   made	   up	   of	   Knl1	   (Kinetochore	   null-­‐1,	  
CASC5	  or	  blinkin	  in	  humans,	  Spc105	  in	  yeast,	  Spc105R	  in	  fly)	  and	  Zwint	  (Zw10	  interacting	  protein);	  the	  
MIS12	  complex	  (MIS12-­‐C),	  constituted	  of	  four	  proteins	  viz.	  Mis12	  (Mis-­‐segregation	  protein	  12,	  Mtw1	  
or	  MIND	  in	  yeast),	  Nsl1	  (DC31	  or	  Mis14),	  Nnf1	  (also	  known	  as	  Pnf1)	  and	  Dsn1	  (also	  known	  as	  Mis13	  in	  
humans,	  Knl3	  in	  C.elegans);	  and	  also	  other	  heterotetrameric	  NDC80	  complex	  (NDC80-­‐C)	  consisting	  of	  
Ndc80	  (also	  known	  as	  Hec1),	  Nuf2,	  Spc24	  and	  Spc25	  [18,	  24,	  29].	  	  
	  




Figure	  1.4:	  Schematic	  view	  of	   the	  
KMN	   network.	   The	   KMN	  network	  
is	  a	  central	  to	  microtubule	  binding	  
and	  is	  made	  up	  of	  10	  proteins	  and	  
is	   sub-­‐divided	   into	   three	   different	  
complexes:	   the	   MIS12	   complex	  
(MIS12C),	   the	   NDC80	   complex	  
(NDC80C)	   and	   the	   KNL1	   complex	  
(KNL1C).	   The	   KMN	   network	  
bridges	   the	   nucleosomes	   and	   the	  
microtubules.	  CENP-­‐T/W	  or	  CENP-­‐
C,	  members	  of	   the	  CCAN	  network	  
associated	   with	   the	   nucleosomes	  
make	   contacts	   with	   MIS12C.	   The	  
KNL1	   complex	   comprises	   of	   Knl1	  
and	   Zwint-­‐1	   (Zwi)	   plays	   a	   major	  
role	  in	  recruiting	  most	  of	  the	  other	  
proteins	   to	   the	   kinetochore.	  
NDC80	  is	  a	  hetero-­‐tetramer	  (Hec1,	  
Nuf2,	  Spc24,	  Spc25).	  Ndc80	  (Hec1)	  
harbors	   primary	   microtubule	  
binding	   sites.	   Nuf2	   and	   the	   N-­‐	  
termini	   of	   Knl1	   have	   also	   been	  
shown	   to	   bind	   microtubules,	   an	  
interaction	   required	   for	   re-­‐
enforcing	   the	   primary	   binding.	  
Spc24,	   Spc25	   interact	   with	   the	  
MIS12C.	   3D	   structure	   and	  
architecture	   of	   the	   KMN	   network	  
is	  now	  available	  [30].	  
Inset	   highlights	   the	   location	   of	  
kinetochores	   on	   the	   chromosome	  
and	   the	   orientation	   of	  
microtubules	   with	   respect	   to	   the	  
chromosome.	  
Source:	  [31]	  
1.1.4 The	  binding	  conundrum	  
Not	  all	  protein	  interactions	  between	  the	  kinetochore	  and	  the	  microtubules	  result	  in	  the	  formation	  of	  
load	  bearing	  attachments.	   In	  a	  nutshell,	  binding	  of	   the	  kinetochore	  to	  the	  microtubules	   is	  necessary	  
but	   not	   sufficient	   for	   the	  metaphase-­‐anaphase	   transition.	   There	   are	   four	   possible	   outcomes	   to	   the	  
kinetochore-­‐microtubule	   interaction	   of	   which	   only	   one	   is	   favorable.	   An	   ideal	   scenario	   is	   of	   bi-­‐
orientation,	  where	  kinetochore	  pairs	  from	  the	  sister	  chromatids	  are	  bound	  to	  microtubule	  fibers	  from	  
opposite	  poles	  and	  are	  in	  a	  state	  of	  ‘tension’	  (they	  experience	  partitioning	  force,	  which	  stretches	  the	  












Figure	  1.5:	  Attachment	  versus	  tension.	  Four	  different	  possibilities	  of	  kinetochore	  microtubule	  attachment	  exist,	  
of	  which	  only	  one	  is	  favorable	  for	  the	  metaphase	  to	  anaphase	  transition.	  The	  ideal	  case	  is	  when	  kinetochores	  of	  
sister	  chromatid	  are	  bound	  to	  microtubules	  from	  opposite	  poles.	  This	  is	  also	  known	  as	  amphitelic	  orientation	  (bi-­‐
orientation).	  Monotelic	   attachment	   precedes	   bi-­‐orientation	   generally	   in	   prometaphase.	   The	   spindle	   assembly	  
checkpoint	   keeps	   the	   cell	   from	   transitioning	   into	   anaphase,	   defects	   in	  which	   lead	   to	   abnormal	   distribution	  of	  
chromosomes.	   In	   syntelic	   attachment,	   both	   sisters	   in	   a	   pair	   connect	   to	   the	   same	   pole	   and	   in	  merotely,	   one	  
chromosome	  is	  attached	  to	  both	  poles.	  Conditions,	  which	  lead	  to	  loss	  of	  bi-­‐orientation	  generally	  are	  unfavorable	  
to	  the	  cell.	  Source:	  [35]	  
	  
Dividing	   cells	   in	   the	   process	   of	   undergoing	   metaphase	   to	   anaphase	   transition	   have	   to	   ensure	   the	  
following:	  	  1) There	  cannot	  be	  any	  unattached	  kinetochore,	  and	  2) The	  attachments	  should	  not	  be	  faulty.	  	  
The	  kinetochore	  hosts	  two	  different	  feedback	  mechanisms	  in	  the	  cell	  and	  oversees	  the	  fulfillment	  of	  
above	   criteria.	   Cells,	   which	   enter	   anaphase	   failing	   to	   meet	   above	   requirements,	   often,	   encounter	  
aneuploidy,	  mis-­‐segregation	  or	  other	  defects[36].	  
1.1.4.1 Spindle	  assembly	  checkpoint	  (SAC)	  
The	  first	  feedback	  mechanism,	  called	  the	  spindle	  assembly	  checkpoint	  (SAC,	  alternatively	  metaphase	  
checkpoint)	   ensures	   that	   there	   are	   no	   unattached	   kinetochores	   before	   the	   cell	   transcends	   into	  
anaphase.	   Certain	   genes,	   conserved	   in	   all	   eukaryotes,	   relay	   the	   kinetochore-­‐binding	   status	   of	   the	  
chromosomes	  in	  the	  cell	  to	  delay	  exit	  from	  mitosis[37,	  38].	  Needless	  to	  mention,	  mutations	  in	  these	  
genes	  compromise	  the	   fidelity	  of	  chromosome	  segregation	  and	  represent	  a	  non-­‐utopian	  case	  of	  cell	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division,	  with	  implications	  in	  tumors	  [39].	  One	  can	  attempt	  to	  define	  a	  SAC	  gene	  as	  a	  gene,	  mutations	  
in	  which	  are	  of	  catastrophic	  consequences	   to	  cells	  due	  to	   their	   tendency	  to	  exit	  mitosis	  overlooking	  
segregation	   errors.	   Gene	   products	   of	   SAC	   genes	   include	   proteins	   such	   as	   Mad1	   (mitotic-­‐arrest	  
deficient),	   Mad2,	   Bub1	   (budding	   uninhibited	   by	   Benzimidazole),	   Bub3,	   BubR1,	   kinases	   Mps1	  
(multipolar	   spindle-­‐1)	  and	  Aurora-­‐B	   [40,	  41].	  There	  are	  other	  proteins,	  which	  are	  an	   integral	  part	  of	  
the	  SAC,	  but	  are	   found	   in	  metazoans	  and	  higher	  eukaryotes.	  These	   include	  proteins,	   some	  of	  which	  
are	   focus	   of	   the	   present	   study:	   ROD,	   Zw10	   and	   Zwilch,	   and	   others	   such	   as	   p31comet,	   Plk1	   (polo-­‐like	  
kinase-­‐1),	   MAP	   (mitogen	   activated	   protein)	   kinase,	   dynein	   and	   dynein	   associated	   proteins	   such	   as	  




Figure	  1.6:	  Principles	  of	  the	  SAC.	  Unattached	  kinetochores	  catalyze	  formation	  of	  the	  mitotic	  checkpoint	  complex	  
(MCC)	  composed	  of	  BubR1,	  Mad2,	  Cdc20	  and	  Bub3,	  which	  blocks	  the	  APC/C.	  The	  MCC	  is	  characteristic	  of	  early	  
stages	   of	   mitosis	   when	   the	   chromosomes	   are	   still	   searching	   for	   stable	   and	   load	   bearing	   microtubule	  
attachments.	   Once	   all	   the	   chromosomes	   are	   aligned	   with	   their	   kinetochores	   attached	   to	   the	   spindle	  
(metaphase),	  MCC	  ceases	  to	  exist	  facilitating	  the	  release	  of	  Cdc20,	  which	  is	  a	  cofactor	  of	  APC/C.	  Activated	  APC/C	  
ubiquitylates	  its	  substrates,	  Securin	  and	  Cyclin	  B1,	  which	  are	  degraded	  by	  the	  proteasome	  leading	  to	  release	  of	  
Separase	   and	   Cdk1.	   Separase	   cleaves	   the	   Scc1	   kleisin	   subunit	   of	   the	   cohesion	   ring	   structure	   leading	   to	   the	  
opening	  of	  the	  ring,	  allowing	  sister	  chromatids	  to	  separate,	  which	  marks	  the	  onset	  of	  anaphase.	  Cdk1	  signals	  the	  
cell	  to	  exit	  mitosis.	  Source:	  [46].	  
	  
The	  molecular	  mechanism	  of	  SAC	  can	  be	  attributed	  to	  the	  action	  of	  proteins	  Mad2,	  BubR1	  (Mad3	  in	  
yeast)	  and	  Bub3	  which	  form	  a	  complex	  called	  as	  the	  Mitotic-­‐checkpoint	  complex	  (MCC)	  [47-­‐49].	  Note,	  
these	  proteins	  are	  recruited	  to	  the	  kinetochore	  directly	  by	  Knl1.	  They	  target	  and	  negatively	  regulate	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Cdc20,	  which	   is	  a	  co-­‐factor	  of	  anaphase-­‐promoting	  complex/cyclosome	  (APC/C)	   [50-­‐52].	  APC/C	   is	  an	  
ubiquitin	   ligase	   that,	   in	   presence	  of	   Cdc20,	   brings	   about	  polyubiquitylation	  of	   proteins	  Cyclin	  B	   and	  
Securin,	  making	   them	   susceptible	   to	   degradation	   by	   the	   proteasome	   [52].	   This	   has	   two-­‐fold	   effect:	  
one,	  Securin,	  which	  is	  an	  inhibitor	  of	  Separase	  (a	  protease,	  that	  targets	  Cohesin,	  a	  protein	  which	  binds	  
the	   two	  sister	   chromatids	   together)	  which	  when	  degraded	   leads	   to	  a	  pool	  of	  active	  Separase	  which	  
then	  goes	  onto	  cleaving	  the	  sister	  chromatids	  and	  sets	  them	  free	  to	  be	  driven	  pole-­‐wards	  [53].	  Two,	  
degradation	  of	  Cyclin	  B	  inactivates	  the	  master	  mitotic	  kinase	  Cdk1	  and	  hence	  initiates	  cytokinesis	  [52].	  
In	   short,	   MCC	   targets	   APC/C	   mediated	   ubiquitylation	   which	   is	   indispensable	   for	   sister	   chromatid	  
separation	  (Figure	  1.6).	  Conversely,	  when	  the	  kinetochores	  are	  unattached,	  Cdc20	  remains	  bound	  to	  
MCC	  and	  hence	  cells	  wait	  to	  get	  into	  anaphase.	  	  
How	  exactly	   is	  Cdc20	  regulated?	  The	  model	  for	  regulation	  of	  Cdc20	  is	  briefly	  described	  below	  and	  is	  
generally	  referred	  to	  as	  the	  ‘template	  model’.	  Protein	  Mad2,	  an	  integral	  part	  of	  MCC,	  populates	  cells	  
as	   two	   different	   conformers	   [49,	   54]	   One,	   open-­‐Mad2	   (O-­‐Mad2),	   which	   is	   free	   or	   unbound	   and	  
generally	   cytosolic	   and	   as	   closed-­‐Mad2	   (C-­‐Mad2),	   which	   is	  Mad2	   bound	   to	   either	  Mad1	   or	   Cdc20.	  
Mad2	  can	  exist	  as	  a	  dimer,	  but	  the	  interaction	  is	  only	  possible	  between	  a	  molecule	  of	  O-­‐Mad2	  and	  a	  C-­‐
Mad2.	  Both	  O-­‐Mad2	  and	  C-­‐Mad2	  homo-­‐dimers	  are	  known	  not	  to	  exist.	  There	  is	  a	  small	  amount	  of	  C-­‐
Mad2	   at	   the	   kinetochores	   (in	   complex	   with	   Mad1).	   This	   then	   recruits	   O-­‐Mad2	   to	   unattached	  
kinetochores	  during	  prometaphase.	  The	  new	  O-­‐Mad2,	  which	  arrives	  at	   the	  kinetochore,	  can	  bind	   to	  
the	   Mad1/C-­‐Mad2	   already	   at	   the	   kinetochore	   making	   a	   transient	   but	   stable	   complex.	   During	   the	  
course	   of	   SAC	   these	   two	   populations	   are	   non-­‐exchanging.	   The	   interaction	   of	   the	   O-­‐Mad2	   with	  
Mad1/C-­‐Mad2	   can	   then	   induce	   a	   conformational	   change	   onto	   the	   O-­‐Mad2	   thereby	   making	   it	  
susceptible	  to	  interact	  with	  Cdc20.	  Hence;	  Mad1/C-­‐Mad2	  acts	  as	  a	  template	  for	  conversion	  of	  O-­‐Mad2	  
to	  Cdc20	  bound	  C-­‐Mad2[55].	  This	  model	  further	  postulates	  that;	  since	  the	  structural	  conformation	  of	  
Mad1/C-­‐Mad2	  is	  similar	  to	  that	  of	  Cdc20/C-­‐Mad2,	  the	  latter	  can	  auto	  catalyze	  (as	  a	  positive	  feedback)	  
conversion	  of	  more	  O-­‐Mad2	  to	  C-­‐Mad2	  [17,	  56](refer	  Figure	  1.7).	  
Extinction	   of	   SAC	   is	   propelled	   by	   attachment	   of	   kinetochore	   to	   microtubules.	   This	   triggers	   the	   C-­‐
Mad2/Cdc20	  complex	  breakdown	  and	  release	  of	  Cdc20,	  which	  is	  now	  available	  to	  bind	  to	  the	  APC/C	  
and	  thereby	  facilitates	  the	  onset	  of	  anaphase	  as	  described	  earlier[52].	  	  
	   	  







Figure	   1.7:	   The	   template	   model.	   When	   the	  
kinetochore	   is	   unattached	   (above)	   during	  
metaphase,	   the	   checkpoint	   is	   activated.	   O-­‐
Mad2	  (unbound,	  shown	  in	  red	  squares	  with	  ‘O’)	  
interacts	   with	   C-­‐Mad2	   (highlighted	   in	   yellow	  
circles,	   bound	   pool	   of	   Mad2	   present	   at	   the	  
kinetochore	  as	  Mad1-­‐Mad2)	  and	  is	  converted	  to	  
C-­‐Mad2	   bound	   to	   Cdc20.	   Both	   the	   C-­‐Mad2	  
populations	   are	   similar	   as	   Mad1	   and	   Cdc20	  
share	  the	  same	  binding	  motif	  and	  Mad2	  adopts	  
the	   same	   conformation	   in	   both	   these	  
complexes.	  Once	  C-­‐Mad2/Cdc20	   is	   formed	   it	   is	  
released	  into	  the	  cytosol	  where	  it	  catalyzes	  the	  
conversion	   of	   cytosolic	   pool	   of	   O-­‐Mad2	   to	   C-­‐
Mad2/Cdc20.	  In	  this	  way	  all	  the	  Cdc20	  required	  
for	   the	   activation	   of	   APC/C	   for	   the	   cell	   to	  
progress	   into	   anaphase	   is	   preoccupied.	   Once	  
the	   kinetochore	   microtubule	   attachments	   are	  
established	   (represented	   below)	   proteins	   such	  
as	   p31comet	   may	   dissociate	   the	   Mad2-­‐Cdc20	  
complex,	   leading	  to	  release	  and	  stabilization	  of	  
Cdc20,	   which	   can	   then	   activate	   the	   CPC.	   Also	  
Mad1-­‐Mad2	  is	  siphoned	  off	  the	  kinetochore	  by	  
dynein-­‐mediated	   mechanisms.	   There	   are	   also	  
other	  theories	  in	  what	  leads	  to	  the	  dissociation	  
of	   the	   C-­‐Mad2/Cdc20,	   which	   will	   not	   be	  
discussed	  here.	  Source:[54]	  
	  
The	  release	  of	  Cdc20	  from	  C-­‐Mad2/Cdc20	  can	  be	  brought	  about	  by	  one	  of	  the	  following	  ways.	  First,	  
disappearance	  of	  the	  unattached	  kinetochores	  may	   lead	  to	  re-­‐activation	  of	  p31comet	  ,	  which	   interacts	  
with	   the	   Mad1/C-­‐Mad2	   and	   hence	   inhibiting	   the	   Mad1/C-­‐Mad2	   O-­‐Mad2	   interaction	   [44,	   57,	   58].	  
Second,	  at	  the	  onset	  of	  anaphase	  the	  dynein/dynactin	  complex	  siphons	  off	  Mad1/C-­‐Mad2	  and	  other	  
kinetochore	  proteins	  and	  hence	  leaving	  little	  or	  no	  room	  for	  the	  formation	  of	  C-­‐Mad2/Cdc20	  [42]	  and	  
third,	   Cdc20	  may	   undergo	   a	   non-­‐degradative	   ubiquitylation	   by	   the	   enzyme	   UbcH10	   and	   this	  might	  
then	  favor	  the	  release	  of	  Cdc20	  from	  the	  Cdc20/C-­‐Mad2	  complex	  [59].	  Lastly,	  since	  the	  recruitment	  of	  
SAC	  proteins	  depends	  on	  the	  phosphor-­‐regulation	  of	  Knl1	  [60-­‐62],	  role	  of	  phosphatases	  in	  extinction	  
of	  SAC	  cannot	  be	  ruled	  out[63].	  
The	  reader	  might	  wonder	  at	  this	  point	  how	  RZZ,	  reported	  as	  a	  SAC	  gene	  earlier,	  contributes	  to	  SAC?	  
The	  explanation	  is	  rather	  straightforward;	  Mad2,	  which	  is	  absolutely	  necessary	  for	  the	  SAC	  activity,	  is	  
transported	   to	   the	   kinetochores	   by	   RZZ.	   A	   somewhat	   detailed	   explanation	   follows	   later	   in	   section	  
1.1.5.2.	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1.1.4.2 Error	  correction	  
On	  a	  conclusive	  note,	  I	  would	  like	  to	  address	  the	  issue	  of	  faulty	  attachments,	  i.e.,	  what	  happens	  if	  the	  
microtubule	   attachment	   is	   syntelic/merotelic?	   Or	   alternatively,	   how	   does	   the	   cell	   machinery	  
distinguish	  between	  tension	  (amphitelic/bi-­‐orientation)	  and	  attachment	  (syntelic/merotelic)?	  Reports	  
of	   increase	   in	   faulty	   attachments	  when	   Aurora	   B	   kinase	   activity	  was	   compromised	   led	   to	   its	   direct	  
implication	   in	   being	   involved	   with	   correction	   of	   attachment	   errors	   [64-­‐66].	   Supplementary	   studies	  
such	  as	   the	  decrease	   in	   the	  number	  of	   improper	  attachments	  once	   the	  kinase	  activity	   is	   restored	   in	  
Aurora	  B	   inhibited	  cells	  and	  similar	  characteristics	  of	   its	  yeast	  homologue,	   Ipl1,	   cemented	   its	   role	   in	  
error	  correction	   [66,	  67].	   Ipl1	   (the	  only	  Aurora	  kinase	   in	  yeast)	  has	  also	  been	  shown	   to	  activate	   the	  
spindle	   checkpoint	   by	   creating	   unattached	   kinetochores,	   thereby	   actually	   recognizing	   wrong	  
attachments	  and	  turning	  them	  in,	  to	  be	  properly	  attached	  [68].	  
The	  exact	  mechanism	  of	  Aurora	  B	  kinase	  action	  remains	  still	  obscure.	  One	  of	  the	  hypotheses,	  floating	  
for	  quite	  some	  time,	  is	  as	  follows:	  Aurora	  B	  interacts	  with	  Borealin,	  Survivin	  and	  INCENP	  to	  form	  what	  
is	   known	   as	   the	   chromosomal	   passenger	   complex	   (CPC)	   [69,	   70].	   CPC	   pervades	   the	   centromere	  
kinetochore	   interface	   primarily	   regulating	   activities	   of	   substrates	   by	   phosphorylation	   (Figure	   1.2).	  
When	  the	  kinetochores	  are	  in	  tension	  (bi-­‐oriented),	  they	  experience	  a	  force	  that	  tends	  to	  stretch	  apart	  
the	   sister	   chromatids	   and	   the	   kinetochore	   itself	   and	   the	   distance	   between	   CPC	   and	   its	   substrates	  
greatly	   increases	   [34,	   71].	  On	   the	  other	  hand	  when	  not	   in	   tension	   (syntelic,	  merotelic	   attachments)	  
this	  complex,	  via	  Aurora	  B,	  modulates	  the	  activity	  of	  the	  microtubule	  binding	  complexes	  (NDC80,	  KMN	  
network)	  reducing	  the	  affinity	  for	  interaction	  [72,	  73]	  (Figure	  1.8).	  Few	  aspects	  of	  this	  model,	  such	  as	  
the	  stretching	  of	  centromeric	  chromatin	  and	  the	  unquestionable	  importance	  of	  Aurora	  B,	  have	  been	  
envisioned.	   However,	   this	   model	   remains	   very	   minimalistic	   and	   its	   validity	   questionable.	   One,	   for	  
example,	   is	   if	   the	   Aurora	   B	   regulation	   is	   distance	   dependent	   then	   unattached	   kinetochores	   should	  
prolong	  to	  exist	  in	  the	  same	  state	  as	  the	  lack	  of	  tension	  facilitates	  Aurora	  B	  to	  be	  in	  the	  vicinity	  of	  its	  
substrates.	   Recent	   studies	   have	   also	   shown	   that	   Aurora	   B	   might	   function	   independent	   of	   CPC	   in	  




















Figure	   1.8:	   Error	   correction-­‐the	   hypothesis.	   Schematic	   representation	  of	   kinetochore-­‐centromere	   interface	   in	  
the	   presence	   and	   absence	   of	   tension.	   Tension	   is	   by	   definition	   a	   state	   when	   the	   kinetochores	   of	   the	   sister	  
chromatids	  bind	  to	  microtubules	  from	  opposite	  spindle	  poles.	  The	  figure	  on	  right	   is	  close	  up	  representation	  of	  
boxed	  area	   in	   the	   left.	  Some	  of	   the	  substrates	  at	   the	  kinetochore-­‐centromere	  are	  phosphorylated	  at	  all	   times	  
(marked	  by	  yellow	  circle	  with	  ‘P’).	  Other	  substrates	  are	  phosphorylated	  only	  in	  the	  absence	  of	  tension.	  When	  the	  
kinetochores	  are	  in	  tension,	  the	  substrates	  are	  beyond	  the	  distance	  constraints	  preventing	  any	  phosphorylation.	  
This	  model	  postulates	  that	  correct	  microtubule-­‐kinetochore	  depends	  on	  kinase	  activity	  of	  proteins	  (CPC)	  present	  
at	  the	  kinetochore-­‐centromere	  interface.	  Source:	  [74].	  
1.1.5 ROD	  –	  Zw10	  –	  Zwilch	  (RZZ)	  complex	  
‘…When	   you	   are	   dealt	   a	   bad	   hand	   of	   cards	   (in	   poker,	   for	   example),	   that's	   a	   rough	   deal.	   The	  
chromosomes	  in	  rough	  deal	  (rod)	  mutants	  were	  "unfairly"	  distributed	  to	  the	  daughter	  cells.	  The	  gene	  
also	   earned	   its	   name	   by	  making	   itself	   extremely	   difficult	   to	   clone	   (this	  was	   back	   in	   the	   days	   before	  
sequenced	  genomes,	  when	  you	  had	  to	  identify	  the	  DNA	  for	  your	  gene	  the	  old	  fashioned	  way).	  
Do	  you	  know	  why	  zw10	  is	  called	  zw10?	  A	  rather	  boring	  reason:	  Back	  in	  the	  1970s	  someone	  wanted	  to	  
estimate	  how	  many	  genes	  there	  are	  in	  the	  whole	  fly	  genome.	  So	  he	  tried	  to	  "saturate"	  a	  small	  interval	  
of	  the	  X	  chromosome	  (from	  Zeste	  to	  White)	  with	  mutations.	  He	  found	  13	  complementation	  groups.	  The	  
10th	  one	  was	  named	  ZW10.	  PS,	  from	  this	  he	  estimated	  there	  were	  about	  5000	  genes	  in	  the	  genome.	  
Unfortunately,	  he	  could	  only	  detect	  genes	  with	  phenotypes,	  of	  course,	  so	  he	  missed	  many	  genes…’	  	  
	  	  	  	  	  	  –	  Roger	  Karess,	  Personal	  Communication.	  
	  
Components	   of	   the	   RZZ	   complex	   were	   not	   all	   identified	   at	   once.	   The	   zw10	   gene	   was	   first	   to	   be	  
identified	  and	  its	  gene	  product,	  Zw10,	  is	  functionally	  most	  diverse	  of	  the	  lot.	  rod	  was	  discovered	  later	  
and	  the	  fact	  that	  proteins	  encoded	  by	  both	  these	  genes,	  form	  a	  stable	  complex	  was	  identified	  almost	  
20	  years	  after	   their	  discovery.	  This	  was	   the	  time	  when	  Zwilch	  was	  discovered	  and	   identified	  to	  be	  a	  
component	   of	   what	   has	   erstwhile	   been	   called	   as	   the	   RZZ	   complex.	   A	   timeline	   of	   events,	   from	   the	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discovery	   of	   Zw10	   as	   an	   essential	   checkpoint	   gene	   to	   the	   current	   knowledge	   of	   the	   complex,	   is	  
summarized	  in	  the	  table	  that	  follows.	  	  
	  
Table	  1.1:	  Timeline	  in	  the	  discovery	  and	  current	  understanding	  of	  the	  RZZ	  complex	  
1985	   Identification	   of	   l(1)Zw10	   as	   a	   gene	   which	   is	   essential	   for	   proper	   mitosis	   in	   Drosophila	  melanogaster	  [75].	  
1989	   Rough	  Deal	  (rod)	  identified	  as	  a	  gene	  required	  for	  proper	  mitotic	  segregation	  in	  Drosophila	  [76].	  
1992	   First	  reports	  of	  redistribution	  of	  the	  zw10	  gene	  product	  in	  Drosophila	  during	  mitosis	  [77].	  
1998	   Zw10	  implicated	  in	  the	  recruitment	  of	  dynein	  and	  dynactin	  to	  the	  kinetochores[78].	  
2000	   ROD	  and	  Zw10	  are	  checkpoint	  proteins	  binding	  to	  the	  kinetochore	  [79]	  
2001	   Zw10	  and	  ROD	  act	  together	  in	  a	  complex,	  which	  is	  evolutionarily	  conserved	  [80].	  
2003	   Zwilch,	  identified	  as	  a	  component	  of	  trimeric	  ROD-­‐Zw10-­‐Zwilch	  complex.	  First	  efforts	  to	  characterize	  the	  RZZ	  complex	  [81].	  
2004	   hZwint-­‐1	  recruits	  hZw10	  and	  hence	  RZZ	  to	  kinetochore	  [82].	  
2005	   Mad2	  is	  recruited	  to	  the	  kinetochores	  by	  the	  RZZ	  complex	  [83].	  
2010	   Structure	  of	  Zwilch	  (67	  kDa)	  solved	  by	  X-­‐ray	  crystallography.	  Also	  isolation	  of	  a	  sub-­‐complex	  of	  RZZ	  (ROD1-­‐350	  and	  Zwilch)	  [84].	  
2011	   Expression	   and	  purification	   of	   the	   RZZ	   complex	   from	   insect	   cells,	   using	   the	  MultiBac	   expression	  system,	  to	  near	  homogeneity	  (unpublished	  data)	  
2013	   First	   3D	   structure	   of	   the	   complex	   determined	   by	   single	   particle	   electron	   microscopy	   at	   13.4	   Å	  (unpublished	  data,	  current	  work)	  
2013	   The	  RZZ	  complex	   is	   implicated	   in	  binding	  and	   inhibiting	   the	  Ndc80	  complex.	  A	  novel	   function	  of	  RZZ	  [85]	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1.1.5.1 ROD	  (rough	  deal)	  
rod	   (rough	   deal)	   gene	  was	   identified	   in	   1989	   in	   an	   independent	   screen	   for	   selection	   of	  mutants	   in	  
Drosophila	  melanogaster	  that	   live	  as	   larvae	  and	  die	  as	  pupae	  in	  an	  attempt	  to	  discover	  mutations	  in	  
genes	  which	  encode	  mitotic	  functions	  [76].	  The	  morphology	  of	  phenotypes,	  which	  survive	  the	  pupae	  
stage	   included	   defects	   in	   eyes,	   wings	   and	   severe	   defects	   in	   the	   cuticle.	   The	   cells	   which	   survive	  
mutations	   in	   rod	   gene	  have	  abnormal	  anaphases	  and	  display	  chromosome	   instability	   in	  most	  of	   the	  
dividing	  tissues	  [76].	  	  
ROD,	   like	  all	   classical	  metaphase	  checkpoint	  components,	   is	   recruited	  and	   localizes	   to	   the	  corona	  of	  
unattached	   kinetochores	   during	   metaphase	   in	   all	   cell	   types	   [79].	   Once	   all	   the	   checkpoints	   are	  
quenched,	  ROD	  is	  redistributed	  along	  the	  microtubules;	  a	  process	  called	  shedding	  that	  is	  mediated	  by	  
dynein	  [86].	  The	  departure	  of	  ROD	  from	  the	  kinetochores,	  though	  in	  anaphase,	  varies	  across	  species.	  
Studies	  in	  Drosophila	  embryos	  elegantly	  show	  that	  ROD	  is	  continuously	  recruited	  from	  the	  cytoplasmic	  
pool	  with	  the	  half-­‐life	  of	  ROD	  at	  the	  kinetochores	  being	  25-­‐45	  s	  [87].	  
The	   ROD	   protein	   is	   the	   largest	   component	   of	   the	   RZZ	   complex	   (240kDa)	   and	   its	   structural	  
characterization	   is	  minimal,	   owing	   to	   its	   obstinacy	   towards	  purification.	   The	  domain	   architecture	  of	  




Figure	  1.9:	  Domain	  organization	  of	  ROD.	  ROD	  is	  the	  largest	  component	  of	  the	  RZZ	  complex	  with	  a	  size	  of	  240	  
kDa.	  ROD	  like	  NAG	  and	  TBL3	  contains	  an	  N-­‐terminal	  β-­‐propeller	  domain	  followed	  by	  an	  NRH	  region.	  Both	  ROD	  
and	   NAG	   are	   predicted	   to	   have	   α-­‐helical	   stack	   repeats	   (α-­‐solenoid),	   which	   extend	   to	   the	   C-­‐terminus	   of	   the	  
protein.	  They	  also	  contain	  a	  Sec39	  domain,	  which	   is	  characteristic	  of	  COPII	  vesicles,	   implicated	   in	   transport	  of	  
substrates.	   A	   distant	   homology	   search	   reveals	   TBL3	   as	   the	   third	   family	   member	   (probability	   of	   homology	  
relationship	  with	  ROD	  is	  95%),	  which	  however	  lacks	  the	  Sec39	  domain.	  	  
	  
This	   is	  based	  purely	  on	  structure	  prediction	  algorithms	   [84].	   It	   is	  predicted	  to	  have	  an	  N-­‐terminal	  β-­‐
propeller	   domain,	   with	   putative	   WD40	   β-­‐propellers	   that	   could	   possibly	   mediate	   a	   variety	   of	  
interactions.	   The	   rest	   of	   the	   protein	   is	   predicted	   to	   have	   a	   secondary	   structure	   that	   is	   primarily	   α-­‐
helical	  with	  a	  region	  of	  sequence	  homology	  to	  Sec39p.	  ROD	  is	  predicted	  to	  be	  structurally	  similar	  to	  
NAG	  (neuroblastoma-­‐amplified	  gene),	  a	  protein	  that	  interacts	  with	  Zw10	  in	  an	  independent	  manner	  to	  
form	   a	   complex	   together	  with	   RINT-­‐1	   called	   the	  NRZ	   complex,	  which	   plays	   role	   in	  Golgi	   retrograde	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trafficking	   (homologous	   to	   the	   yeast	   Dsl1	   complex).	   It	   is	   not	   surprising	   that	   the	   two	   Zw10	   binding	  
proteins	  ROD	  and	  NAG	  are	  predicted	  to	  be	  structurally	  similar.	  These	  proteins	  have	  a	  conserved	  region	  
(novel)	   called	   the	  NAG-­‐ROD	  homology	  domain	   (NRH).	  This	  domain	  has	  been	   identified	  also	   in	  other	  
proteins	  like	  TBL3	  (transducing	  beta	  like-­‐3)	  [84].	  
1.1.5.2 	  Zw10	  
Zw10	  is	  functionally	  the	  most	  versatile	  protein	  of	  all	  the	  components	  that	  make	  up	  the	  RZZ	  complex.	  
Most	  of	  the	  interactions	  mediated	  by	  the	  RZZ	  complex	  were	  discovered	  and	  originally	  identified	  with	  
Zw10	   [78,	   88-­‐90].	   The	   gene	   zw10	  was	   consequence	   of	   a	   screen,	   designed	   to	   detect	   errors	   in	   the	  
transmission	  of	  mitotic	  chromosomes	  in	  Drosophila	  [75].	  Integrity	  of	  Zw10	  (gene	  product	  of	  zw10)	  was	  
soon	   implicated	   for	   accurate	   chromosome	   segregation	   [77]	   and	   was	   found	   conserved	   across	   all	  
eukaryotes	  (the	  only	  protein	  of	  RZZ	  complex	  found	  in	  lower	  eukaryotes)	  [91].	  The	  localization	  of	  Zw10	  
parallels	   the	   pattern	   of	   ROD	   (as	   described	   in	   section	   above	   also	   in	   the	   section	   dealing	   with	   RZZ	  
dynamics)	  [92].	  Zw10	  is	  recruited	  to	  the	  kinetochore	  by	  Zwint-­‐1	  [82],	  which	  is	  an	  integral	  part	  of	  Knl1	  
complex	  and	  therefore	  of	  the	  flagship	  KMN	  network.	  In	  essence,	  Zw10	  links	  the	  checkpoint	  signaling	  
(as	   a	   member	   of	   RZZ	   necessary	   for	   the	   SAC)	   to	   the	   structural	   chassis	   (the	   KMN	   network)	   of	   the	  
kinetochore	  [89].	  
In	  mammals	   and	   in	   yeast,	   Zw10	   (and	   its	   homologues)	   forms	   a	   second	   complex	   together	  with	   NAG	  
(Sec39p	  in	  yeast)	  and	  RINT1	  (Tip20p	  in	  yeast)	  called	  the	  NRZ	  complex,	  which	  is	  enriched	  in	  Golgi	  and	  
ER	   compartments	   of	   the	   cell	   and	   interacts	   with	   the	   ER	   membrane	   SNARE	   proteins	   [93,	   94].	   In	  
Drosophila,	  loss	  of	  Zw10	  leads	  to	  Golgi	  fragmentation	  and	  loss	  of	  Golgi	  stack	  integrity	  [95]	  hinting	  at	  its	  
possible	   role	   in	   ER-­‐Golgi	   trafficking.	  Whether	  Drosophila	   Zw10	  mediates	   anterograde	   or	   retrograde	  
trafficking	  between	  ER	  and	  Golgi	   remains	  yet	   to	  be	  answered.	  Consistent	  with	   its	   role	   in	  membrane	  
trafficking,	  depletion	  of	  Zw10	   leads	  to	  premature	  halting	  of	   furrow	   ingression	  and	  thereby	  failure	  of	  
cytokinesis	   in	  Drosophila	  spermatocytes[95].	  One	  may	  be	  convinced	  that	  the	  failure	  of	  cytokinesis	   in	  
Drosophila	   spermatocytes	   is	   just	   a	   reflection	   of	   lack	   of	   dynein/dynactin	   in	   Zw10	   depleted	   cells.	  
However	  studies	  suggest	  this	  is	  not	  the	  case	  [95].	  
Structural	  information	  from	  the	  yeast	  homologue	  of	  Zw10,	  Dsl1p	  is	  available	  [96,	  97].	  Crystal	  structure	  
of	  N-­‐terminus	  of	  Dsl1p	  (37-­‐355)	  was	  determined	  in	  complex	  with	  Tip20p	  (RINI1	  homologue	  in	  yeast)	  
[98]	   and	   the	   C-­‐terminus	   (333-­‐684)	   in	   complex	   with	   Sec39p	   (NAG	   homologue	   in	   yeast.	   ROD	   also	  
contains	  the	  sec39	  repeat,	  refer	  to	  Figure	  1.9)	  [96].	  
1.1.5.3 Zwilch	  
The	   interdependencies	   of	   ROD	   and	   Zw10	   proteins	   on	   each	   other	   for	   kinetochore	   localization,	   the	  
similarities	   in	   their	  mutant	  phenotypes	  and	  their	   function	   in	  dynein	  transport	   led	  to	   the	  speculation	  
that	  they	  form	  a	  complex.	  This	  was	  confirmed	  shortly	  after,	  where	  these	  proteins	  were	  shown	  to	  form	  
a	   stable	   complex	   [80].	  By	   this	   time	  at	   the	  beginning	  of	   last	  decade,	   it	  was	  also	  established	   that	   the	  
proteins	   ROD	   and	   Zw10	   do	   not	   effect	   the	   kinetochore	   localization	   of	   other	   spindle	   assembly	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checkpoint	   (SAC)	   proteins	   such	   as	  Mad1,	   hBUBR1	   and	   hBUB1,	   although	   dynein,	   which	   is	   known	   to	  




Figure	  1.10:	  Structure	  of	  Zwilch.	  (a)	  Cartoon	  model	  of	  Zwilch.	  Zwilch	  is	  the	  smallest	  sub-­‐unit	  of	  the	  RZZ	  complex,	  
with	   the	   size	   of	   67	   kDa.	   It	   is	   known	   to	   interact	   with	   N-­‐terminus	   of	   ROD.	   The	   structure	   of	   Zwilch	   is	   not	   a	  
representation	  of	  the	  full-­‐length	  protein,	  but	  a	  protein	  from	  a	  construct	  that	  contained	  two	  interacting	  segments	  
of	   it	  (residues	  1-­‐334	  and	  335-­‐591).	  However	   in	  the	  representation	  here	  the	  structure	  is	  highlighted	  as	   if	   it	  was	  
continuous	  with	   the	  N-­‐terminus	   being	   represented	   in	   blue	   to	   the	   C-­‐terminus	   represented	   in	   red.	   (b)	   Cartoon	  
model	  after	  180°	  rotation	  relative	  to	  (a).	  The	  protein	  can	  be	  thought	  of	  having	  two	  different	  domains.	  The	  one	  in	  
orange	  contains	  mostly	  β-­‐sheets	  (domain	  1)	  and	  the	  one	  represented	  in	  blue	  (domain	  2)	  is	  α-­‐helical.	  (c)	  Topology	  
map	  of	  Zwilch.	  Source:	  [84]	  
	  
The	  complexity	  and	  the	  numerous	  functional	  characteristics	  of	  the	  ROD/Zw10	  protein	  complex	  led	  to	  
the	  wild	  speculation	  that	  these	  may	  be	  part	  of	  a	   larger	  complex,	  with	  yet	  unidentified	  proteins.	  This	  
hypothesis	   was	   further	   fuelled	   with	   the	   observation	   that	   Drosophila	   embryo	   extracts,	   when	  
fractionated	   by	   size	   exclusion	   chromatography	   and	   probed	   with	   antibodies	   against	   DmZw10	  
(Drosophila	   Zw10)	   and	   DmROD	   (Drosophila	   ROD),	   led	   to	   the	   observation	   that	   both	   these	   proteins	  
were	  found	  in	  fractions	  corresponding	  to	  molecular	  weight	  of	  700-­‐900	  kDa	  [80].	  Upon	  the	  use	  of	  anti-­‐
Zw10	  antibody	   immobilized	  column	  to	  purify	  the	  complex	  from	  Drosophila	  embryo	  extracts	  an	  extra	  
protein	  band	  was	  observed.	  This	  newly	   identified	  protein	  was	  attributed	  as	  a	  product	  of	  CG18729,	  a	  
gene	  predicted	   by	   Berkeley	  Drosophila	   project	  with	   a	  molecular	  weight	   of	   75	   kDa	   (the	   protein	  was	  
named	  Zwilch	  because	  of	   a	   very	   trivial	   reason:	   the	  authors	  undertaking	   the	   study	  when	  performing	  
initial	   database	  queries	   to	   identify	   related	  proteins,	   ended	  up	  with	  no	   results	   as	   in	   ‘zilch’)	   [81].	   The	  
human	  Zwilch	  protein	  (hZwilch	  or	  Zwilch)	  has	  a	  molecular	  weight	  of	  67	  kDa.	  Subsequently,	  Zwilch	  was	  
shown	   to	   localize	   at	   the	   outer	   kinetochore	   at	   prometaphase,	   kinetochore-­‐microtubules	   during	  
metaphase	  and	  again	  on	  kinetochores	   in	   the	  anaphase.	  This	   trend	  which	   is	  also	  observed	  with	  ROD	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and	   Zw10	   proteins	   and	   their	   co-­‐localization	   at	   all	   times	   during	   metaphase-­‐anaphase	   transition	  
cemented	  the	  fact	  that	  ROD,	  ZW10	  and	  Zwilch	  are	  part	  of	  the	  same	  complex	  [81].	  	  
Zwilch	  remains	  the	  only	  protein	  of	  known	  structure	  that	  belongs	  to	  the	  RZZ	  complex.	  There	  has	  been	  
absolutely	  no	  study	  whatsoever	  in	  relation	  to	  the	  structure	  of	  domains/proteins	  or	  the	  full	  length	  RZZ	  
complex.	  The	  structure	  of	  Zwilch	  was	  solved	  by	  X-­‐ray	  crystallography	  (at	  2.55	  Å,	  P3221	  space	  group)	  
[84].	  The	  protein	  can	  be	  thought	  of	  consisting	  of	   two	  domains	  as	  observed	  from	  the	  X-­‐ray	  structure	  
and	   are	   depicted	   in	  Figure	   1.10.	   Domain	   1	   has	   no	   sites	   of	   strong	   conservation,	  where	   as	   there	   are	  
conserved	  regions	  in	  Domain	  2,	  which	  might	  act	  as	  receptors	  or	  binding	  sites	  for	  other	  proteins.	  
1.1.5.4 Recruitment	  of	  RZZ	  to	  the	  kinetochores	  
Before	  moving	  on	  to	  understand	  the	  relevance	  of	  RZZ	  in	  cell	  division,	  an	  imminent	  question	  remains	  to	  
be	  answered.	  What	  protein/protein	  complexes	  recruit	  the	  RZZ	  complex	  to,	  its	  locus,	  the	  corona	  of	  the	  
kinetochore?	  	  
The	  recruitment	  of	  various	  proteins	  and	  especially	  the	  checkpoint	  proteins	  are	  highly	  interdependent.	  
Following	  this	   line	  of	   thought	  one	  would	  expect	  RZZ	   localization	  to	  the	  kinetochore	  follow	  the	  same	  
trend.	   However,	   it	   was	   shown	   that	   recruitment	   of	   RZZ	   is	   independent	   of	   Bub3,	   BubR1	   [99],	   Mps1	  
[100],	   Cenp-­‐F	   [82]	   or	  Mad2	   [83].	   Yeast	   two-­‐hybrid	   assays	   revealed	   a	   protein,	   later	   named,	   Zwint-­‐1	  
(Zw10	   interacting	  protein)	  while	  screening	   for	  binding	  partners	  of	  Zw10	  [88].	  Zwint-­‐1	   (or	  simply	   just	  
Zwint),	  a	  43	  kDa	  protein	  and	  a	  component	  of	  KMN	  network,	  localizes	  to	  the	  kinetochore	  prior	  to	  Zw10	  
in	  prophase	  and	  remains	  at	  the	  kinetochore	  till	  the	  onset	  of	  anaphase	  [91].	  Biochemical	  experiments	  
revealed	  that	  Zwint-­‐1	  harbors	  a	  Zw10	  binding	  region	  in	  the	  first	  80	  amino	  acids	  of	  its	  N-­‐terminus	  [82].	  
Localization	   experiments	   also	   show	   Zwint-­‐1	   and	   Zw10	   co-­‐localize	   during	   metaphase	   making	   it	   a	  
possible	   candidate	   for	   recruiting	  RZZ.	  Cells	   depleted	  of	   Zwint-­‐1	   (siRNA	   treatment)	   show	  a	   complete	  
loss	  of	  Zw10	  (and	  hence	  RZZ)	  from	  the	  kinetochores	  hinting	  at	  the	  necessity	  of	  Zwint-­‐1	  for	  engaging	  
RZZ	  at	  the	  kinetochores	  [101].	  The	  converse	  is	  not	  true.	  Cells	  depleted	  of	  Zwint-­‐1	  also	  exit	  mitosis	  in	  
presence	   of	  microtubule	   inhibitors	   and	   display	   characteristics	   such	   as	   entangled	   chromosomes,	   un-­‐
separated	  sister	  chromosomes	  and	  aneuploidy	  phenotypes	  similar	   to	  cells	  which	   lack	  RZZ,	   indicating	  
that	  RZZ	  cannot	  function	  if	  it	  is	  not	  recruited	  [82].	  Zwint-­‐1	  is	  also	  part	  of	  the	  KNL-­‐1	  complex	  and	  hence	  
the	  KMN	  network,	  and	  is	  recruited	  to	  the	  kinetochore	  by	  Knl1	  (Figure	  1.4)	  [18].	  
These	  results	  identify	  Zwint-­‐1	  as	  necessary	  and	  sufficient	  for	  kinetochore	  targeting	  and	  localization	  of	  
Zw10	  and	  thereby,	  the	  RZZ	  complex.	  Why	  and	  how	  Zwint-­‐1	  gets	  the	  signal	  to	  recruit	  RZZ	  remains	  yet	  
to	  be	  answered.	  	  
1.1.5.5 Localization	  dynamics	  of	  the	  RZZ	  complex:	  
ROD,	  ZW10	  and	  Zwilch	  form	  a	  stable	  complex	  at	  the	  corona	  (Figure	  1.2)	  of	  the	  kinetochore	  called	  the	  
RZZ	   complex.	   Depletion	   of	   any	   of	   the	   components	   leads	   to	   loss	   of	   functional	   complex	   [81].	   The	  
characteristics	   of	   their	   association	   prior	   to	   their	   localization	   are	   unknown.	   All	   three	   proteins	   are	  
cytoplasmic	   during	   interphase	   [77,	   87].	   At	   the	   onset	   of	   prophase,	   when	   the	   nuclear	   envelope	  
breakdown	   is	   triggered,	   they	   start	   accumulating	   at	   the	   kinetochore	   [90].	   Like	   all	   other	   checkpoint	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proteins,	   the	   amount	   of	   RZZ	   at	   the	   kinetochore	   starts	   decimating	   as	   the	   cell	   prepares	   its	   transition	  
from	   metaphase	   to	   anaphase.	   In	   other	   words,	   once	   the	   kinetochore	   microtubules	   have	   attached,	  
migration	  of	  RZZ	  along	  the	  microtubules	  towards	  the	  poles	  is	  observed,	  predominantly	  bound	  to	  the	  
kinetochores	  of	  the	  migrating	  sister	  chromatids	  [77,	  80].	  Also,	  once	  the	  kinetochores	  are	  engaged	  in	  
favorable	   interactions	   with	   microtubules,	   RZZ	   is	   ushered	   away	   from	   the	   kinetochores	   along	   the	  
microtubules	   in	   a	   dynein	   dependent	  manner,	   a	   process	   referred	   to	   as	   ‘shedding’	   [42,	   86].	   Once	   in	  
anaphase,	  the	  spatial	  and	  temporal	  localization	  dynamics	  of	  ROD	  and	  Zw10	  is	  not	  coherent	  and	  varies	  
for	  different	  species;	  for	  example,	  in	  HeLa	  cells	  ROD	  departs	  from	  the	  kinetochores	  in	  early	  anaphase	  
where	   as	   Zw10	   in	   late	   anaphase	   [79].	   Recent	   localization	   studies	   on	   RZZ	   also	   reveal	   that	   there	   is	   a	  
continuous	   flux	   of	  material	   being	   recruited	   from	   the	   cytoplasmic	   stock	   and	   other	   being	   shed	   along	  
kinetochore-­‐microtubules,	   mediated	   by	   dynein	   [87].	   In	   essence,	   the	   RZZ	   complex	   is	   a	   short-­‐lived	  
complex	   localizing	   transiently	   to	   the	   kinetochore,	   the	   fate	   of	   its	   components	   and	   their	   association	  
before	  prometaphase	  and	  beyond	  anaphase	  remains	  poorly	  understood.	  
1.1.6 Functions	  of	  the	  RZZ	  complex	  
1.1.6.1 Recruitment	  of	  dynein	  	  
The	  necessity	   for	  motor	  proteins	  at	  kinetochores	  can	  be	   justified	  with	  a	   simple	  argument	   that	  once	  
the	  microtubules	  are	  attached,	  satiating	  all	  the	  requirements,	  the	  sister	  chromatids	  need	  to	  be	  driven	  
polewards	  [102].	  Three	  such	  well-­‐characterized	  motor	  proteins	  localizing	  to	  mammalian	  chromosomes	  
are	  dynein	  [103-­‐105],	  Cenp-­‐E	  and	  Kinesin-­‐1	  [17].	  Cytoplasmic	  dynein	  (minus	  end	  directed	  microtubule	  
motor)	  is	  implicated	  in	  a	  multitude	  of	  cellular	  processes	  and	  its	  importance	  is	  unquestionable,	  mainly	  
due	   to	   its	   role	   in	   transporting	   cargo	   (proteins,	   vesicles,	   mRNA)	   along	   microtubules.	   Loss	   of	   the	  
cytoplasmic	   dynein	   from	   cells	   leads	   to	   severe	   defects,	   ones	   implicated	   in	   cell	   division	   are:	   severe	  
retardation	   in	   anaphase	   migration	   of	   the	   sister	   chromatids	   [106],	   accumulation	   of	   proteins	   which	  
require	  dynein	  for	  removal	  from	  kinetochore	  and	  hence	  a	  delayed	  metaphase	  [42,	  86]	  and	  defects	  in	  
spindle	  positioning	  [107].	  	  






Figure	   1.11:	   Organization	   of	  
dynein,	   dynactin	   and	   their	  
interaction	  with	   an	   organelle.	   (a)	  
Cytoplasmic	   dynein	   is	   found	   in	   all	  
animal	   cells	   and	   is	   indispensible	  
for	   many	   cellular	   functions	  
including	   organelle	   transport.	   The	  
molecular	   mass	   of	   dynein	   is	  
1.5MDa	   and	   contains	  
approximately	   12	   polypeptide	  
units.	   It	   is	   made	   up	   of	   two	  
identical	   heavy	   chains	   (DHC)	  
responsible	   for	   ATPase	   activity,	  
two	   intermediate	   chains	   (DIC)	  
which	  help	   in	  anchoring	  dynein	  to	  
its	   cargo,	   and	   several	   other	   light	  
(DLC)	   and	   light	   intermediate	  
chains	   (DLIC).	   Architecturally,	   it	  
can	  be	  divided	  into	  stalk,	  head	  and	  
stem	   regions.	   (b)	   Dynactin	  
organization.	   p150	   is	   generally	  
referred	   to	   as	   dynamitin.	   (c)	  
Model	   for	   interaction	   of	  
dynein/dynactin	   with	   a	   cellular	  
structure.	   For	   simplicity,	   only	   few	  
sub-­‐units	  are	  shown.	  Source:[108]	  	  
	  
The	  connection	  between	  Zw10	  and	  dynein	  was	  established	  while	  understanding	  the	  effects	  of	  Zw10	  
mutations,	  where	   loss	  of	  Zw10	   resulted	   in	  plummeting	   the	   levels	  of	  dynein	  at	   the	  kinetochore	   [78].	  
Observing	   fluorescently	   tagged	   dynein	   heavy	   chain	   (DHC,	   refer	   to	   Figure	   1.11)	   in	   absence	   of	   Zw10	  
mutants	   revealed	   DHC	   co-­‐localization	  with	   Zw10	   in	   prometaphase	   and	   its	   loss	   from	   kinetochore	   in	  
cells	   with	   mutations	   in	   Zw10	   [78].	   Yeast	   two-­‐hybrid	   assays	   led	   to	   identification	   of	   dynamitin	   (p50	  
component	  of	  dynactin,	  refer	  to	  Figure	  1.11	  for	  architecture)	  as	  Zw10	  interacting	  protein.	  Studies	  also	  
showed	  that	  DHC	  and	  dynamitin	  co-­‐localize	  with	  Zw10	  at	  the	  kinetochore	  [78]	  leading	  to	  a	  prominent	  
discovery	   that	   RZZ	   is	   very	   important	   for	   recruiting	   dynein	   to	   the	   kinetochores.	  Mutations	   in	   rod	  or	  
zwilch	  also	  abolish	  the	  recruitment	  of	  dynein	  supporting	  the	  above	  hypothesis	  [81].	  To	  sum	  it	  up,	  the	  
Zw10/RZZ	   complex	   recruits	   dynein	   to	   the	   kinetochore,	   which	   is	   essential	   for	   removal	   of	   variety	   of	  
proteins	  once	  the	  SAC	  is	  off	  including	  the	  components	  of	  RZZ	  [42,	  86].	  
1.1.6.2 Transport	  of	  Mad2:	  to	  and	  off	  the	  kinetochore	  
Co-­‐localization	  experiments	  targeting	  different	  SAC	  proteins	  led	  to	  the	  revelation	  that	  ROD	  and	  Mad2	  
show	  near	  perfect	  overlap	  of	  fluorescent	  signal	  in	  prometaphase	  not	  only	  at	  the	  kinetochores	  but	  also	  
along	  the	  kinetochore-­‐microtubule	  axis	  at	  the	  onset	  of	  anaphase	  [83].	  This	  behavior	  is	  different	  from	  
BubR1	   and	   other	   SAC	   components	   in	  many	  ways	   viz.	   BubR1	   remains	   associated	   throughout	   at	   the	  
kinetochores	  and	  localizes	  slightly	  more	  internally	  at	  the	  kinetochore	  than	  ROD	  [83].	  Mad2	  is	  depleted	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considerably	   at	   the	   kinetochore	   in	   rod	   or	   zw10	   depleted	   cells	   [83,	   89].	   Mad2	   is	   removed	   from	  
attached	   kinetochores	   transitioning	   into	   anaphase	   by	   the	   dynein-­‐dynactin	   complex,	   which	   as	  
mentioned	  above	  (1.1.6.1)	   is	  dependent	  on	  RZZ	  for	   its	  kinetochore	   localization	  [42].	  Taken	  together,	  
these	   facts	   hint	   at	   strong	   dependence	   and	   association	   of	  Mad1-­‐Mad2	   on	   RZZ	   during	   its	   lifespan	   at	  
kinetochores.	   The	  nature	  of	   this	   association	   remains	  mysterious	   and	  needs	   to	  be	  understood.	   Two-­‐
hybrid	  screens,	  immunoaffinity	  columns	  and	  co-­‐immunoprecipitation	  experiments	  have	  not	  shed	  any	  
light	   on	   this	   interaction	   [78,	   81].	   Mad1/Mad2	   association	   with	   the	   RZZ	   complex	   is	   an	   important	  
biochemical	   process,	   failing	   which	   the	   cell	   is	   left	   with	   dire	   consequences	   to	   face.	   Decoding	   this	  
association	  remains	  essential,	  and	  this	  may	  involve	  proteins/complexes	  hitherto	  unknown.	  
1.1.6.3 Role	  in	  formation	  of	  stable	  end-­‐on	  coupled	  attachments	  
Following	   the	   discovery,	   which	   implicated	   RZZ	   in	   recruiting	   cytoplasmic	   dynein/dynactin	   to	   the	  
kinetochore,	  a	  new	  protein	  named	  spindly	  was	  identified	  in	  Drosophila	  [109].	  Spindly	  acts	  downstream	  
of	  the	  RZZ	  complex	  and	  is	  required	  for	  targeting	  dynein,	  but	  not	  dynactin	  to	  the	  kinetochores.	  Using	  a	  
carefully	  manipulated	   early	  C.	   elegans	  embryo	   system	   it	  was	   identified	   that	   although	  both	  RZZ	   and	  
spindly	  are	   required	   for	  accurate	  chromosome	  segregation,	  although	  deletion	  of	  spindly	  has	  a	  more	  
drastic	  effect	  [110].	  
Chromosome	  movement	   depends	   primarily	   on	   the	   binding	   of	  microtubules	   to	   the	   NDC80	   complex	  
forming	   a	   load	   bearing	   attachment.	   Loss	   of	   NDC80	   complex	   does	   not	   exhibit	   a	   ‘kinetochore-­‐null’	  
phenotype	  as	   residual	   chromosome	  movements	  are	  observed	   [25]	  with	  dynein/dynactin	  being	   their	  
source	  [29,	  111].	  Loss	  of	  RZZ,	  leads	  to	  loss	  of	  checkpoint	  but	  the	  formation	  of	  load	  bearing	  attachment	  
occurs	  but	  at	  a	  slower	  rate.	  Loss	  of	  both	  RZZ	  and	  spindly,	  however,	  leads	  to	  the	  formation	  of	  the	  load	  
bearing	   attachment	   at	   an	   enhanced	   rate.	   The	   most	   important	   discovery	   came	   along	   very	   recently	  




Figure	   1.12:	   RZZ	  mediated	   inhibition	  of	  NDC80.	  The	  model	  highlights	  how	  microtubule	   is	  captured	  by	  dynein	  
and	   then	   transferred	   to	   the	   NDC80	   complex	   to	   form	   a	   stable	   end	   on	   attachment.	  Microtubules	   are	   laterally	  
captured	  by	   dynein	   (left,	   lateral	   state)	   and	   in	   this	   state,	   RZZ	   inhibits	  NDC80	  by	   binding	   to	   the	   ‘tail’	   of	  NDC80	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complex.	   Given	   the	   short	   half-­‐life	   of	   the	   microtubules,	   de-­‐polymerization	   events	   lead	   to	   shortening	   of	  
microtubules	   until	   the	   point	   where	   dynein	   remains	   bound	   which	   prevents	   further	   de-­‐polymerization.	   This	  
represents	   the	   intermediate	   state,	  where	   dynein	   remains	   bound	   at	   the	   end.	   This	  model	   postulates	   that	   end-­‐
coupled	  force	  helps	  in	  orienting	  the	  chromosome	  and	  at	  this	  point,	  due	  to	  events	  yet	  unknown,	  NDC80	  complex	  
is	  alleviated	  from	  inhibition	  by	  RZZ.	  The	  model	  further	  postulates	  that	  the	  alleviation	  of	  RZZ	  mediated	  inhibition	  
only	  occurs	  under	  conditions	  when	  ‘merotely’	  is	  minimal.	  
	  
Currently,	  the	  state	  of	  understanding	  of	  this	  complex	  problem	  can	  be	  summarized	  in	  the	  figure	  above	  
(Figure	   1.12)	   [85].	   Kinetochore	   dynein	   (minus	   end	   directed	   motor,	   depicted	   in	   light	   blue)	   laterally	  
captures	   a	   microtubule	   (left)	   and	   in	   this	   scenario	   Ndc80	   remains	   inhibited	   by	   RZZ	   in	   a	   Aurora	   B	  
independent	  manner	  [85].	  Since	  the	  half-­‐life	  of	  microtubules	  is	  short,	  it	  starts	  depolymerizing	  from	  the	  
‘plus’	  end	  and	  at	  a	  certain	  stage	  reaches	  the	  kinetochore	  where	  it	  is	  stabilized	  by	  dynein	  (intermediate	  
stage,	  center	  in	  Figure	  1.12).	  Following	  this,	  loss	  of	  the	  RZZ	  complex	  (due	  to	  yet	  unidentified	  reasons;	  
conformational	  change,	  binding	  of	  other	  proteins?)	  releases	  NDC80	  complex,	  which	  can	  then	  bind	  to	  
the	  microtubule	   in	   an	   end-­‐coupled	  manner	   forming	   stable	   kinetochore-­‐microtubule	   interactions.	   In	  
essence,	  RZZ	  remains	  associated	  and	  inhibits	  NDC80	  complex	  till	   it	   is	  liberated	  from	  the	  kinetochore,	  
so	  that	  proper	  kinetochore-­‐microtubule	  attachments	  can	  occur.	  The	  signaling	  cascade	  still	  remains	  to	  
be	  deciphered.	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1.2 	  Neuronal	  ceroid	  lipofuscinoses	  
The	  neuronal	  ceroid-­‐lipofuscinoses	  (NCLs)	  are	  genetically	  inherited	  neurodegenerative	  diseases.	  These	  
diseases	  are	  characterized	  at	   the	  cellular	   level	  by	  accumulation	  of	  auto-­‐fluorescent	  storage	  material	  
(ceroid	  and	  lipofuscin)	  in	  the	  lysosome	  of	  neurons	  and	  other	  cell	  types.	  Clinically,	  these	  disorders	  are	  
characterized	   by	   seizures,	   progressive	   deterioration	   of	   cognition	   (dementia),	   loss	   of	   vision	   and	  
impairment	   of	   motor	   function	   (ataxia,	   spasticity)	   [112].	   NCLs	   have	   been	   classified	   traditionally	  
depending	  on	  the	  age	  of	  onset	  and	  ultrastructure	  of	  the	  storage	  material	  [113].	  Broadly	  these	  diseases	  
can	  be	  divided	   into	   classes	   such	   as	   congenital,	   infantile	   (INCL),	   late	   infantile	   (LINCL),	   juvenile	   (JNCL)	  
and	   adult	   (ANCL).	   The	  molecular	   basis	   and	   genes	   responsible	   for	   various	  NCLs	  have	  been	   identified	  
and	  are	  listed	  in	  Table	  1.2.	  NCLs	  are	  not	  an	  outcome	  of	  a	  particular	  subset	  of	  proteins.	  For	  example,	  
the	   first	   two	  types	  of	  NCLs	   listed	   in	   the	   table	  are	  caused	  due	  to	  mutations	  or	  defects	   in	   the	  soluble	  
protein	  PPT1	  (palmitoyl-­‐protein	  thioesterase	  1)	  whereas	  JNCL	  occurs	  due	  to	  defects	  in	  the	  membrane	  
protein	  Cln3p,	  the	  function	  of	  which	  is	  unknown	  [113].	  
	  
Table	  1.2	  NCLs	  (I,	  infantile;	  LI,	  late	  infantile;	  J,	  juvenile;	  A,	  adults;	  C,	  congenital)	  
Name	   Age	  of	  onset	   Gene	  
INCL,	  Santavuori-­‐Haltia	  disease,	  CLN1	   6-­‐24	  months	   CLN1/PPT1	  on	  1p32	  
LINCL,	  Jansky-­‐Bielchowsky	  disease,	  CLN2	   2-­‐4	  years	   CLN2/TPP2	  on	  11p15.5	  
JNCL,	  Batten	  disease	   4-­‐10	  years	   CLN3	  on	  16p12.1	  
LINCL,	  CLN5	   4-­‐7	  years	   CLN5	  on	  13q21.1-­‐q32	  
LINCL,	  CLN6	   1.5–8	  years	   CLN6	  on	  15q21-­‐q23	  
INCL,	  CLN7	   	   MFSD8	  on	  4q28.1-­‐q28.2	  
LINCL,	  CLN8	   3-­‐7.5	  years	   CLN8	  on	  8pter-­‐8p22	  
ANCL,	  Kufs	  disease,	  both	  autosomal	  dominant	  
and	  recessive	  versions	  
15-­‐50	  years	   Additive	  effect	  of	  mutations	  
on	  all	  of	  the	  above	  
CNCL,	  CLN10	   On	  or	  before	  birth	   CTSD	  on	  11p15.5	  
1.2.1 Juvenile	  neuronal	  ceroid-­‐lipofuscinosis	  
Juvenile	   neuronal	   ceroid-­‐lipofuscinosis	   (JNCL),	   alternatively	   known	   as	   Batten	   disease	   or	   Spielmeyer-­‐
Vogt-­‐Sjogren	   disease	   is	   the	  most	   common	   of	   all	   the	   neuronal	   ceroid-­‐lipofuscinoses	   known.	   Clinical	  
features	  including	  loss	  of	  vision,	  myoclonic	  seizures,	  loss	  of	  cognitive	  function	  and	  motor	  dysfunction	  
characterize	   the	   disease.	   Distinguishable	   pathological	   features,	   characteristic	   of	   this	  
neurodegenerative	  disorder	   constellation,	   are	  progressive	  neuronal	   loss	   along	  with	   accumulation	  of	  
auto-­‐fluorescent	  storage	  material	   (like	   lipofuscin)	   in	   the	  cytoplasm	  of	  neurons	  and	  other	  cells	   [114].	  
The	   international	   Batten	   disease	   consortium,	   in	   1995,	   identified	   a	   gene	   mutated	   in	   JNCL	   as	   Cln3	  
(OMIM	  607042)	  [115].	  Cln3	  was	  mapped	  onto	  chromosome	  16,	  the	  precise	  locus	  being	  16p12.1.	  It	   is	  
organized	  into	  15	  exons	  (Figure	  1.14),	  with	  an	  open	  reading	  frame	  of	  1314	  bp.	  Cln3	  encodes	  a	  protein	  
with	  a	  molecular	  weight	  of	  48	  kDa,	  which	  is	  referred	  to	  as	  Cln3p.	  Although	  JNCL	  is	  the	  most	  common	  
of	   all	   NCLs,	   the	   molecular	   basis	   of	   the	   disease	   is	   still	   unknown.	   This	   is	   mainly	   because	   Cln3p	   is	   a	  
protein	  with	  very	  high	  hydrophobicity,	  making	  it	  adamant	  towards	  characterization.	  






Figure	  1.13:	  Schematic	   representation	  of	  mutations	   in	  cln3.	  Cln3	   is	  made	  of	  15	  exons.	  Many	  mutations	  in	  the	  
gene	  have	  been	  identified	  causative	  of	  JNCL.	  Approximately	  41	  mutations	  in	  the	  gene	  have	  been	  identified	  with	  
JNCL,	  the	  most	  common	  of	  which	  is	  the	  1.02kB	  genomic	  deletion	  leading	  to	  the	  truncation	  of	  the	  protein.	  The	  
mutations	  shown	  in	  the	  figure,	  above	  the	  cDNA	  are	  point	  mutations	  in	  the	  ORF	  and	  those	  below	  are	  deletions,	  
insertions	   or	   point	   mutations	   in	   the	   introns.	   Missense	   mutations	   are	   represented	   in	   boldface	   and	   the	   point	  
mutations	   in	   introns	   in	   italics.	   A	   complete	   and	   updated	   list	   of	  mutations	   can	   be	   found	   on	   the	   NCL	  mutation	  
database	  (www.ucl.ac.uk/ncl).	  Source:	  [116]	  
1.2.2 Cln3p	  
1.2.2.1 Topology	  and	  predicted	  structure	  
Cln3p	  is	  an	  integral	  membrane	  protein	  with	  varied	  predictions	  regarding	  its	  trans-­‐membrane	  helices.	  
Topology	  prediction	  algorithms	  predict	   anywhere	  between	  5	   and	  8	  helices	   spanning	   the	  membrane	  
(all	   α-­‐helical)	   [117].	   Experimental	   pursuit	   of	   topology	   led	   to	   two	  models,	   one	   predicting	   five	   [118]	  
trans-­‐membrane	   helices	   and	   other	   six	   [119].	   The	  models	   are	   similar	   except	   for	   the	   following	  major	  
difference:	   the	  model	  which	   predicts	   five	   trans-­‐membrane	   helices,	   also	   predicts	   that	   the	  N-­‐	   and	   C-­‐	  
termini	  of	  the	  protein	  are	  on	  opposite	  sides	  of	  the	  membrane,	  whereas	  in	  the	  alternative	  model	  (with	  
six	  helices)	  the	  N-­‐	  and	  C-­‐	  termini	  are	  on	  the	  same	  side	  of	  the	  membrane	  and	  are	  cytosolic.	  Recently,	  















Figure	   1.14:	   Topology	   of	   Cln3p.	   Cln3p	   is	   made	   up	   of	   438	   amino	   acids,	   most	   of	   which	   are	   predominantly	  
hydrophobic.	  Various	  prediction	  algorithms	  have	  churned	  out	  varying	  results	  for	  the	  topology	  of	  Cln3p.	  The	  most	  
commonly	  accepted,	  however,	  is	  the	  six	  trans-­‐membrane	  model.	  The	  N-­‐	  and	  C-­‐termini	  are	  cytosolic.	  The	  protein	  
is	   predicted	   and	   shown	   to	   undergo	   a	   variety	   of	   post-­‐translational	   modifications.	   N-­‐glycosylation	   sites	   are	  
indicated	  with	   blue	   forks,	   and	   the	   zigzag	   dotted	   line	   indicates	   prenylation	   (at	   the	   very	   C-­‐terminus).	   The	   two	  
lysosomal	  targeting	  domains	  are	  also	  cytosolic.	  Red	  circles	  represent	  missense	  point	  mutations	  and	  the	  ones	  in	  
yellow	  represent	  the	  nonsense	  mutations.	  Residue	  404	  (H/R)	  represents	  a	  polymorphism	  that	  has	  been	  reported	  
(dark	  blue).	  Residues	  which	  are	  colored	  dually,	  represent	  both	  missense	  and	  nonsense	  mutations.	  Source:	  [121]	  
	  
The	   topology	   as	   predicted	   by	   the	   six	   trans-­‐membrane	   model	   is	   depicted	   in	   Figure	   1.14.	   Salient	  
features	  of	  this	  model	  are	  as	  follows:	  
1. The	  N-­‐	  and	  C-­‐	  termini	  of	  the	  six-­‐pass	  trans-­‐membrane	  protein	  are	  cytosolic.	  
2. An	  amphipathic	  helix,	  which	  lies	  perpendicular	  to	  the	  membrane,	  between	  helices	  5	  and	  6.	  
3. Some	  of	  the	  point	  mutations	  that	  cause	  JNCL	  lie	  in	  the	  helix	  mentioned	  above	  and	  most	  of	  them	  
occur	  in	  loops	  facing	  the	  lumen.	  
4. All	  the	  motifs	  that	  direct	  the	  protein	  to	  the	  lysosome	  are	  cytosolic.	  
5. And	  lastly,	  all	  the	  plausible	  sites	  for	  glycosylation	  lie	  in	  the	  lumen.	  
The	  protein	  Cln3p	   is	  known	  to	  undergo	  post-­‐translational	  modifications	  (PTMs).	  PTMs	  are	   important	  
for	  proper	  folding	  and	  functionality	  of	  the	  protein.	  The	  protein	  undergoes	  N-­‐glycosylation	  [122,	  123],	  
which	  may	  be	  important	  for	  its	  functional	  role	  but	  has	  been	  shown	  of	  no	  relevance	  in	  trafficking.	  The	  
protein	  has	  ten	  serines	  and	  three	  threonines	  that	  could	  undergo	  phosphorylation.	  It	  has	  been	  shown	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to	  undergo	  phosphorylation	  as	  a	  posttranslational	  modification	  [124],	  but	  not	  mannose-­‐6-­‐phosphate	  
modification.	   It	   remains	  unclear,	   at	   this	  point	   in	   time,	   if	   the	  protein	  undergoes	  other	  modifications.	  
Cln3p	  has	  a	  CAAX	  box	  (435CQL438S)	  motif,	  which	  has	  potential	  to	  be	  modified	  with	  isoprenoids	  but	  it	  
is	   not	   sure	   as	   of	   yet	   if	   it	   gets	   modified	   by	   an	   anchor	   in-­‐vivo	   [125].	   The	   sites	   for	   possible	   post-­‐
translational	  modifications	  are	  highlighted	  (Figure	  1.14).	  
1.2.2.2 Mutations	  in	  Cln3p	  cause	  JNCL	  
The	  NCL	  mutation	  database	  (www.ucl.ac.uk/ncl)	  lists	  all	  the	  mutations	  in	  Cln3,	  causative	  of	  JNCL,	  that	  
have	   been	   identified	   to	   date.	   41	   such	  mutations	   are	   known,	  most	   prominent	   of	  which	   is	   a	   1.02-­‐kb	  
genomic	   deletion	   mutation	   [115].	   Most	   patients	   are	   homozygous	   for	   this	   mutation	   (74%),	   but	   a	  
significant	  number	  of	  patients	  are	  heterozygous	  with	  1.02-­‐kb	  contributing	   to	  one	  and	  other	  being	  a	  
rare	  mutation	  (22%).	  Four	  large	  deletions,	  five	  small	  deletions,	  ten	  missense,	  ten	  nonsense,	  six	  splice	  
site	  mutations	  and	   five	   insertions	  make	  up	  rare	  mutations	  and	  are	  cause	  of	  disease	   for	  a	  significant	  
demographic.	   A	   concise	   representation	   of	   mutations	   in	   the	   cDNA	   is	   depicted	   in	   Figure	   1.13,	   and	  
mutations	   at	   the	   level	   of	   amino	  acids	   are	  highlighted	   in	  Figure	   1.14	   (yellow	  and	   red	   colored	  amino	  
acids	  representing	  nonsense	  and	  missense	  mutations	  respectively).	  Minimal	  numbers	  of	  patients	  (4%)	  
are	  also	  heterozygous	  with	  two	  rare	  mutations	  on	  both	  alleles	  [116].	  
A	   closer	   look	  at	   the	   topology	  establishes	   that	  most	  of	   the	  mutations	  are	  on	   the	   luminal	   side	  of	   the	  
trans-­‐membrane	   region,	   especially	   in	   the	   highly	   conserved	   luminal	   loop	   2	   [126,	   127].	   It	   is	   widely	  
predicted	   that	   the	   mutations	   lead	   to	   inefficiency	   in	   folding	   and	   hence	   affect	   the	   stability	   and	  
trafficking	   of	   the	   protein	   resulting	   in	   lesser	   stable	   versions	   of	   the	   protein.	   Supplementing	   the	  
prediction	   above	   is	   the	   observation	   that	  mutant	   protein	   variants	   generally	   have	   residual	   activity	   as	  
compared	  to	  wild	  type	  protein	  and	  can	  partially	  rescue	  Cln3	  null	  phenotypes	  [126,	  128,	  129].	  
Lastly,	   it	   is	   currently	   unknown	   whether	   mutations	   involving	   genomic	   deletion	   (like	   the	   1.02kb	  
deletion)	  encode	  for	  a	  stable	  protein	  [130,	  131].	  
1.2.2.3 Localization	  behavior	  of	  Cln3p	  
One	  may	  undermine	   the	   importance	  of	   this	  protein,	  as	   its	   functional	   relevance	  has	  not	  been	  clearly	  
identified.	  This	  is	  ramification	  of	  the	  fact	  that	  functional	  relevance,	  mostly,	  is	  implicated	  and	  inferred	  
upon	  from:	  one,	   the	  definite	  sub-­‐cellular	   localization	  of	   the	  protein	  and	  two,	  presence	  of	  conserved	  
motifs/domains	  or	  sequences.	  Various	  studies	  have	  been	  undertaken	  to	  understand	  where	  and	  how	  
the	   protein	   localizes	   in	   the	   cell.	   Not	   amusingly,	   in	   reality,	   different	   approaches	   have	   led	   to	   its	  
identification	  in	  different	  cellular	  compartments,	  making	  things	  hard	  to	  comprehend.	  The	  justification	  
for	  uncharacteristic	  sub-­‐cellular	  localization	  is	  simply	  based	  on	  the	  very	  high	  hydrophobicity	  of	  Cln3p,	  
which	   makes	   generation	   of	   monoclonal	   antibodies	   against	   the	   native	   protein	   impossible.	   Instead	  
various	  peptide	  antibodies	  have	  been	  used,	  yielding	  incongruous	  results.	  
Cln3p	   has	   been	   an	   understudy	   of	   numerous	   localization	   attempts	   by	   techniques	   such	   as	   confocal	  
microscopy,	  immunofluorescence,	  cell	  fractionation	  and	  immunocytochemistry.	  It	  has	  been	  shown	  to	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populate	   membranes	   of	   cellular	   compartments	   including:	   the	   Golgi	   [132,	   133],	   ER	   [122,	   133],	  
lysosome	  [119,	  123],	  plasma	  membrane	  [134]	  and	  endosomes	  [119].	  It	  has	  also	  been	  shown	  to	  dwell	  
at	  synaptic	  vesicles[128],	  nuclei,	  cytoplasm	  [135]	  and	  at	  the	  presynaptic	  vesicles	  [136]	  in	  neurons.	  The	  
pattern	   of	   localization	   has	   been	   summarized	   in	   Table	   1.3	   that	   follows.	   What	   is	   evident	   is	   that	  
distribution	  of	  Cln3p	  depends	  on	  the	  cell/tissue	  type	  and	  the	  method	  of	  study	  (studying	  endogenous	  
expression	   levels	  vs.	  expression	  of	   tagged	  proteins.	   In	   the	   table	   that	  has	  been	   indicated	   in	   the	   right	  
most	  column	  where	  the	  antibody	  against	  a	  particular	  region	  or	  the	  tag	  used	  for	  overexpression	  have	  
been	  mentioned).	  	  
Immunofluorescence	  experiments	  coupled	  with	  cellular	  fractionation	  techniques	  highlighted	  lysosome	  
as	   primary	   destination	   of	   Cln3p	   [137].	   Endogenous	   protein	   was	   also	   shown	   to	   populate	   lysosomes	  
[134].	   Two	  motifs	  were	   identified	   for	   the	   lysosomal	   targeting	   of	   Cln3p:	  A	   di-­‐leucine	  motif	   at	   amino	  
acids	   425-­‐426	   and	   a,	   MX9G	   motif	   [119].	   Deletion	   of	   any	   of	   the	   motifs	   compromises	   the	   protein’s	  
ability	   to	   reach	   lysosomes,	   deeming	   them	   absolutely	   indispensable.	   Finding	   that	   Btn1p	   (yeast	  
homologue	  of	  Cln3p)	   localizes	  to	  the	  vacuole,	  an	  organelle	  that	   is	   the	   lysosomal	  equivalent,	   in	  yeast	  
confirms	   lysosome	   as	   a	   primary	   destination	   for	   Cln3p	   [138].	   Since	   NCL	   is	   primarily	   a	   brain	   related	  
disease,	  Cln3p’s	   localization	  was	   investigated	   in	  neurons	  and	  brain	  tissue.	   It	  was	  found	  to	   localize	  at	  
the	  synaptic	  vesicles	  in	  murine	  primary	  telencephalic	  neurons	  [139],	  at	  the	  lipid	  rafts	   in	  bovine	  brain	  
tissue	  [140],	  at	  the	  endosomes	  along	  neuronal	  processes	  and	  lysosomes	  in	  the	  cell	  body	  [119].	  Disease	  
causing	   mutations	   of	   the	   protein	   when	   analyzed,	   in	   some	   cases,	   show	   a	   defective	   lysosomal	  
localization	  hinting	  at	  a	  possible	  explanation	  for	  the	  molecular	  basis	  of	  the	  disease	  [139].	  
In	  essence,	  Cln3p	  is	  a	  protein	  that	  resides	  mainly	  at	  the	  lysosome,	  involved	  in	  targeting	  and	  trafficking	  
pathways.	   It	  may	  either	  be	  sorted	  out	  of	  the	  Golgi	  or	  the	  plasma	  membrane,	  following	  which	  it	  gets	  
internalized	   into	   the	   endocytic	   system	   and	   is	   ultimately	   integrated	   into	   the	   lysosomal	   membrane	  
[141].	  
	  
Table	  1.3	  Comprehensive	  overview	  on	  the	  localization	  pattern	  of	  Cln3p	  
Primary	  localization	  
(Reference/s)	   Cell	  type/Tissue	   (Antibody/Tag)	  
Mitochondria	  
[142]	   Retina	  sections	  of	  mouse	   20-­‐aa	  internal	  
Golgi	  
[133]	  
Fibroblasts-­‐	  HeLa,	  COS7	  cells	  
HeLa	   C,N-­‐terminal	  GFP	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Lysosome	  (late	  endosomes	  
in	  certain	  cases)	  




NRK,	  mouse	  primary	  neurons	  
A549	  cells	  
HeLa,	  NRK,	  hippocampal	  neuronal	  cells	  
Embryonic	  testicular	  cells	  
Mouse	  liver	  hepatocytes	  
aa	  242-­‐258	  
N	  –terminal	  GFP	  
aa	  4-­‐19(h	  345/Cln3)	  
aa	  (251-­‐265/	  Q438)	  
aa(1-­‐33),	  h385cln3	  






N,C	  terminal	  GFP	  
C	  terminal	  GFP	  
Neuronal	  synapses	  
[136]	  
Mouse	  brain	  &	  primary	  retinal	  cultures	  
	   h,m	  385/Cln3	  
Cell	  Membrane,	  lipid	  rafts,	  
nuclei	  
[135,	  140]	  
Human	  autopsy	  and	  bovine	  brain	  tissue	   aa	  (2-­‐18,64-­‐76,	  250-­‐264,	  321-­‐340)	  




Human	  neurons	  hNT2	  and	  fibroblasts	   aa	  (58-­‐77)	  
1.2.2.4 Functional	  roles	  
The	  precise	  function	  of	  Cln3p	  has	  remained	  an	  enigma,	  since	  its	  discovery.	  Various	  attempts	  to	  decode	  
the	   function	   of	   Cln3p	   have	   hinted	   at	   different	   possibilities.	   A	   lot	   of	   interesting	   findings	   stem	   from	  
studying	  Btn1p	  (the	  fission	  yeast	  homologue	  of	  Cln3p,	  39%	  identical	  and	  59%	  similar	  to	  Cln3p)	  [126,	  
138,	  145-­‐147].	  What	  follows	  is	  a	  synopsis	  of	  the	  diverse	  roles	  that	  it	  has	  been	  attributed	  to.	  	  
1.2.2.4.1 Role	  in	  transport	  of	  amino	  acids,	  small	  molecules	  and	  in	  lysosomal	  pH	  homeostasis	  
Structural	   classification	   of	   proteins	   (SCOP)	   and	   Pfam	   servers	   predict	   a	   similarity	   of	   the	   structure	   of	  
Cln3p	  (PF02487)	  with	  members	  of	  major	  facilitator	  superfamily	  (MFS)	  (Pfam	  clan	  CL0015).	  MFS	  is	  one	  
of	   the	   two	   major	   superfamilies	   of	   membrane	   proteins	   known.	   They	   transport	   drugs,	   sugars,	   small	  
molecules,	  metabolites	  and	  all	  kind	  of	  ions	  [148].	  Although	  they	  contain	  12	  trans-­‐membrane	  helices,	  it	  
is	   well	   known	   that	   the	   N-­‐terminal	   half	   is	   similar	   to	   the	   C-­‐terminal	   half	   of	   the	   protein,	   a	   result	   of	  
internal	  tandem	  gene	  duplication.	  Not	  surprisingly	  Btn1p	  (fission	  yeast	  homologue	  of	  Cln3p)	  has	  been	  
implicated	  in	  the	  transport	  of	  arginine	  and	  galactosylceramide	  [145,	  149].	  	  
Deletion	  of	  btn1	  leads	  to	  abnormalities	  in	  pH	  and	  other	  vacuolar	  defects,	  which	  could	  be	  rescued	  by	  
Cln3p	  [126].	  Elevated	  lysosomal	  pH	  is	  a	  hallmark	  of	  JNCL	  and	  other	  NCLs	  [150]	  Changes	  in	   lysosomal	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pH	  affect	  the	  intracellular	  processing	  of	  various	  proteins,	  for	  example,	  amyloid-­‐beta	  protein	  precursor,	  
which	  is	  involved	  in	  Alzheimer’s	  disease	  [151].	  
1.2.2.4.2 Role	  as	  a	  fatty-­‐acid	  desaturase	  
It	  was	  also	  predicted	   that	  Cln3p	  has	  a	   low	  homology	   to	   fatty	  acid	  desaturases	   [152].	  This	   led	   to	   the	  
discovery	   of	   hitherto	   unknown	   activity	   of	   Cln3p.	   It	   was	   shown	   that	   lysates	   expressing	   Cln3p	   could	  
introduce	  a	  double	  bond	  at	  the	  Δ-­‐9	  position	  of	  palmitate	  group	  [152].	  Brain	  and	  pancreactic	  tissues	  of	  
Cln3-­‐knockout	   mice	   showed	   remarkably	   less	   desaturase	   activity	   towards	   S-­‐palmitoylated	   H-­‐Ras	  




Figure	   1.15:	   Desaturase	   activity	   of	   Cln3p.	   Lysates	   and	   tissue	   extracts	   containing	   Cln3p	   have	   been	   shown	   to	  
exhibit	   desaturase	   activity,	  where	   a	  double	  bond	   is	   introduced	   in	   the	  Δ-­‐9	  position	  of	   palmitate	  moiety	  of	   the	  
palmitoylated	  proteins.	   The	   reaction	  however	  has	  not	  been	   studied	  with	  purified	   components.	  A	   schematic	   is	  
shown.	  
	  
Many	  proteins	  involved	  in	  signaling	  (neurotransmitters,	  cytokine	  receptors,	  H-­‐Ras,	  and	  src-­‐kinases)	  get	  
associated	  with	  the	  membrane	  as	  a	  consequence	  of	  their	  palmitoylation	  [153].	  Change	  in	  the	  nature	  
of	   the	   fatty	   acid	   (from	   saturated	   to	   desaturated)	   could	   possibly	   lead	   to	   alteration	   in	   spatial	   and	  
temporal	  localization	  of	  these	  proteins	  and	  may	  influence	  downstream	  events.	  Desaturase	  activity	  of	  
Cln3p	  is	  fascinating	  find,	  in	  lieu	  of	  the	  fact	  that	  infantile	  NCL	  (INCL)	  is	  caused	  due	  to	  mutations	  in	  PPT1;	  
a	  protein	  that	  catalyzes	  removal	  of	  palmitoyl	  groups	  from	  post-­‐translationally	  modified	  proteins	  [154].	  
1.2.2.4.3 Role	  in	  apoptosis	  
Hallmarks	   of	   JNCL	   include	   massive	   cortical	   neuronal	   death	   and	   loss	   of	   photoreceptor	   cells	   [112]	  
making	   apoptosis	   an	   underlying	   mechanism	   for	   neuro-­‐degeneration	   amongst	   JNCL	   patients	   [155].	  
Overexpression	   of	   Cln3p	   rescues	   cells,	   subjected	   to	   chemical	   treatment	   with	   vincristine,	  
staurosporine,	   etc.,	   from	   death	   [156].	   A	   fascinating	   discovery	   that	   Cln3p	   is	   overexpressed,	   both	   at	  
mRNA	   and	   protein	   levels,	   in	   variety	   of	   cancer	   cell	   lines	   including	   breast,	   colon,	   prostate,	   ovarian,	  
melanoma,	   neuroblastoma	   and	   glioblastoma	   (also,	   upto	   330%	   higher	   than	   normal	   in	   80%	   of	   solid	  
human	  colon	   cancer	   cases)	  made	   it	   a	  plausible	   candidate	   for	   cancer	  drug-­‐discovery.	  When	   the	  Cln3	  
protein	  levels	   in	  cell	   lines	  (above	  mentioned)	  are	  blocked,	  using	  adenovirus-­‐mediated	  antisense	  Cln3	  
methodology,	   there	   is	   a	   phenomenal	   reduction	   in	   growth	   and	   viability	   of	   cells	   [157].	   In	   essence,	  
antisense-­‐Cln3	  methodology	  could	  be	  valid	  for	  treatment	  of	  some	  types	  of	  cancers	  and	  Cln3p	  could	  be	  
a	  target	  for	  screening	  cancer	  therapeutics.	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1.2.2.4.4 Role	  in	  post-­‐Golgi	  anterograde	  and	  retrograde	  trafficking	  
A	   considerable	   amount	   of	   endogenous	   Cln3p	   localizes	   to	   the	   Golgi	   [133].	   The	   Golgi	   is	   proximally	  
connected	  to	  the	  endocytic	  pathway,	  involved	  in	  recycling	  protein	  and	  lipid	  cargo.	  Loss	  of	  Cln3p	  halts	  
the	  exit	  of	  the	  mannose-­‐6-­‐phosphate	  receptor	  from	  the	  Golgi	  [158],	  which	  plays	  the	  very	  crucial	  role	  
of	  delivering	  digestive	  enzymes	   to	   the	   lysosome.	  Similarly	  deletion	  of	  Btn1	   (S.	  pombe	  homologue	  of	  
Cln3)	   leads	  to	  disintegration	  of	  Golgi	  morphology	  and	  abnormalities	   in	  trafficking	  of	  Vps10p	  (protein	  
involved	  in	  vacuole	  protein	  sorting)	  and	  other	  proteins	  [146].	  Recent	  studies	  have	  also	  highlighted	  the	  
direct	   involvement	   of	   Btn1	   on	   the	   Golgi	   SNARE	   (soluble	   N-­‐ethyl-­‐maleimide	   sensitive	   fusion	   protein	  
attachment	   receptor)	  assembly	  and	   there	  by	   the	  endosome-­‐Golgi	   retrograde	   transport	   [159].	  Taken	  
together,	  recent	  advances	  indicate	  strongly	  that	  the	  Cln3p	  may	  be	  involved	  in	  post-­‐Golgi	  trafficking.	  
Apart	  from	  these	  Cln3p	  has	  been	  shown	  to	  interact	  with	  plethora	  of	  proteins	  like	  AP-­‐1,	  AP-­‐3	  (adaptor	  
protein	  in	  clathrin-­‐mediated	  endocytosis),	  fodrin,	  Hook1,	  TPP1	  leading	  to	  speculations	  of	  wider	  roles	  
and	  functionalities.	  Lastly,	  since	  JNCL	  patient	  cells	  harbor	  a	  defect	  in	  maturation	  of	  autophagosomes,	  a	  
step	  that	  needs	  concomitant	  fusion	  of	  autophagosomes	  with	  functional	  endosomes	  and/or	  lysosomes,	  
role	   of	   Cln3p	   in	   autophagy	   can	   not	   be	   undermined	   [121].	   Cln3p	   could	   possibly	   be	   involved	   in	  
interactions	  with	   autophagy	   proteins	   such	   as	  Atg-­‐3	   and	  Atg-­‐7,	  which	   are	   necessary	   for	   assembly	   of	  
inner	  and	  outer	  membranes	  of	  nascent	  phagophore	  and	  oversee	  its	  maturity.	  	  
Cln3p,	   with	   its	   myriad	   of	   possible	   interactions	   and	   speculative	   roles	   remains	   fascinating	   to	   be	  
understood	  structurally	  and	  biochemically.	  
	   	  
Introduction	   	  
	  
38	  
1.3 Aim	  and	  motivation	  
The	  work	  described	   in	   the	   thesis	   is	   assimilated	   from	   two	  different	  projects.	   The	  aim	  with	   regard	   to	  
each	  of	  the	  project	  follows	  
	  
Structure	  of	  the	  RZZ	  complex:	  	  
	  
The	   3-­‐subunit	   Rod-­‐Zwilch-­‐Zw10	   (RZZ)	   complex	   is	   a	   crucial	   component	   of	   the	   spindle	   assembly	  
checkpoint	   (SAC)	   in	  higher	  eukaryotes.	   It	   is	   required	   for	   kinetochore	   localization	  of	   the	  Mad1-­‐Mad2	  
checkpoint	   complex	   and	   the	   microtubule	   motor	   dynein.	   It	   therefore	   contributes	   not	   only	   to	  
kinetochore-­‐microtubule	  attachment	  but	  also	  to	  the	  dynein-­‐dependent	  stripping	  of	  SAC	  components	  
upon	  checkpoint	  satisfaction.	  How	  the	  RZZ	  complex	  fulfills	  these	  different	  roles	  and	  integrates	  signals	  
from	  the	  kinetochore-­‐microtubule	  interface	  remains	  unclear.	  	  
The	  RZZ	  complex	  will	  be	  purified	   in	  the	  department	  of	  Mechanistic	  cell	  biology	  (AG	  Musacchio).	  The	  
quality	   of	   protein	   will	   be	   monitored	   by	   negative	   stain	   electron	   microscopy	   after	   each	   round	   of	  
optimization.	   As	   soon	   as	   the	   production	   of	   RZZ	   is	   optimized,	   I	   will	   perform	   negative	   stain	   electron	  
microscopy	  analysis	  on	  the	  sample.	  This	  would	  then	  give	  an	  idea	  on	  how	  the	  complex	  looks,	  flexibility,	  
symmetry	   and	   other	   important	   structural	   aspects	   of	   the	   complex.	   If	   the	   complex	   takes	   all	   the	  
orientations	  on	  ice	  then	  I	  would	  use	  a	  common-­‐lines	  approach	  to	  generate	  initial	  model,	  otherwise	  I	  
would	   perform	   a	   random	   conical	   tilt	   analysis.	   I	   will	   then	   go	   on	   (depending	   on	   the	   nature	   of	   the	  
complex)	  to	  generate	  3D	  electron	  density	  map	  of	  the	  complex.	  The	  sample	  will	  then	  be	  optimized	  for	  
high-­‐resolution	   structure	  determination	  using	   cryo-­‐electron	  microscopy.	   I	  will	   try	   to	  understand	   the	  
organization	  of	  proteins	  in	  the	  complex	  using	  antibody	  labeling	  and	  cross-­‐linking	  studies.	  I	  will	  model	  
the	   various	   proteins	   of	   unknown	   structure	   and	   fit	   them	   into	   the	   structure.	   The	   choice	   of	   fitting	  
procedure	   will	   depend	   on	   the	   resolution	   of	   the	   structure.	   Also,	   if	   I	   manage	   to	   achieve	   a	   structure	  
below	   sub-­‐nanometer	   resolution,	   the	   density	   will	   be	   modeled	   using	   various	   programs	   and	   the	  
implications	  of	  the	  structure	  will	  be	  studied	  in	  vivo.	  
	  
Structure	  of	  human	  Cln3p:	  	  
	  
Cln3p	   is	   the	   protein	   implicated	   in	   Batten’s	   disease;	   the	  most	   devastating	   of	   all	   the	   inheritable	   NCL	  
disorders.	  The	  extent	  and	  severity	  of	  symptoms	  varies	  amongst	  individuals	  (occurs	  only	  in	  children).	  It	  
has	  been	  nearly	   two	  decades	  since	  the	  discovery	  of	   the	  protein	  and	  there	   is	   little	  or	  no	   information	  
from	  biochemical	  perspective.	  This	  is	  predominantly	  due	  to	  the	  low	  endogenous	  expression	  level	  and	  
hence,	   problems	  with	  obtaining	  high	   yields	   of	   properly	   folded	  protein.	  Nevertheless,	   understanding	  
the	  function	  of	  the	  protein	  and	  its	  role	  in	  cellular	  pathways	  remain	  essential	  for	  figuring	  out	  ways	  to	  
alleviate	  the	  suffering	  of	  patients	  and	  finally	  to	  find	  a	  cure	  to	  the	  disease.	  Understanding	  the	  structure	  
would	   give	   valuable	   insights	   in	   the	   function	   of	   the	   protein	   and	   subsequently	   new	   structure-­‐based	  
therapeutic	  strategies	  can	  be	  sought	  to	  tackle	  the	  disease.	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Having	  this	  in	  mind,	  I	  need	  to	  express	  the	  full-­‐length	  human	  protein	  in	  sufficiently	  large	  amounts	  using	  
various	   expression	   systems	   for	   protein	   production.	   As	   the	   bacterial	   expression	   system	   is	   inept	   in	  
proper	   folding	   of	   membrane	   proteins,	   I	   will	   try	   and	   optimize	   expression	   of	   protein	   in	   insect	   cell	  
expression	   system.	   Fusion	   constructs	   with	   different	   reporter	   and	   purification	   tags	   for	   facilitated	  
tracking	   and	   convenient	   purification	   will	   be	   used.	   I	   will	   use	   a	   selection	   of	   purification	   methods	   to	  
achieve	  the	  highest	  possible	  purity	  for	  three-­‐dimensional	  x-­‐ray	  crystallography	  studies.	  Besides	  this,	  I	  
will	  also	  use	  electron	  crystallography	  and	  lipidic	  mesophases	  for	  crystallization	  trials.	  I	  would	  also	  like	  
to	   address	   the	   biochemical	   function	   of	   the	   protein.	   Therefore,	   assays	   will	   be	   set-­‐up	   to	   try	   and	  
understand	   the	   protein	   function.	   Finally,	   I	   would	   also	   like	   to	   address	   the	   oligomerization	   state	   and	  
nature	  of	  protein	  in	  an	  attempt	  to	  understand	  what	  role	  it	  plays	  inside	  the	  human	  cell.	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2 Materials	  and	  Methods	  
2.1 Materials	  
2.1.1 Chemicals	  
Table	  2.1	  List	  of	  all	  the	  chemicals	  used	  for	  this	  research	  work	  
Name	   Manufacturer	  
Acetonitrile	   Sigma-­‐Aldrich	  
Acrylamide/Bisacrylamide	  	   AppliChem	  
Ammonium	  peroxodisulfate	  (APS)	   Serva	  
Ammonium	  sulfate	   AppliChem	  
Ampicillin	   Gerbu	  
β-­‐mercaptoethanol	   Serva	  
Bacto-­‐agar	   Roth	  	  
Bacto-­‐tryptone	   Sigma-­‐Aldrich	  
BCIP/NBT	  solution	   Roche	  
Bradfored	  reagent	   Roth	  
Brain	  polar	  lipids	  extract	   Avanti	  polar	  lipids	  Inc.	  
CH3COONa	   Sigma-­‐Aldrich	  
CoCl2	   	  
C-­‐flat	  holey	  carbon	  grid	   Protochip	  Inc.	  
CHAPS	   Affimetrix	  (Anatrace)	  
Chloramphenicol	  	   Roth	  
Chloroform	  	   J.T.	  Baker	  
Complete	  protease	  inhibitor	  cocktail	   Roche	  
Coomassie	  Brilliant	  Blue	   BioMol	  Feinchem.	  GmbH	  
Cymal-­‐6	   Glycon	  
DDM	   Affimetrix	  (Anatrace)	  
DLPC	   Avanti	  polar	  lipids	  Inc.	  
DM	   Affimetrix	  (Anatrace)	  
DMSO	   Sigma-­‐Aldrich	  
DNAse	  I	   Roche	  
DOPC	   Avanti	  polar	  lipids	  Inc.	  
DOPG	   Avanti	  polar	  lipids	  Inc.	  
Dried	  milk	  powder	  (fat	  free)	   Sigma-­‐Aldrich	  
DTE	   Sigma-­‐Aldrich	  
DSS	  (Disuccinimidyl	  suberate)	   Pierce	  
EDTA	   Sigma-­‐Aldrich	  
E.	  coli	  polar	  lipids	  extract	   Avanti	  polar	  lipids	  Inc.	  
Ethanol	  (absolute	  p.a.)	   J.T.	  Baker	  
Fetal	  Calf	  Serum	  (FCS)	   GIBCO	  (Invitrogen)	  
Fluoromount	   Serva	  
Fos-­‐Choline-­‐®12	   Affimetrix	  (Anatrace)	  
Fos-­‐Choline-­‐®13	   Affimetrix	  (Anatrace)	  
Formaldehyde	   Sigma-­‐Aldrich	  
Glucose	   Sigma-­‐Aldrich	  
Glutathione	  	   Roth	  
Glycerol	   Sigma-­‐Aldrich	  
HCl	   J.T.	  Baker	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HEPES	   Gerbu	  Biotechnik	  GmbH	  
Holey	  carbon	  girds	   Agar	  scientific	  	  
Imidazole	  	   Roth	  	  
Incidur	   Ecolabs	  
IPTG	   Roth	  	  
Kanamycin	   Gerbu	  
KCl	   Sigma-­‐Aldrich	  
KH2PO4	   Sigma-­‐Aldrich	  
K2HPO4	   Sigma-­‐Aldrich	  
Liver	  polar	  lipids	  extract	   Avanti	  polar	  lipids	  Inc.	  
Lysozyme	   Sigma-­‐Aldrich	  
Methanol	  (absolute	  p.a.)	   J.T.	  Baker	  
MgCl2	   Sigma-­‐Aldrich	  
MnCl2	   Sigma-­‐Aldrich	  
MNG-­‐3	   Affimetrix	  (Anatrace)	  
N2	  (liquid)	   Air	  Liquid	  
NaCl	   J.T.	  Baker	  
NaHCO3	   Sigma-­‐Aldrich	  
NaH2PO4	   Sigma-­‐Aldrich	  
Na2HPO4	   Sigma-­‐Aldrich	  
NaN3	   Sigma-­‐Aldrich	  
NaOH	   J.T.	  Baker	  
OG	   Affimetrix	  (Anatrace)	  
Pefabloc	   Roth	  
Phenylmethylsulfonyl	  fluoride	  (PMSF)	   Sigma-­‐Aldrich	  
Sodium	  dodecyl	  sulfate	  (SDS)	   Boehringer	  
Tetrabutyl	  ammonium	  bromide	   Merck	  	  
Tetramethylethylen	  diamine	  (TEMED)	   Serva	  
Tris-­‐HCl	   Roth	  
Triton-­‐X100	   Sigma-­‐Aldrich	  
Tween-­‐20	   Calbiochem	  
Uranyl	  format	   SP1-­‐chem	  	  
X-­‐Gal	   Sigma	  Aldrich	  
Yeast	  extract	   Roth	  
Yeast	  nitrogen	  base	   Roth	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2.1.2 Devices	  and	  instruments	  
Table	  2.2	  List	  of	  instruments	  used	  for	  the	  work	  
Instrument	   Manufacturer	  
ÄKTA	  purifier	  -­‐	  Box,	  pHIC,	  UV,	  P	  -­‐	  900	   GE	  Healthcare	  
Analytical	  balance	  PT1200	   Satorius	  
Automatic	  pipette	  Pipetus	   Hirschmann	  Laborgeräte	  
Automatic	  pump	  SP	  quick	   Heidolph	  
Autoclave	  LABOKLAV	  100	   SHP	  Steriltechnik	  
Centrifuge	  Allegra	  X-­‐22	  R	   Beckman	  Coulter	  
Centrifuge	  Avanti	  J-­‐20	  XP	   Beckman	  Coulter	  
Clean	  Bench,	  Insect	  cell	  S-­‐1000	   BDK	  
Column,	  SEC,	  Superose	  6	  10/300	  GL	   GE	  Healthcare	  
Column,	  SEC,	  Superose	  12	  10/300	  GL	   GE	  Healthcare	  
Column,	  IEC,	  Mono	  Q	   GE	  Healthcare	  
Column,	  IEC,	  Mono	  S	   GE	  Healthcare	  
Column,	  IMAC,	  XK	  16	   GE	  Healthcare	  
Confocal	  fluorescence	  Microscope	  	   Leica	  	  
Cryo	  plunge3	   Gatan	  Inc.	  
Dryblock,	  Dri-­‐BLOCK	  BD-­‐2A,	  42°C	  
	  Dryblock,	  Dri-­‐BLOCK	  BD-­‐2P,	  96°C	  
	  Electron	  Microscope	  JEM-­‐1400	   JEOL	  
Electron	  Microscope	  3200	  FSC	   JEOL	  
Fluorescence	  Imaging	  System	  Versa	  Doc	   BIO-­‐RAD	  GmBH.	  
Fluorescence	  Microscope	   Zeiss	  
Fluorescence	  Multititer	  Plate	  Reader	  POLARstar	  Omega	   BMG	  Labtech	  
Fractionizer	  Frac-­‐950	   Beckman	  Coulter	  
High	  vacuum	  coating	  system	  MED020	   Bal-­‐tec	  	  
Ice	  machine	  AF	  100	  
	  Imaging	  System	  RockImager	  1000	   Formulatrix	  
Incubator	  Excella	  E	  24	  	  
	  Incubator,	  30°C	   BINDER	  
Incubator,	  37°C	   BINDER	  
Incubator,	  37°C	   NewBrunswick	  Scientific	  
Incubator	  ED	  115	   BINDER	  
Light	  Microscope	   Zeiss	  
Microwave	  Continent	  MW	  800	  G	   IKA	  Labortechnick	  
Magnetic	  stirrer	  RCT	  basic	   Heidolph	  
Magnetic	  stirrer	  MR	  3000	   Microfluidics	  
Microfluidizer	  M-­‐100	  S	   Eppendorf	  research	  plus	  
Micropipettes	   Biorad	  
Objective	  	   Leica	  	  
PAGE	  chamber	   Biorad	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Pipetting	  robot	  mosquito	  HTS	  	   TPP	  Labtec	  
pH	  meter	  761	  Calimatic	   Knick	  
Plasmid	  Isolating	  Robot	  QIAcube	   QIAGEN	  
Power	  Source	  PAC	  3000	   Biorad	  
Precision	  balance	  TP-­‐124	  A	   Denver	  Instruments	  
Refrigerator,	  4°C	   SIMENS	  
Refrigerator,	  Premium/Comfort	  NoFrost,	  -­‐20°C	   LIEBHERR	  
Refrigerator,	  C-­‐MDF-­‐U	  50	  V,	  -­‐80°C	   SANYO	  
Rotor,	  UC,	  Ti	  45	   Beckman	  Coulter	  
Rotor,	  UC,	  Ti	  70	   Beckman	  Coulter	  
Rotor,	  UC,	  TLA	  100.4	   Beckman	  Coulter	  
Rotor,	  C,	  JA-­‐10	   Beckman	  Coulter	  
Rotor,	  C,	  JA-­‐25.50	   Beckman	  Coulter	  
Rotor,	  C,	  JLA-­‐8.1000	   Beckman	  Coulter	  
Safety	  hood	   Waldner	  service	  
Scanner	  CanoScan	  LiDE	  60	   Canon	  
Shaker	  ST5	  CAT	  
	  Shaker	  KS	  130	  Basic	   IKA	  
Spectrofluorometric	  detector	  RF-­‐551	   Beckman	  Coulter	  
Tabletop	  Centrifuge	  5415	  D	   Eppendorf	  
Tabletop	  Centrifuge	  5415	  R	   Eppendorf	  
TITAN	  Krios	  	   FEI	  
Thermomixer	  compfort	   Eppendorf	  
Thermal	  Cycler	  PTC-­‐200	   MJ	  Research	  
Thermocycler	  primus	  96	  advanced	  gradient	   peqlab	  
UV/Vis-­‐	  spectrophotometer	  ND-­‐1000	  NanoDrop	   peqlab	  Biotechnologie	  GmbH	  
Ultracentrifuge	  Optima	  L-­‐70	  K	  	   Beckman	  Coulter	  
Ultracebtrifuge	  Optima	  TL	  100	   Beckman	  Coulter	  
Vortex	  shaker	  Genie	  2	   Scientific	  Industries	  
	  
2.1.3 Dispensables	  and	  kits	  
Table	  2.3	  Consumables	  and	  kits	  
Consumable	   Manufacturer	   Details	  
96-­‐well	  crystallization	  plates	  Corning	  
CrystalEX	  Microplate	  3550	   Corning	  Inc.	   	  
96-­‐well	  crystallization	  plates	  Corning	  
CrystalEX	  Microplate	  3553	   Corning	  Inc.	   	  
96-­‐well	  crystallization	  plates	  V-­‐Shaped	   Corning	  Inc.	   	  
Amicon	  ultra-­‐4	   Millipore	   Cut-­‐off:	  10	  kDa	  
Amicon	  ultra-­‐15	   Millipore	  	   Cut-­‐off:	  10	  kDa	  
Cell	  culture	  flask	   Becton	  Dickinson	  Falcon	   75	  cm²	  
Cell	  culture	  plate	   BD	  Biosciences	   10	  cm	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Crystallography	  kits	   Qiagen	   Optimized	  kits	  containing	  
various	  precipitant	  
solutions.	  
Dialysis	  bag	  	   Spectrum	  labs	   Cut-­‐off:	  12-­‐14	  kDa	  
FuGENE	  HD	   Roche	   	  
Glass	  slide	  	   Thermo	  Fisher	  Scientific	   6	  x	  2	  cm	  
Graduated	  pipettes	  1,	  5,	  10,	  25	  mL	  
serological	  
Sarstedt	  	   	  
Insect	  cell	  culture	  bottle	   Bellco	  Glass	   	  
Micropipette	  tips	  	   Sarstedt	  	   10,	  100	  µL	  Biosphere	  
Micropipette	  tips	  (ReFill-­‐System)	  	   Nerbe	  plus	  	   10	  µL,	  200	  µL,	  1250	  µL	  
Ni-­‐NTA	  resin	   QIAGEN	   50-­‐mL	  volume	  
PVDF	  membrane	  	   Whatman	   Polyvinylidene	  fluoride	  
Parafilm	  	   Pechiney	  Plastic	  Packaging	  	   Parafilm	  "M"	  
PD-­‐10	  column	   GE	  Healthcare	   Desalting	  column	  
Qiaprep	  Spin	  MiniPrep	   Plasmid	  purification	   Qiagen	  
Reaction	  tubes	  	   Eppendorf	  	   0.5,	  1.5,	  2.0	  mL	  
Reaction	  tubes	  	   BectonDickinson	  Falcon	  	   15	  and	  50	  mL	  
VivaSpin	  500	  columns	  	   Sartorius	  stedim	  biotech	   Cut-­‐off:	  10	  kDa	  
	  
2.1.4 Enzymes	  and	  antibodies	  
Table	  2.4	  List	  of	  enzymes	  and	  antibodies	  used	  
Enzyme	   Manufacturer	  
γ-­‐phosphatase	   AG	  Musacchio	  
BSA	   Thermo	  Scientific	  Pierce	  
Dnase	  I	   Roche	  Bioscience	  
DpnI,	  FastDigest	   Fermentas	  
MangoTaq	  DNA	  Polymerase	   Bioline	  
Phusion	  High-­‐Fidelity	  DNA	  Polymerase	   Finnzymes	  
PNGase	  F	   NEB	  
Precision	  Protease	   Dortmund	  Protein	  Facility	  
Trypsin	   Sigma-­‐Aldrich	  
Cln3p-­‐	  Goat	  polyclonal	  antibody	   Santa	  Cruz	  biotech	  
Mouse	  anti-­‐His	   Sigma	  Aldrich	  
Goat	  anti-­‐mouse	  (fusion	  with	  alkaline	  phosphatase)	   Calbiochem	  
Polyclonal-­‐ROD	  antibody	  
Generated	   at	   the	   antibody	   facility,	   Milan	   (AG	  
Musacchio)	  
	  
	   	  




Table	  2.5	  Media	  and	  composition	  
Name	   Ingredients	  
LB,	  for	  1	  L	  
	  
	  
1%	  (w/v)	  bacto-­‐tryptone	  (10	  g)	  
0.5%	  (w/v)	  yeast	  extract	  (5	  g)	  
200	  mM	  NaCl	  (10	  g)	  
ddH20	  to	  1	  L,	  pH	  7.0	  
	  
Insect	  cell	  growth	  medium	  
	  
TC100	  +	  10%	  FCS	  
	  
Mammalian	  cell	  growth	  medium	  
	  
	  
DMEM/F12	  1:1	  (PAN	  Biotech)	  
	  10	  %	  FCS	  (GIBCO)	  
	  1:1000	  Penicillin	  (5,000	  U)	  
	  Streptomycin	  (5,000	  μg)	  (PenStrep,	  Invitrogen)	  
	  
SOC,	  for	  1	  L	  
	  
	  
2%	  (w/v)	  bacto-­‐tryptone	  (20	  g)	  
0.5%	  (w/v)	  yeast	  extract	  (5	  g)	  
10	  mM	  NaCl	  (0.584	  g)	  
2.5	  mM	  KCl	  (0.186	  g)	  
10	  mM	  MgCl2	  (0.952	  g)	  
20	  mM	  glucose	  (3.603	  g)	  
	  ddH20	  to	  1	  L,	  pH	  7.0	  
	  
TB,	  for	  1	  L	  
	  
	  
1.2%	  (w/v)	  bacto-­‐tryptone	  (12	  g)	  
2.4%	  (w/v)	  yeast	  extract	  (24	  g)	  
4	  mL	  glycerol	  
15	  mM	  KH2PO4	  (2,13	  g)	  
72	  mM	  K2HPO4	  (12,54	  g)	  
ddH20	  to	  1	  L,	  pH	  7.0	  
2TY,	  for	  1L	  
	  
1.6%	  (w/v)	  bacto-­‐tryptone	  (16	  g)	  
1%	  (w/v)	  yeast	  extract	  (5	  g)	  
200	  mM	  NaCl	  (10	  g)	  
	  ddH20	  to	  1	  L,	  pH	  7.0	  
	  
TC-­‐100	  medium	  (for	  5L)	  
	  
5	  L	  autoclaved	  H2O	  
110	  g/L	  TC-­‐100	  powder	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2.1.6 Insect	  and	  Mammalian	  cell	  lines,	  bacterial	  strains	  
Table	  2.6	  List	  of	  strains	  and	  cell	  lines	  used	  for	  the	  study	  
Name	   Source	   General	  information	  
	  




F-­‐	   ompT	   hsdSB(RB
-­‐	   mB
-­‐)	   gal	   dcm	   λ(DE3	   [lacI	  
lacUV5-­‐T7	   gene	   1	   ind1	   sam7	   nin5])	   pLysSRARE	  
(CamR)	  
DH10EmbacY	   Geneva	  Biotech	  
	  
Used	  for	  Bac-­‐to-­‐Bac	  system	  
	  






Fʼ	  {proAB+	  laclq	  lacZΔM15	  Tn10(TetR)	  Δ(ccdAB)}	  
mcAr	   Δ(mrr-­‐hsdRMS-­‐mcrBC)	   φ80(lacZ)ΔM15	  
Δ(lacZYA-­‐argF)	   U169	   endA1	   recA1	   supE44	   thi-­‐1	  
gyrA96	  reAl1	  tonA	  panD	  
	  




Immortalized	  ovarian	  cancer	  insect	  cell	  line	  used	  
for	  baculovirus	  production	  
	  




Immortalized	  ovarian	  cancer	  insect	  cell	  line	  used	  
for	  baculovirus	  production	  
XL-­‐1	  Blue	  (E.coli)	   XL-­‐1	  Blue	  
	  
Fʼ	   {proAB+	   laclq	   lacZΔM15	   Tn10(TetR)}	   recA1	  
endA1	  gyrA96	  thi-­‐1	  hsdR17	  supE44	  reAl1	  lac	  
	  
2.1.7 Software	  and	  scripts	  
Table	  2.7	  List	  of	  software	  and	  scripts	  used	  for	  analysis	  of	  data	  
Software	   Source	  
Chimera	   UCSF	  Chimera	  
CTFGUI-­‐update-­‐15-­‐10-­‐12.py	   (script	   for	   CTF	  
and	  defocus	  estimation)	  
Dr.	  Rouslan	  Efremov	  and	  Dr.	  Christos	  Gatsogiannis	  
EPU-­‐	  For	  automated	  data	  collection	   FEI	  
EMTools-­‐	  For	  automated	  data	  collection	   TVIPS	  GmBH	  
ImageJ	   http://imagej.nih.gov/ij/	  
I-­‐Tasser	   http://zhanglab.ccmb.med.umich.edu/I-­‐TASSER/	  
Phyre2	   http://www.sbg.bio.ic.ac.uk/phyre2/htmL/page.cgi?id=index	  
PyMOL	   Schrödinger,	  LLC	  
SPARX/EMAN2	   http://blake.bcm.edu/emanwiki/EMAN2	  
Versa	  Doc	  Quantity	  One	  4.6.9	   BIO-­‐RAD	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2.1.8 Solutions	  and	  buffers	  	  
2.1.8.1 General	  buffers	  
Table	  2.8	  List	  of	  common	  buffer,	  solutions	  and	  their	  composition	  
Name	   Composition	  
Antibody	  solution	  (for	  Western	  blot)	  
	  
1:4000	  (or	  as	  manufacturer	  specified)	  
0.5%	  (w/v)	  dried	  milk	  powder	  
0.3	  mM	  NaN3	  
Fill	  up	  with	  TBS	  
Blocking	  solution	  (for	  Western	  blot)	  
5%	  (w/v)	  Milk	  powder,	  fill	  it	  up	  with	  TBS	  
Lysis	  buffer	  (until	  unless	  specified	  otherwise)	  
	  
50	  mM	  HEPES	  
500	  mM	  NaCl	  
10%	  Glycerol	  
5	  mM	  TCEP	  
1	  mM	  EDTA	  
1	  mM	  PMSF	  
1	   protease	   inhibitor	   cocktail	   tablet/	   50	   mL	   of	  
buffer	  
5	  µg/ml	  Dnase	  I	  
	  
Paraformaldehyde	  fixation	  solution	  
	  





2.7	  mM	  KCl	  
1.7 mM NaH2PO4 
10	  mM	  Na2HPO4	  
137	  mM	  NaCl	  
pH	  7.5	  with	  HCl	  
Phosphoimager	  destaining	  solution	  
	  
50	  mM	  CH3COONa,	  20%	  MeCN	  
γ-­‐phosphatase	  fixing	  solution	  
	  
50	  %	  Methanol,	  10%	  Acetic	  acid	  
γ-­‐phosphatase	  reaction	  buffer	  
	  
50	  mM	  HEPES	  
100	  mM	  NaCl	  
2	  mM	  DTT	  
0.01%	  Brij	  35	  	  
Phosphorylation	  (by	  Mps1)	  reaction	  buffer	  
	  
25mM	  HEPES	  pH	  8.5	  
250mM	  NaCl,	  2mM	  TCEP	  
10	  mM	  MgCl2	  
1μM	  ATP	  
Semi-­‐native	  running	  buffer	  
	  
25	  mM	  Tris	  
187.5	  mM	  Glycine	  
0.04%	  SDS	  
	  
Solubilization	  buffer	  for	  screening	  
	  
1%	  of	  detergent	  	  
20	  mM	  Tris-­‐HCl	  pH	  7.5	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150	  mM	  NaCl,	  10	  mM	  Tris	  pH	  7.5	  	  
TBS-­‐TT	  
	  
250	  mM	  NaCl	  
10	  mM	  Tris	  
0.025%	  (v/v)	  Tween-­‐20	  
0.1%	  (v/v)	  Triton	  X-­‐100	  
pH	  7.4	  
Transfer	  buffer	  (for	  Western	  blot)	  
	  
25	  mM	  Tris	  
192	  mM	  Glycine,	  
10%	  (v/v)	  Methanol	  
	  
Uranyl	  formate	  staining	  solution	  
	  
0.0375	  g	  was	  added	  to	  5	  mL	  of	  boiling	  water	  and	  
stirred	   for	   5	   min.	   Then	   6	   µl	   of	   5	   M	   NaOH	   was	  
added	  and	  stirred	  for	  another	  5	  min	  
XL-­‐MS	  reaction	  buffer	  
	  
25	  mM	  Hepes	  pH	  8.5	  
250	  mM	  NaCl	  
2	  mM	  TCEP	  
2.1.8.2 Buffers	  for	  purification	  of	  Cln3p	  in	  Fos-­‐Choline-­‐13	  
Table	  2.9	  List	  of	  buffers	  required	  for	  purification	  of	  Cln3p	  and	  their	  composition	  
Name	   Composition	  
Pre-­‐solubilization	  buffer	  
	  
50	  mM	  HEPES	  
500	  mM	  NaCl	  
1%	  OG,	  2	  mM	  TCEP	  




50	  mM	  HEPES	  
500	  mM	  NaCl	  
0.5%	  Fos-­‐13,	  2	  mM	  TCEP	  
1	  mM	  PMSF	  
10%	  Glycerol	  
IMAC	  (immobilized	  metal	  affinity	  chromatography)	  
Wash	  A	  buffer	  (wash	  buffer	  A-­‐fos)	  
	  
20	  mM	  HEPES	  
500	  mM	  NaCl	  
0.05%	  Fos-­‐13	  
10%	  Glycerol	  
1	  mM	  TCEP	  
1	  mM	  PMSF	  
5	  mM	  Imidazole	  
IMAC	  (immobilized	  metal	  affinity	  chromatography)	  
Wash	  B	  buffer	  (wash	  buffer	  B-­‐fos)	  
	  
20	  mM	  HEPES	  
500	  mM	  NaCl	  
0.05%	  Fos-­‐13	  
10%	  Glycerol	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1	  mM	  TCEP	  
1	  mM	  PMSF	  
20	  mM	  Imidazole	  
Elution	  buffer	  (elution	  buffer-­‐fos)	  
	  
20	  mM	  HEPES	  
300	  mM	  NaCl	  
0.1%	  Fos-­‐13	  
10%	  Glycerol	  
1	  mM	  TCEP	  
1	  mM	  PMSF	  
150-­‐200	  mM	  Imidazole	  
Dialysis	  buffer	  (dialysis	  buffer-­‐fos)	  
	  
20	  mM	  HEPES	  
300	  mM	  NaCl	  
0.1%	  Fos-­‐13	  
10%	  Glycerol	  
1	  mM	  TCEP	  
1	  mM	  PMSF	  
Size	  exclusion	  chromatography	  buffer	  
(SEC	  buffer-­‐fos)	  
	  
20	  mM	  HEPES	  
300	  mM	  NaCl	  
0.1%	  Fos-­‐13	  
10%	  Glycerol	  
1	  mM	  TCEP	  
1	  mM	  PMSF	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2.1.8.3 Buffers	  for	  purification	  of	  Cln3p	  in	  MNG-­‐3	  
Table	  2.10	  List	  of	  buffers	  for	  purification	  of	  Cln3p	  (detergent	  exchange)	  and	  their	  composition	  
Name	   Composition	  
IMAC	  (immobilized	  metal	  affinity	  chromatography)	  
Wash	  A	  buffer	  (wash	  buffer	  A-­‐mng)	  
	  
20	  mM	  HEPES	  
500	  mM	  NaCl	  
0.01-­‐0.05%	  MNG-­‐3	  
10%	  Glycerol	  
1	  mM	  TCEP	  
1	  mM	  PMSF	  
5	  mM	  Imidazole	  
IMAC	  (immobilized	  metal	  affinity	  chromatography)	  
Wash	  B	  buffer	  (wash	  buffer	  B-­‐mng)	  
	  
20	  mM	  HEPES	  
500	  mM	  NaCl	  
0.01-­‐0.05%	  MNG-­‐3	  
10%	  Glycerol	  
1	  mM	  TCEP	  
1	  mM	  PMSF	  
20	  mM	  Imidazole	  
Elution	  buffer	  (elution	  buffer-­‐mng)	  
	  
20	  mM	  HEPES	  
300	  mM	  NaCl	  
0.05-­‐0.1%	  MNG-­‐3	  
10%	  Glycerol	  
1	  mM	  TCEP	  
1	  mM	  PMSF	  
150-­‐200	  mM	  Imidazole	  
Dialysis	  buffer	  (dialysis	  buffer-­‐mng)	  
	  
20	  mM	  HEPES	  
300	  mM	  NaCl	  
	  0.05-­‐0.1%	  MNG-­‐3	  
10%	  Glycerol	  
1	  mM	  TCEP	  
1	  mM	  PMSF	  
Size	  exclusion	  chromatography	  buffer	  
(SEC	  buffer-­‐mng)	  
	  
20	  mM	  HEPES	  
300	  mM	  NaCl	  
0.05-­‐0.1%	  MNG-­‐3	  
10%	  Glycerol	  
1	  mM	  TCEP	  
1	  mM	  PMSF	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2.1.8.4 Buffers	  for	  purification	  of	  RZZ	  and	  mini-­‐RZZ	  
Table	  2.11	  Buffers	  for	  purification	  of	  RZZ	  and	  mini-­‐RZZ	  
Name	   Composition	  
Lysis	  buffer	  
	  
50	  mM	  HEPES	  pH	  8.5	  
200	  mM	  NaCl	  
5%	  glycerol	  
2	  mM	  TCEP	  
Protease	  inhibitor	  cocktail	  tablet	  (1	  per	  50	  mL)	  
PMSF	  
IMAC	  (immobilized	  metal	  affinity	  chromatography)	  
Wash	  buffer	  	  
	  
50	  mM	  HEPES	  pH	  8.5	  
200	  mM	  NaCl	  
5%	  glycerol	  
2	  mM	  TCEP	  
20	  mM	  Imidazole	  
Size	  exclusion	  chromatography	  buffer	  
	  
	  
20	  mM	  HEPES	  pH	  8.5	  
250	  mM	  NaCl	  
2	  mM	  TCEP	  
	  
2.1.8.5 Buffers	  for	  purification	  of	  Zw10	  
Table	  2.12	  Buffers	  for	  purification	  of	  Zw10	  
Name	   Composition	  
Lysis	  buffer	  
	  
1x	  PBS	  pH	  8.5	  
150	  mM	  NaCl	  
5%	  glycerol	  
2	  mM	  TCEP	  
Protease	  inhibitor	  cocktail	  tablet	  (1	  per	  50	  mL)	  
PMSF	  
IMAC	  (immobilized	  metal	  affinity	  chromatography)	  
Wash	  buffer	  	  
	  
1x	  PBS	  pH	  8.5	  
150	  mM	  NaCl	  
5%	  glycerol	  
2	  mM	  TCEP	  
20	  mM	  Imidazole	  
Elution	  buffer	  
	  
1x	  PBS	  pH	  8.5	  
150	  mM	  NaCl	  
5%	  glycerol	  
2	  mM	  TCEP	  
200	  mM	  Imidazole	  
Ion	  exchange	  buffer	  A	  
	  
50	  mM	  HEPES	  pH	  8.5	  
100	  mM	  NaCl	  
2	  mM	  TCEP	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Ion	  exchange	  buffer	  B	  
	  
50	  mM	  HEPES	  pH	  8.5	  
1	  M	  NaCl	  
2	  mM	  TCEP	  
Size	  exclusion	  chromatography	  buffer	  
	  
	  
20	  mM	  HEPES	  pH	  8.5	  
250	  mM	  NaCl	  
2	  mM	  TCEP	  
2.1.9 	  Vectors	  and	  plasmids	  
Table	  2.13	  List	  of	  vectors	  and	  plasmids	  used	  for	  the	  work	  
No.	   Name	  (as	  enlisted	  in	  the	  AG	  Raunser	  database)	   Features	  
p007	   pOPINF_Nterm10HisTagPP	   N-­‐10x-­‐His,	  PP	  
p012	   pOPINE_Cterm_10HisTag	   C-­‐10xHis	  
P068	   pOPINE_6His_EGFP_PP_LacZ	   N-­‐6xHis,	  EGFP,	  PP	  
p231	   pOPINE_EGFP_Cln3mouse	   N-­‐	  short	  linker,	  GFP,	  6xHis,	  PP	  
p232	   pOPINE_EGFP_Cln3	  human	   N-­‐	  short	  linker,	  GFP,	  6xHis,	  PP	  
p261	   pOPINE_EGFP_Cln3	  rat	   N-­‐	  short	  linker,	  GFP,	  6xHis,	  PP	  
p262	   pOPINF_Nterm10His_Cln3	  human	   N-­‐10x-­‐His,	  PP	  
p263	   pOPINF_Cterm10His_Cln3	  human	   C-­‐10x-­‐His	  
p265	   pOPINF_Nterm10His_Cln3	  mouse	   N-­‐10x-­‐His,	  PP	  
p266	   pOPINF_Nterm10His_Cln3	  rat	   N-­‐10x-­‐His,	  PP	  
p454	   pFH_Cln3	  human	   N-­‐6x-­‐His	  
p496	   pOPIN_6His_3C_	  short	  linker_Cln3	  human	   N-­‐	  short	  linker,	  6xHis,	  PP	  
p497	   pOPIN_6His_Cherry_3C_medium	  linker_Cln3	  human	   N-­‐	  medium	  linker,	  mCherry,	  6xHis,	  PP	  
p506	   pOPIN_His_Sumo_short	  linker_Cln3	  human	   N-­‐Short	  linker,	  6x	  His,	  PP,	  Sumo	  
p507	   pOPIN_His_Sumo_medium	  linker_Cln3	  human	   N-­‐medium	  linker,	  6x	  His,	  PP,	  Sumo	  
p508	   pOPIN_His_Sumo_large	  linker_Cln3	  human	   N-­‐large	  linker,	  6x	  His,	  PP,	  Sumo	  
p509	   pOPIN_His_Cherry_3C_large	  linker_Cln3	  human	   N-­‐	  long	  linker,	  mCherry,	  6xHis,	  PP	  
p510	   pOPIN_His_Cherry_3C_short	  linker_Cln3	  mouse	   N-­‐	  short	  linker,	  mCherry,	  6xHis,	  PP	  
p511	   pOPIN_His_	  3C_short	  linker_Cln3	  human	   N-­‐	  short	  linker,	  6xHis,	  PP	  
p512	   pOPIN_His_	  3C_large	  linker_Cln3	  human	   N-­‐	  large	  linker,	  6xHis,	  PP	  
	   RFP-­‐GalT	   Golgi	  marker	  
	   RFP-­‐PMP2	  	   Peroxisomal	  marker	  
	   LAMP-­‐RFP	   Lysosomal	  marker	  
	  
	   	  




2.2.1 Methods:	  RZZ	  complex	  
Anika	  Altenfeld	  or	  Sabine	  Wohlgemuth	  (AG	  Musacchio)	  optimized	  and	  purified	  all	  the	  proteins	  for	  this	  
part	  of	  work.	  I	  therefore	  will	  summarize	  very	  briefly	  the	  protocols	  used	  for	  generation	  of	  complexes.	  	  
2.2.1.1 Purification	  of	  RZZ	  complex	  
A	  cell	  pellet	  of	  1	  L	  of	   insect	  cell	  culture	  expressing	  Zw10	  is	  suspended	  into	  45	  mL	  of	   lysis	  buffer.	  The	  
cells	  were	  lysed	  by	  sonication	  (3	  x	  30s,	  at	  4°C)	  and	  the	  debris	  removed	  by	  centrifugation	  at	  20,000	  rpm	  
for	  60	  min,	  4°C.	  The	  supernatant	  was	  loaded	  onto	  a	  5	  mL	  pre-­‐equilibrated	  Ni-­‐NTA	  column	  at	  the	  speed	  
of	  3	  mL/min	  using	  a	  peristaltic	  pump.	  The	  resin	  was	  washed	  with	  4000	  mL	  of	  wash	  buffer,	  followed	  by	  
elution	  (2	  mL	  fractions).	  All	  the	  fractions	  were	  analyzed	  by	  SDS-­‐PAGE.	  The	  best	  fractions	  were	  pooled	  
(10	  mL),	   concentrated	   and	   the	   pool	   diluted	  with	   40	  mL	   of	   ion	   exchange	   buffer	   A.	   The	   sample	  was	  
loaded	   on	   to	   a	   ResQ	   (strong	   anion	   exchanger)	   column	   with	   a	   50	   mL	   super	   loop	   (flow	   rate	   of	   0.5	  
mL/min).	   The	   gradient	   was	   increased	   using	   ion	   exchange	   buffer	   B.	   Eluted	   fractions	   were	   analyzed	  
again	  by	  SDS-­‐PAGE,	  pooled,	  concentrated	  (MWCO	  10	  kDa)	  to	  500	  μL	  and	  loaded	  onto	  a	  Superdex	  200	  
10/300	   size-­‐exclusion	   chromatography	   column.	   Part	   of	   protein	   was	   analyzed	   by	   negative	   stain	  
electron	  microscopy	  and	  the	  rest	  was	  concentrated	  and	  subjected	  to	  crystallization	  trials.	  
2.2.1.2 Purification	  of	  R-­‐(nGFP)Z-­‐Z	  and	  R-­‐Z(cGFP)-­‐Z	  
The	   protocol	   for	   purification	   of	   R-­‐(nGFP)Z-­‐Z	   and	   R-­‐Z(cGFP)-­‐Z	   (N-­‐	   and	   C-­‐	   terminally	   labeled	   Zw10	  
versions	  of	  RZZ)	  parallels	  that	  of	  RZZ	  described	  above.	  The	  major	  difference	  is	  that	  Zw10	  is	  expressed	  
as	  a	  fusion	  protein	  (respective	  viruses	  for	  fusion	  proteins	  are	  generated)	  and	  the	  tag	  (6XHis,	  GFP)	  was	  
not	  cleaved	  in	  the	  final	  step.	  
2.2.1.3 Purification	  of	  mini-­‐RZZ	  
Individual	  viruses	  (only	  ROD1-­‐1250	  was	  required	  to	  be	  generated,	  previously	  generated	  viruses	  for	  Zw10	  
and	  Zwilch	  were	  used)	  were	  generated	  and	  the	  proteins	  co-­‐expressed	  in	  Tnao38	  insect	  cells.	  The	  cell	  
pellet	  was	  suspended	  in	  100	  mL	  of	  lysis	  buffer,	  sonicated	  (3	  x	  35	  s,	  4°C)	  and	  the	  lysate	  centrifuged	  at	  
25,000	   rpm	   at	   4°C.	   The	   supernatant	   was	   then	   loaded	   onto	   the	   IMAC	   (5	   mL	   Ni-­‐NTA	   column,	   pre-­‐
equilibrated	  with	  wash	  buffer)	  using	  a	  peristaltic	  pump	  at	  a	  flow	  rate	  of	  2	  mL/min.	  Following	  this	  the	  
column	  was	  washed	  with	  400	  mL	  of	  wash	  buffer	  and	  the	  protein	  eluted	  as	  1	  mL	   fractions	  using	   the	  
elution	  buffer.	  The	   fractions	  were	  analyzed	  by	  SDS-­‐PAGE,	  pooled,	   concentrated	   (Amicon,	  MWCO-­‐10	  
kDa)	  to	  500	  µL	  and	  loaded	  onto	  a	  Superose	  6	  10/300	  size-­‐exclusion	  chromatography	  column.	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2.2.1.4 Purification	  of	  Zw10	  
A	  cell	  pellet	  of	  1L	  of	   insect	   cell	   culture	  expressing	  Zw10	   is	   suspended	   into	  45mL	  of	   lysis	  buffer.	  The	  
cells	  were	  lysed	  by	  sonication	  (3	  x	  30s,	  at	  4°C)	  and	  the	  debris	  removed	  by	  centrifugation	  at	  20,000	  rpm	  
for	  60	  min,	  4°C.	  The	  supernatant	  was	  loaded	  onto	  a	  5	  mL	  pre-­‐equilibrated	  Ni-­‐NTA	  column	  at	  the	  speed	  
of	  3mL/min	  using	  a	  peristaltic	  pump.	  The	  resin	  was	  washed	  with	  4000	  mL	  of	  wash	  buffer,	  followed	  by	  
elution	  (2	  mL	  fractions).	  All	  the	  fractions	  were	  analyzed	  by	  SDS-­‐PAGE.	  The	  best	  fractions	  were	  pooled	  
(10	  mL),	   concentrated	   and	   the	   pool	   diluted	  with	   40	  mL	   of	   ion	   exchange	   buffer	   A.	   The	   sample	  was	  
loaded	   on	   to	   a	   ResQ	   (strong	   anion	   exchanger)	   column	   with	   a	   50	   mL	   super	   loop	   (flow	   rate	   of	   0.5	  
mL/min).	   The	   gradient	   was	   increased	   using	   ion	   exchange	   buffer	   B.	   Eluted	   fractions	   were	   analyzed	  
again	  by	  SDS-­‐PAGE,	  pooled,	  concentrated	  (MWCO	  10	  kDa)	  to	  500	  µL	  and	  loaded	  onto	  a	  Superdex	  200	  
10/300	   size-­‐exclusion	   chromatography	   column.	   Part	   of	   protein	   was	   analyzed	   by	   negative	   stain	  
electron	  microscopy	  and	  the	  rest	  was	  concentrated	  and	  subjected	  to	  crystallization	  trials.	  
2.2.1.5 Cross-­‐linking	  and	  Mass	  spectrometry	  (XL-­‐MS)	  
For	  the	  cross-­‐linking,	  1mg	  of	  Disuccinimidyl	  Suberate	  (DSS)	  was	  dissolved	  in	  53	  µL	  of	  DMSO	  (Stock	  1).	  
20	  µL	  of	  stock	  1	  was	  dissolved	  in	  250	  µL	  of	  reaction	  buffer	  (25	  mM	  Hepes	  pH	  8.5,	  250	  mM	  NaCl,	  2	  mM	  
TCEP;	  Stock	  2).	  DSS	  (stock	  2)	  and	  the	  protein	  were	  mixed	   in	  ratios	  as	   indicated	   in	  the	  table,	  and	  the	  
reaction	  volume	  was	  maintained	  at	  200	  µL.	  Reactions	  were	  carried	  out	  either	  for	  30	  min.	  at	  37	  °C	  or	  at	  
4°C	  overnight.	  22	  mL	  NH4CO3	  was	  added	  to	  stop	  the	  reaction	  (incubated	  for	  15	  min	  37°C).	  The	  samples	  
were	  then	  sent	  to	  the	  laboratory	  of	  Dr.	  Franz	  Herzog	  at	  Gene	  Center,	  Munich	  for	  further	  analysis.	  
2.2.1.6 Phosphorylation	  of	  RZZ	  
The	  reaction	  was	  carried	  out	   in	  phosphorylation	  buffer	  (25mM	  Hepes	  8.5,	  250mM	  NaCl,	  2mM	  TCEP,	  
10	  mM	  MgCl2,	  1μM	  ATP).	  Briefly,	  5	  μM	  of	  RZZ	  was	  incubated	  with	  same	  amount	  of	  Mps1	  for	  30	  min	  at	  
RT.	  Following	  this	  the	  mixture	  was	  centrifuged	  at	  13,400	  rpm	  and	  the	  supernatant	   loaded	  onto	  a	  S6	  
3.2/15	  column	  and	  50	  µL	  fractions	  were	  collected.	  	  
2.2.1.7 Electron	  Microscopy	  
Electron	   microscopy	   is	   a	   technique	   where	   one	   visualizes	   objects/samples	   (proteins,	   complexes,	  
sections)	   placed	   in	   the	   microscope	   by	   impinging	   electrons.	   The	   optics	   of	   imaging	   is	   essentially	  
conserved	  from	  light	  microscopy	  and	  only	  differs	  in	  the	  technicalities.	  The	  ‘lenses’	  for	  example	  in	  the	  
electron	  microscope	  are	  not	  curved	  surfaces	  but	  applied	  electric	  and	  magnetic	  field,	  which	  influences	  
the	   behavior	   of	   electrons.	   In	   single	   particle	   analysis,	   one	   essentially	   tries	   to	   formulate	   the	   three-­‐
dimensional	  (3D)	  object	  from	  its	  two-­‐dimensional	  projections	  (2D).	  A	  classic	  example	  of	  object	  and	  its	  
orthogonal	  projections	  is	  shown	  below	  (Figure	  2.1).	  	  
	  





Figure	   2.1:	   Principle	   of	   single	  
particle	   electron	   microscopy.	  
The	   object	   in	   the	   figure,	  
depending	  on	  how	  it	   is	  projected	  
can	   have	   M,	   T	   or	   I as	   its	  
projections.	   Once,	   the	   angles	   of	  
projections	   and	   their	   relative	  
orientation	   with	   respect	   to	   one	  
another	   are	   known,	   one	   can	  
reconstruct	   the	   object.	   This	   is	  
essentially	   the	   principle	   behind	  
single	   particle	   electron	  
microscopy,	   where	   the	  
sample/object	   can	   take	   various	  
orientations	   on	   the	   grid	   and	  
hence	   gives	   rise	   to	   variety	   of	  
projections.	   By	   determining	   the	  
angles	   (Euler	   angles)	   and	  
orientation	   parameters	   of	   these	  
projections	   the	   3D	   structure	   of	  
the	   sample	   is	   generated.	   Source:	  
World	  wide	  web.	  
	  
	  
In	   reality,	   things	  are	  way	  more	  complex	  as	   the	  protein/object	   can	   take	  all	  possible	  orientations	  and	  
there	  is	  little	  information	  about	  the	  relative	  orientation	  of	  all	  particles.	  Another	  major	  problem	  is	  the	  
conformational	  variability	  of	  the	  sample	  (where	  protein	  or	  protein	  complexes	  exist	  and	  adopt	  distinct	  
conformations	  in	  solution	  but	  are	  random	  in	  ice).	  Finally,	  electron	  microscopy	  data	  is	  extremely	  noisy	  
mainly	  because	  one	  cannot	  use	  high	  dose	  of	  electrons,	  due	  to	  the	  susceptibility	  of	  biological	  samples	  
to	   damage.	   These	   problems	  make	   structure	   determination	   by	   electron	  microscopy	   challenging	   and	  
tedious.	  Besides	   this,	  one	   is	  generally	  challenged	  by	  the	  size	  of	   the	  sample	  that	  can	  be	  used	   for	   the	  
study.	  Negative	  stain	  electron	  microscopy	   (ns-­‐EM)	  requires	   the	  sample	  be	  no	   less	   than	  100	  kDa	  and	  
incase	  of	  cryo-­‐EM	  the	  sample	  has	  to	  have	  a	  size	  of	  about	  300	  kDa.	  
One	  generally	  uses	  ns-­‐EM	  for	  low-­‐resolution	  information	  and	  to	  generate	  initial	  models,	  if	  there	  is	  no	  
a	   priori	   information	   about	   the	   sample.	   In	   negative	   stain	   electron	   microscopy,	   a	   heavy-­‐metal	   salt	  
solution	   is	   used	   to	   enhance	   the	   contrast	   of	   the	   sample	   as	   it	   forms	   a	   thin	   layer	   over	   the	   sample	  
examined.	  In	  Cryo-­‐electron	  microscopy,	  the	  sample	  applied	  on	  the	  grid	  is	  frozen	  into	  liquid	  ethane	  at	  
relatively	  high	  speed	  leading	  to	  formation	  of	  vitreous	  ice,	  which	  preserves	  the	  ‘native’	  state,	  and	  high-­‐
resolution	   features	   of	   the	   sample.	   Cryo-­‐EM	   offers	   the	   possibility	   to	   understand	   high-­‐resolution	  
information	  but	   suffers	  drastically	   from	   lack	  of	   contrast	   in	   the	   images.	   It	   is	   of	   general	  procedure	   to	  
visualize	  and	  extract	  as	  much	  information	  as	  possible	  from	  negative	  stain	  EM	  and	  then	  follow	  it	  up	  by	  
cryo-­‐EM	  analysis.	  	  
The	  steps	  in	  structure	  determination	  by	  single	  particle	  analysis	  of	  images	  from	  EM	  (negatively	  stained	  
or	  cryo)	  are	  more	  or	  less	  same	  and	  can	  be	  divided	  into	  the	  following	  steps:	  
1.	  Particle	  selection:	  single	  particle	  images	  of	  desired	  size	  (depends	  on	  the	  pixel	  size:	  for	  example,	  RZZ	  
(negative	  stain)	  300	  x	  300	  size	  boxes	  were	  used	  and	  for	  cryo,	  a	  box	  size	  of	  512	  x	  512	  was	  used)	  are	  
boxed	  out	  from	  micrograph	  either	  manually	  or	  automatically.	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2.	  Averaging:	  images	  of	  similar	  views	  are	  aligned	  and	  averaged	  to	  achieve	  higher	  signal	  to	  noise	  ratio.	  
This	   process	   involves	   both	   rotational	   and	   translational	   shifting	   of	   individual	   particle	   images,	   which	  
generally	  gives	  information	  about	  the	  2D	  views	  of	  the	  sample	  and	  its	  inherent	  heterogeneity.	  
3.	   Determination	   of	   initial	   model/orientation	   parameters:	   an	   ab	   initio	   estimation	   of	   parameters	   is	  
obtained	  using	   the	   tilt	   approaches	   (random	  conical	   tilt,	   orthogonal	   tilt	   reconstruction),	  or	   common-­‐
lines	   based	   approaches	   (angular	   reconstitution	   with	   common-­‐lines).	   Various	  methods,	   operating	   in	  
real	   and	   Fourier	   space,	   have	  been	   implemented	   to	   calculate	   reconstructions	   and	  different	   software	  
packages	  make	  use	  of	  these	  diverse	  methods.	  A	  detailed	  explanation	  is	  beyond	  the	  scope	  of	  this	  work,	  
but	  a	  comprehensive	  overview	  can	  be	  found	  in	  many	  reviews	  [160,	  161].	  
4.	   Iterative	  refinement:	  each	  image	  is	  matched	  with	  the	  re-­‐projected	  images	  from	  the	  reconstructed	  
volume	   of	   the	   last	   iteration	   to	   determine	   orientation	   parameters	   for	   new	   reconstruction	   until	   it	  
reaches	  the	  convergence.	  
2.2.1.7.1 Negative	  staining	  
4	  µL	  of	  the	  sample	  was	  adsorbed	  for	  1	  min	  at	  25°C	  onto	  freshly	  glow-­‐discharged,	  carbon-­‐coated	  grids	  
(Agar	   scientific;	   G2400C).	   The	   sample	   was	   blotted	   (Whatman	   no.	   4),	   and	   the	   grids	   subsequently	  
washed	  with	  the	  size-­‐exclusion	  chromatography	  buffer	  (respective	  buffers	  in	  which	  each	  of	  the	  sample	  
was	   purified,	   for	   complexes	   and	   membrane	   proteins	   washing	   with	   water	   can	   lead	   to	   unfavorable	  
sample	  quality)	  and	  stained	  with	  0.07%	  of	  uranyl	   formate	  (SPI	  supplies),	  unless	  stated	  otherwise.	  All	  
the	   images	   were	   collected	   on	   a	   JEOL	   JEM1400	   electron	  microscope	   equipped	   with	   a	   LaB6	   cathode	  
operated	  at	  120	  kV.	  All	  the	  images	  were	  collected	  in	  low-­‐dose	  conditions	  (19	  e/Å2)	  at	  a	  magnification	  
of	  67,200	  X	  on	  a	  4k	  x	  4k	  camera	  (TVIPS	  F416).	  
2.2.1.7.2 	  2D	  analysis	  
For	  the	  2D	  negative	  stain	  analysis,	  particles	  were	  windowed	  out	  manually	  out	  of	  the	  collected	  images	  
using	   the	   e2boxer	   tool	   embedded	   in	   the	   EMAN2	   suite.	   Almost	   all	   the	   datasets	   were	   subjected	   to	  
binning	  for	  faster	  and	  effective	  use	  of	  the	  cluster	  space.	  The	  pixel	  size	  was	  adjusted	  correspondingly.	  
Particles	   were	   aligned	   and	   classified	   using	   reference-­‐free	   alignment	   and	   k-­‐means	   classification	  
programs	   implemented	   in	  SPARX.	  Some	  datasets	  were	  subjected	  to	  and	  analyzed	  by	   iterative	  stable	  
alignment	   and	   clustering	   (ISAC)	   procedures,	   also	   implemented	   in	   SPARX.	   For	   samples	   where	   the	  
averages	   were	   not	   so	   informative,	   custom-­‐made	   masks	   (using	   e2display	   tool	   in	   EMAN2)	   were	  
generated,	   and	   local	   alignments	   were	   performed.	   Following	   table	   lists	   all	   particles	   selected	   for	   2D	  
processing	  for	  various	  datasets.	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Table	  2.14	  List	  of	  number	  of	  particles	  selected	  manually	  for	  various	  datasets	  	  
Dataset	   Particles/boxsize	   Essential	  details	  
mini-­‐RZZ	   3424,	  256	  
Negative	   stain,	   defocus	   (-­‐1.5	   μm),	   JEOL1400,	   pixel	  
size	  -­‐2.3	  Å/pix.	  
mini-­‐RZZ	  (tilt-­‐pairs)	   1200,	  256	  
Negative	   stain,	   defocus	   (-­‐1.5	   &	   -­‐1.8	   μm),	   tilt	   angles	  
55°	  and	  0°,	  JEOL1400,	  pixel	  size	  -­‐2.3	  Å/pix.	  
R-­‐(nGFP)Z-­‐Z	   6964,	  350	  
Negative	   stain,	   defocus	   (-­‐1.5	   μm),	   JEOL1400,	   pixel	  
size	  -­‐2.3	  Å/pix.	  
R-­‐Z(cGFP)-­‐Z	   5756,	  350	  
Negative	   stain,	   defocus	   (-­‐1.5	   μm),	   JEOL1400,	   pixel	  
size	  -­‐2.3	  Å/pix.	  
RZZ	   4000,	  300	  
Negative	   stain,	   defocus	   (-­‐1.5	   μm),	   JEOL1400,	   pixel	  
size	  -­‐2.3	  Å/pix.	  
RZZ	  (tilt-­‐pairs)	   1700,	  300	  
Negative	   stain,	   defocus	   (-­‐1.5	   &	   -­‐1.8	   μm),	   tilt	   angles	  
55°	  and	  0°,	  JEOL1400,	  pixel	  size	  -­‐2.3	  Å/pix.	  
RZZ	  (cryo-­‐positve)	   4880,	  168	  
defocus	   (-­‐2	   to	   3	   μm),	   JEOL	   3200FSC,	   collected	  
automatically	  using	  EMtools	  software,	  pixel	  size-­‐1.25	  
Å/pix.	  
RZZ	   with	   ROD	   polyclonal	  
antibody	   targeted	   towards	  
the	  N-­‐terminus	  
500,	  300	  
Negative	   stain,	   defocus	   (-­‐1.5	   μm),	   JEOL1400,	   pixel	  
size	  -­‐2.3	  Å/pix.	  
RZZ	  (cryo)	   35404,	  512	  
Cryo,	  defocus	   (-­‐2	   to	  3	  μm),	   JEOL	  3200FSC,	   collected	  
manually	  and	  also	  using	  EMtools	  software,	  pixel	  size-­‐
1.25	  Å/pix.	  
RZZ	  (focal-­‐pairs)	   8550,	  512	  
Cryo,	  defocus	  range	  (-­‐2.5	  to	  3	  μm	  and	  corresponding	  
close	   to	   focus	   images	  at	   -­‐0.8-­‐1.5	  μm),	   JEOL3200FSC,	  
collected	  manually,	  pixel	  size	  -­‐2.3	  Å/pix.	  
RZZ	  (leiden)	   5000,	  600	  
Cryo,	  defocus	  (-­‐1.5	  to	  -­‐2.3	  μm),	  TITAN	  Krios,	  Falcon	  II	  
direct	   detector,	   7	   frames	   with	   total	   dose	   60	   e/Å2,	  
collected	  using	  EPU	  software,	  pixel	  size	  –	  1.14	  Å/pix.	  
Zw10	   10111,	  168	   Negative	  stain,	  Defocus	  (-­‐1.5	  μm),	  JEOL1400	  
2.2.1.7.3 Random	  conical	  tilt	  
For	  the	  negative	  stain	  3D	  reconstructions,	  tilt	  pairs	  were	  collected	  at	  tilt	  angles	  of	  55°	  and	  0°,	  and	  the	  
particle	  pairs	  were	  selected	  using	  the	  e2RCTboxer	  program	  embedded	  in	  EMAN2	  suite.	  The	  un-­‐tilted	  
stack	   of	   particles	   was	   used	   for	   reference	   free	   alignment	   and	   classification.	   A	   random	   conical	   tilt	  
reconstruction	  of	  the	  tilted	  particles	  was	  calculated	  from	  the	  particles	  corresponding	  to	  the	  best	  (un-­‐
tilted)	   class	   averages	   by	   back-­‐projection,	   followed	   by	   back-­‐projection	   refinement.	   Symmetry	  
assignment	  was	  essential	   for	  RZZ	  complex.	  2D	  averages	  revealed	  that	   the	  sample	  had	  C2	  symmetry.	  
Reconstructions	   were	   performed	   in	   the	   presence	   and	   absence	   of	   symmetry	   and	   revealed	   similar	  
density	   maps.	   C2	   symmetry	   was	   used	   for	   further,	   negative	   stain	   RZZ	   refinement	   steps.	   The	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reconstructions	   were	   further	   refined	   by	   iterative	   projection	   matching	   procedure	   implemented	   in	  
SPARX,	  until	  further	  convergence	  was	  achieved.	  The	  resolution	  of	  final	  reconstructions	  was	  estimated	  
by	  the	  Fourier	  Shell	  Correlation	  criterion	  (FSC0.5).	  This	  was	  a	  general	  approach	  used	  for	  RZZ	  and	  mini-­‐
RZZ	  datasets,	  the	  details	  of	  number	  of	  particles	  and	  the	  sizes	  of	  windows	  (in	  pixels)	  used	  for	  boxing	  are	  
listed	  in	  Table	  2.14.	  
2.2.1.7.4 Cryo-­‐EM	  
Holey	   carbon	   grids	   (Quantifoils,	   Protochips)	  were	   freshly	   glow	  discharged	   (two	   times	   on	   the	   darker	  
side	  and	  once	  on	  the	  lighter	  side	  of	  the	  grid)	  and	  4	  µL	  of	  the	  RZZ	  was	  applied.	  0.02%	  (w/v)	  Triton	  was	  
added	   to	   the	   sample	   just	   before	   its	   application	   onto	   the	   grid.	   After	   30	   s	   the	   sample	  was	  manually	  
blotted	   (Whatman	   4)	   followed	   by	   application	   of	   another	   1.7	   µL	   of	   the	   sample	   that	  was	   vitrified	   by	  
plunging	   (1	   s	   blotting)	   into	   liquid	   ethane	   using	   a	   Cryoplunge3	   (Cp3,	   Gatan	   Inc.)	   The	   humidity	   was	  
maintained	  to	  be	  around	  90%.	  Images	  were	  collected	  a	  JEOL	  3200FSC	  electron	  microscope	  equipped	  
with	   a	   field-­‐emission	   gun	   at	   an	   operation	   voltage	   of	   200	   kV,	   and	   a	   defocus	   range	   of	   1.5-­‐3	   μm.	   An	  
omega	  in-­‐column	  energy	  filter	  was	  used	  with	  a	  slit	  width	  of	  15	  eV.	  The	  images	  were	  recorded	  with	  an	  
8k	  x	  8k	  CMOS	  camera	  F816	  (TVIPS)	  at	  a	  pixel	  size	  of	  1.25	  Å/pixel	  using	  minimal	  dose	  conditions.	  
	  
2.2.1.7.5 CTF	  estimation	  and	  processing	  
The	  Contrast	   transfer	   function	   (CTF)	  parameters	   and	   the	  defocus	  were	  estimated	   for	   all	   the	   images	  
collected.	   Images	   with	   astigmatism,	   drift	   or	   poor	   CTF	   fit	   were	   discarded	   and	   not	   used	   for	   further	  
processing.	   Images	   were	   then	   binned	   four-­‐times	   to	   facilitate	   processing.	   Single	   particles	   were	  
manually	  selected	  using	  the	  e2boxer	  program	  (embedded	  in	  EMAN2	  suite)	  and	  windowed	  into	  128	  x	  
128	   pixel	   boxes	   (details	   in	   Table	   2.14).	   3D	   reconstructions	   were	   created	   by	   projection	   matching	  
procedure	   implemented	   in	   SPARX	   software	  package.	   The	  negative	   stain	   reconstruction	  was	  used	   as	  
the	   starting	   template	   for	   all	   the	   refinement	   procedures.	   C2	   symmetry	   was	   imposed	   on	   all	   the	  
refinement	  runs,	  as	  determined	  by	  the	  random	  conical	  tilt	  approach.	  Mask	  necessary	  for	  improvement	  
of	   structure	   and	   calculating	   Fourier	   Shell	   Correlation	   (FSC)	  was	   used.	   It	  was	   generated	   in	   SPARX	  by	  
low-­‐pass	   filtering	   the	  density	  map,	  binarizing	   it,	   and	   then	  expanding	   the	  binary	  volume	  by	  Gaussian	  
pixels.	  The	  resolution	  was	  always	  estimated	  by	  FSC0.5	  criteria.	  
2.2.2 Methods:	  Cln3p	  
2.2.2.1 Transformation	  into	  E.coli	  
Freshly	  thawed	  100	  µL	  cell-­‐aliquot	  (E.	  coli	  XL-­‐1	  Blue	  cells)	  was	  mixed	  with	  plasmid	  DNA	  (usually	  100	  –	  
200	  ng)	  and	  subsequently	  incubated	  on	  ice	  for	  30	  minutes.	  The	  cells	  were	  then	  transiently	  incubated	  
at	  42	  °C	  (heat	  shock)	  for	  1	  min	  to	  initiate	  the	  DNA	  uptake,	  following	  which	  they	  were	  allowed	  to	  stand	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for	  another	  minute.	  700	  µL	  SOC-­‐medium	  was	  then	  added	  to	  the	  cells	  and	  whole	  suspension	  incubated	  
for	  one	  hour	  at	  37	  °C.	  The	  cells	  were	  then	  pelleted	  (3	  min,	  6000	  rpm)	  and	  re-­‐suspended	  in	  a	  very	  small	  
volume	   of	   the	   supernatant	   (rest	  was	   discarded)	   and	   plated	   on	   LB	   agar	   plates	  with	   the	   appropriate	  
antibiotic	  resistance	  marker	  (125	  µg/mL).	  The	  plates	  were	  incubated	  overnight	  at	  37°C	  for	  colonies	  to	  
grow.	  
2.2.2.2 Expression	  screen	  in	  bacteria	  
A	  single	  clone/colony	  from	  a	  LB	  agar	  plate	  was	  used	  to	  inoculate	  30	  mL	  of	  LB	  medium	  containing	  125	  
μg/mL	  ampicillin	  (w/v,	   in	  a	  100	  mL	  flask)	  for	  an	  overnight	  culture.	  After	  overnight	  incubation,	  two	  1-­‐
liter	  flasks	  one	  with	  250	  mL	  2TY	  medium	  containing	  125	  μg/mL	  ampicillin	  (w/v)	  and	  another	  with	  250	  
mL	  TB	  medium	  containing	  125	  μg/mL	  ampicillin	  (w/v)	  were	  inoculated	  with	  2.5	  mL	  of	  the	  pre-­‐culture	  
each.	  The	  cultures	  were	  grown	  till	   the	  desirable	  OD600	  was	  reached	   following	  which,	  expression	  was	  
induced	  using	  IPTG	  (Isopropyl	  β-­‐D-­‐1-­‐thiogalactopyranoside)	  and	  three	  70	  mL	  aliquots	  of	  each	  type	  of	  
media	  were	  made	  and	  incubated	  each	  at	  25°C,	  30°C	  and	  37°C.	  Samples	  (15	  mL)	  were	  taken	  after	  1h,	  
2h,	   3h	   and	   overnight.	   Various	   conditions	   of	   expression	   the	   O.D	   and	   the	   amount	   of	   IPTG	   used	   for	  
expression	   are	   listed	   in	   Table	   2.15	   and	   are	   labeled	   from	   1-­‐23.	   The	   cells	   were	   centrifuged	   and	   the	  
resulting	   cell	   pellet	   was	   stored	   at	   -­‐20°C,	   till	   further	   use.	   The	   cell	   pellets	   were,	   subsequently	   lysed;	  
membranes	  extracted	  and	  solubilized	  to	  identify	  expression,	  by	  western	  blot	  analysis.	  
	  
Table	  2.15	  List	  of	  conditions	  in	  screening	  for	  expression	  
	   Condition	   O.D,	  IPTG	  
1	   2TY,	  25°C,	  1	  h	   0.8,	  0.5	  mM	  
2	   2TY,	  25°C,	  2	  h	   0.8,	  0.5	  mM	  
3	   2TY,	  25°C,	  3	  h	   0.8,	  0.5	  mM	  
4	   2TY,	  30°C,	  1	  h	   0.8,	  0.5	  mM	  
5	   2TY,	  30°C,	  2	  h	   0.8,	  0.5	  mM	  
6	   2TY,	  30°C,	  3	  h	   0.8,	  0.5	  mM	  
7	   2TY,	  37°C,	  1	  h	   0.8,	  0.5	  mM	  
8	   2TY,	  37°C,	  2	  h	   0.8,	  0.5	  mM	  
9	   2TY,	  37°C,	  3	  h	   0.8,	  0.5	  mM	  
10	   TB,	  25°C,	  1	  h	   0.8,	  0.5	  mM	  
11	   TB,	  25°C,	  2	  h	   0.8,	  0.5	  mM	  
12	   TB,	  25°C,	  2	  h	   0.8,	  0.5	  mM	  
13	   TB,	  30°C,	  1	  h	   0.8,	  0.5	  mM	  
14	   TB,	  30°C,	  2	  h	   0.8,	  0.5	  mM	  
15	   TB,	  30°C,	  3	  h	   0.8,	  0.5	  mM	  
16	   TB,	  37°C,	  1	  h	   0.8,	  0.5	  mM	  
17	   TB,	  37°C,	  2	  h	   0.8,	  0.5	  mM	  
18	   TB,	  37°C,	  3	  h	   0.8,	  0.5	  mM	  
19	   2TY,	  20°C,	  O/N	   1.2,	  0.5	  mM	  
20	   2TY,	  25°C,	  O/N	   0.8,	  0.5	  mM	  
21	   TB,	  20°C,	  O/N	   1.2,	  0.5	  mM	  
22	   TB,	  25°C,	  O/N	   0.8,	  0.5	  mM	  
23	   TB,	  37°C	  for	  4	  h	  followed	  by	  25°C	  O/N	   Auto-­‐induction	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2.2.2.3 Virus	  generation	  and	  insect	  cell	  expression	  
Plasmid	  DNA,	  harboring	  the	  gene	  of	  interest	  was	  mixed	  with	  the	  restricted	  baculovirus	  DNA	  (BACmid),	  
transfection	  agent	  and	  TC	  100	  media.	  Strong	  polyhedrin	  promoter	  drives	  the	  expression	  of	  proteins	  in	  
the	  late	  phase	  of	  infection.	  	  
The	  pictorial	  flowchart	  highlighting	  essential	  steps	  in	  generating	  a	  working	  stock	  of	  virus	  is	  illustrated	  
as	  Figure	  2.2.	  Initial	  transfection	  yielded,	  a	  P1	  viral	  stock,	  which	  was	  propagated	  further	  at	  low	  MOIs	  
(0.01	   -­‐	  0.1)	   to	  generate	   large	  amount	  of	  potent	  virus.	  However,	   for	  expression	  high	  MOI	   (1-­‐10)	  was	  
used.	  MOI	  can	  be	  defined	  by	  the	  equation	  as	  follows:	  
	  
	   MOI   =    Volume  [Virus]  x  Concentration  [Virus]Volume[Cell  culture]  x  Concentration  [Cell  culture]	  
	  
Sf21	  cells	  with	  a	  density	  of	  0.5	  x	  106	  in	  TC	  100	  Medium,	  supplemented	  with	  Pen/Strep,	  Pluronic	  and	  10	  
%	  FCS,	  were	  used	  for	  expression.	  Insect	  cell	  cultures	  were	  transfected	  under	  the	  clean	  bench	  with	  the	  
virus:cell	  ratio	  of	  1:10,	  1:100,	  1:1000	  and	  1:10000.	  The	  expression	  was	  monitored	  after	  every	  6	  h	  by	  
fluorescence	   microscopy	   for	   proteins	   expressed	   as	   fusions	   with	   fluorescent	   tags.	   For	   constructs	  
without	  a	  fluorescent	  reporter	  tag,	  the	  expression	  was	  monitored	  by	  western	  blot	  analysis.	  Expression	  
is	  best	  when	  cells	  are	   infected	  with	  virus	  at	  MOI	  of	  10	  (assuming	  the	  virus	   is	  very	  potent,	  typically	  a	  
titer	   range	   of	   10^9	   pfu/mL)	   and	   after	   72	   h	   or	   infection.	   Cells	   were	   harvested	   after	   72	   h	   and	  
centrifuged	  at	  6,000	  rpm	  for	  20	  minutes,	  following	  which	  they	  were	  washed	  with	  TBS.	  The	  cell	  pellet,	  
if	  not	  processed	  directly	  was	  flash	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐20	  °C,	  till	  further	  use.	  
	  
	  
Figure	  2.2:	  Schematic	  of	  virus	  generation	  and	  propagation	  
2.2.2.4 Lysis	  and	  membrane	  isolation	  
The	  Cell	  pellet	  was	  resuspended	  in	  lysis	  buffer	  (usually	  50	  mL	  for	  a	  cell	  pellet	  from	  1L	  of	  insect	  cells),	  
the	  suspension	  stirred	  for	  30	  min	  at	  4	  °C	  and	  then	  lysed	  using	  a	  microfluidizer	  at	  a	  pressure	  of	  700	  psi.	  
This	  step	  was	  repeated	  3	  -­‐	  4	  times	  and	  the	  temperature	  was	  maintained	  at	  4°C.	  Following	  this,	  the	  cell	  
lysate	  was	  centrifuged	  for	  25	  min	  at	  15,000	  rpm	  (4	  °C).	  To	   isolate	  membranes	  from	  the	  supernatant	  
pool	  and	  to	  get	  rid	  of	  the	  nuclear	  and	  cytosolic	  fraction,	  the	  supernatant	  from	  the	  previous	  step	  was	  
subjected	  to	  ultracentrifugation	  (Ti	  70	  rotor,	  50,000	  rpm,	  90	  min,	  4	  °C).	  The	  pellet	  was	  homogenized	  in	  
50	  mM	  HEPES	  and	  used	  either	  directly	  for	  purification	  or	  frozen	  for	  subsequent	  use	  at	  a	  later	  date.	  For	  
proteins	   expressed	   with	   fluorescent	   tags,	   the	   membrane	   would	   reflect	   the	   color	   of	   the	   tag	   used	  
intensively.	  Otherwise,	   the	  purification	  was	  not	   really	   good.	  After	   incubation	   for	  30	  min	  at	  4	   °C	   the	  
suspension	  was	  pelleted	  down	  again	  (Ti	  70	  rotor,	  55,000	  rpm,	  30	  min,	  4	  °C),	  the	  supernatant	  discarded	  
and	   the	   pellet	   was	   then	   homogenized	   in	   solubilization	   buffer	   containing	   0.5	   %	   (w/v)	   Fos-­‐13.	   The	  
Materials	  and	  methods	   	  
	  
62	  
mixture	  was	  gently	  stirred	  3	  hours	  at	  4°C.	  Finally,	   insolubilized	  membrane	  remains	  were	  centrifuged	  
down	  (Ti	  70	  rotor,	  55,000	  rpm,	  30	  min,	  4	  °C)	  and	  discarded.	  	  
2.2.2.5 Detergent/solubilization	  screen	  
The	  membranes	  were	  isolated	  as	  described	  above	  and	  resuspended	  in	  TBS.	  100	  µl	  of	  membrane	  was	  
mixed	  with	  200	  µl	  of	  solubilization	  buffer	  containing	  respective	  detergents	  (1%)	  and	  incubated	  for	  2	  h	  
at	  4°C.	  For	  this	  study,	  various	  detergents	  were	  tested	  (DDM	  (n-­‐Dodecyl-­‐ß-­‐maltoside),	  DM	  (n-­‐decyl-­‐ß-­‐
maltoside),	   CHAPS,	   OG	   (n-­‐Octyl-­‐β-­‐D-­‐Glucopyranoside),	   Fos-­‐Choline-­‐12,	   Fos-­‐Choline-­‐13,	   Cymal-­‐6	   and	  
Triton-­‐X100).	  A	  sample	  was	  taken	  from	  each	  detergent-­‐membrane	  mixture	   (this	  sample	  was	   labeled	  
before	   centrifugation	   (BC)).	   The	   rest	  was	   centrifuged	  at	  55,000	   rpm	   for	  30	  minutes	  at	  4°C.	  Another	  
sample	   was	   taken	   from	   the	   supernatant	   of	   each	   detergent-­‐membrane	   mixture	   and	   named	   ‘after	  
centrifugation’	   (AC).	  Samples	  were	  mixed	  with	  SDS-­‐loading	  buffer	  run	  on	  semi-­‐denaturing	  SDS-­‐PAGE	  
and	  scanned	  for	  in-­‐gel	  fluorescence.	  The	  detergent	  that	  gave	  the	  same	  band	  intensity	  before	  and	  after	  
centrifugation	  was	   considered	   optimal.	   In	   order	   to	   optimize	   the	   solubilization	   efficiency	   parameter	  
such	  as	  detergent	  concentration,	  salt	  concentration	  or	  longevity	  of	  solubilization	  was	  altered.	  	  
2.2.2.6 Purification	  of	  hCln3p	  (EGFP	  at	  the	  N-­‐terminus)	  
The	  protocol	  for	  EGFP-­‐Cln3p	  (human,	  construct	  p232,	  AG	  Raunser	  database)	  will	  be	  described;	  other	  
Cln3p	  constructs	  were	  purified	  along	  similar	   lines.	  EGFP-­‐Cln3p	  was	  expressed	   in	  Sf21	  cells	  at	  MOI	  of	  
10.	  	  
NOTE:	  The	  purification	  is	  best	   if	  the	  membranes	  are	  intensively	  green,	   incase	  of	  deviation	  from	  norm	  
(may	  occur	  due	  to	  various	  reasons	  passage	  number	  of	  cells,	  problems	  with	  virus)	  the	  protocol	  does	  not	  
give	  best	  results	  and	  needs	  to	  modified	  spontaneously	  and	  diligently.	  
Cells	  were	  harvested	  after	  72	  h,	   lysed	  and	   the	  membrane	  extracted	   following	  procedures	  described	  
above.	   For	   small-­‐scale	   purification,	   3	  mL	  of	   the	  membrane	   (in	   50mM	  HEPES)	  was	   solubilized	   in	   the	  
solubilization	  buffer	   in	   final	  volume	  of	  15	  mL	   for	  3	  hours	  at	  4°C	  with	  gentle	  shaking.	  The	  solubilized	  
sample	  was	  centrifuged	  at	  55,000	  rpm	  for	  30	  minutes	  at	  4°C,	  the	  supernatant	  filtered	  (ø	  0.2	  µm)	  and	  
added	  to	  1.5	  mL	  of	  (Ni-­‐NTA	  or	  TALON)	  resin	  already	  calibrated	  with	  the	  wash	  buffer	  A-­‐fos	  (with	  0.05%	  
Fos-­‐Choline-­‐13).	   5	   mM	   imidazole	   was	   also	   added	   to	   reduce	   non-­‐specific	   binding	   and	   the	   ‘resin-­‐
solubilized	  membrane’	   suspension	  was	   incubated	  with	  mild	  agitation	  at	  4°C	   for	  1h.	  The	  sample	  was	  
packed	   in	   Econo-­‐Pac	   chromatography	   column	   (BIO-­‐RAD).	   The	   resin	  was	  washed	  with	   10-­‐20	   column	  
volumes	  (CV,	  15	  mL	  in	  this	  case)	  of	  washing	  buffer	  A	  and	  with	  5-­‐10	  CV	  of	  washing	  buffer	  B	  (the	  volume	  
of	   second	   wash	   was	   reduced	   if	   there	   was	   considerable	   amount	   of	   protein	   being	   leeched	   off	   the	  
column).	  Protein	  was	  eluted	  with	  5	  CV	  of	  the	  elution	  buffer	  in	  to	  0.5	  mL	  fractions	  manually.	  Aliquots	  
from	   the	   solubilized	   membrane	   fraction,	   flow-­‐through,	   washing	   steps	   and	   eluted	   fractions	   were	  
loaded	   on	   a	   semi-­‐denaturing	   SDS-­‐PAGE	   to	   follow	   the	   purification	   profile	   of	   the	   protein.	   Gels	   were	  
scanned	  for	  fluorescence	  with	  the	  VersaDoc	  (mCherry:	  Filter:	  605BP.:	  Illumination:	  Blue	  LED:	  Gain;	  4x;	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Binning:	  4x4.	  GFP:	  Filter:	  530BP.:	  Illumination:	  Blue	  LED:	  Gain;	  4x;	  Binning:	  2x2),	  Coomassie	  stained	  or	  
subjected	  to	  western	  blotting	  (in	  cases	  where	  there	  were	  no	  fluorescent	  reporter	  tags).	  	  
Large	  scale	  purifications,	   followed	  similar	   lines	  where	  5	  mL	  of	  pre-­‐packed	   IMAC	  columns	  were	  used,	  
the	   loading	   and	   wash	   steps	   carried	   out	   using	   a	   peristaltic	   pump	   and	   the	   eluting	   protein	   was	  
fractionated	  using	  ÄKTA	  purifier.	  
2.2.2.7 Detergent	  exchange	  	  
The	  only	  case	  where	  detergent	  exchange	  worked	  was	  when	  the	  detergent	  was	  exchanged	  from	  Fos-­‐
Choline-­‐13	   to	   MNG-­‐3	   on	   the	   IMAC	   column.	   Briefly,	   after	   the	   membranes	   were	   solubilized	   in	   Fos-­‐
Choline-­‐13,	  filtered	  and	  loaded	  onto	  the	  metal-­‐affinity	  resin/columns,	  the	  wash	  steps	  were	  carried	  out	  
with	  a	  buffer	  containing	  0.05%	  of	  MNG-­‐3	   (instead	  of	  Fos-­‐13,	   called	  wash	  buffer-­‐mng).	  Similarly,	   the	  
elution	  buffer	  had	  Fos-­‐Choline-­‐13	  substituted	  with	  MNG-­‐3	  (0.1	  %).	  Everything	  else	  was	  maintained	  as	  
before.	  	  
2.2.2.8 Tag	  cleavage	  
The	  cleavage	  of	  tag	  (EGFP-­‐6x-­‐His	  or	  just	  6x-­‐His)	  worked	  only	  in	  the	  case	  of	  constructs	  with	  large	  linker.	  
Dennis	  Quentin	   optimized	   the	   protocol.	   The	   cleavage	   of	   tag	  was	   carried	   out	   in	   two	   different	  ways.	  
One,	   the	   eluate	   (in	   MNG-­‐3	   buffer)	   was	   pooled,	   and	   a	   dialysis	   set	   up	   to	   get	   rid	   of	   the	   imidazole,	  
overnight.	  The	  dialysis	  buffer	  was	  spiked	  with	  PreScission	  protease	  (generated	  by	  DPF,	  used	  0.03-­‐0.06	  
mg/	   1mg	   of	   purified	   Cln3p).	   The	   pooled	   protein	   was	   concentrated	   (Amicon	   MWCO:	   50kDa)	   and	  
subjected	   to	   size-­‐exclusion	   chromatography	   (Superose	   6	   10/300	   GL).	   Alternatively,	   elution	   buffer	  
consisting	  of	  protease	  and	  no	  imidazole	  was	  used.	  The	  cleavage	  reaction	  was	  carried	  on	  the	  column.	  
The	   flow	   through	   was	   collected	   and	   concentrated	   (Amicon	   MWCO:	   50kDa)	   and	   subjected	   to	   size-­‐
exclusion	  chromatography	  (Superose	  6	  10/300	  GL).	  
Both	  of	  the	  following	  methods	  led	  to	  precise	  cleavage	  of	  the	  tag,	  but	  best	  results	  were	  obtained	  with	  
the	  latter.	  	  
2.2.2.9 Chromatography	  methods:	  Size	  exclusion	  and	  ion-­‐exchange	  chromatography	  
All	  chromatography	  based	  purification	  methods	  were	  performed	  using	  the	  ÄKTA	  purifier	  at	  4	  °C.	  For	  
size	   exclusion	   chromatography	   either	   Superose	   6	   10/30	   GL	   or	   Superose	   12	   10/30	   GL	   columns	   was	  
used.	  The	  column	  was	  equilibrated	  with	  filtered	  (ø	  0.2	  µm)	  and	  degased	  SEC	  buffer.	  All	  the	  SEC	  buffers	  
used	   for	   Cln3p	   contained	   detergent.	   After	   injecting	   the	   desired	   volume	   in	   the	   loading	   loop	   (usually	  
between	   100	   µL	   and	   1	   mL),	   a	   preset	   program	   with	   a	   constant	   flow-­‐rate	   of	   0.3	   mL/min	   was	   used.	  
Fractions	   (0.5-­‐1	  mL)	  were	   collected	   automatically.	   The	   Adsorption	   at	   280	   nm	   and	   the	   fluorescence	  
(detector	  RF-­‐551,	   low	  sensitivity)	  were	  monitored	   (GFP:	  Ex.	  420	  nm;	  Em.	  550	  nm;	  mCherry:	   Ex.	  520	  
nm;	   Em.	   650	   nm).	   The	   fractions	   corresponding	   to	   the	   appearing	   peaks	   were	   analyzed	   by	   semi-­‐
denaturing	  SDS-­‐PAGE	  or	  Western	  blot.	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For	   ion	   exchange	   chromatography	   Mono	   S	   column	   was	   used	   with	   flow	   rate	   between	   0.3	   and	   0.5	  
mL/min.	  Before	  loading	  the	  elution	  fractions	  from	  IMAC,	  they	  were	  pooled	  and	  desalted	  to	  a	  final	  salt	  
concentration	   of	   50	  mM	  using	   PD	   10	   desalting	   columns.	   The	   protocol	   for	   desalting	  was	   as	   per	   the	  
associated	   manual	   (for	   PD	   10	   columns).	   Absorption	   at	   280	   nm	   and	   fluorescence	   were	   monitored	  
similar	  to	  SEC	  chromatography.	  A	  salt	  gradient	  from	  50	  to	  500	  mM	  salt	  was	  used	  to	  elute	  the	  proteins.	  
Peaks	  were	  analyzed	  either	  with	  semi	  denaturing	  SDS	  PAGE	  or	  with	  western	  blot.	  
2.2.2.10 Methods	  for	  analysis	  	  
2.2.2.10.1 Semi-­‐denaturing	  SDS-­‐PAGE	  
10-­‐15	  %	   gels	  were	  used	   for	   all	   the	   SDS-­‐PAGE	  analysis.	   Before	   loading,	   samples	  were	  mixed	  with	   4x	  
semi-­‐denaturing	   sample	   buffer	   and	   gels	   run	  with	   a	   standard	   protein	  weight	  marker	   at	   150	   V.	   Gels	  
were	   scanned	   for	   in-­‐gel	   fluorescence	   (if	   necessary,	   for	   proteins	   with	   fluorescent	   tags)	   and	  
subsequently	   stained	   by	   Coomassie	   solution	   for	   10	   to	   30	   min.	   Excess	   dye	   was	   removed	   and	   gels	  
destained	  by	   transferring	   into	  a	  10	  %	  acetic	  acid	  solution	  and	  was	   further	   incubated	  until	   solely	   the	  
protein	  bands	  were	  visible.	  
In	  contrast	  to	  the	  normal	  SDS-­‐PAGE,	  samples	  were	  not	  heated	  before	  loading	  and	  loading	  buffer	  had	  
minimal	  amount	  of	  SDS	   to	  preserve	   the	   folding	  of	   fluorescent	   reporter	   tags	   (mCherry	  and	  GFP)	  and	  
hence	   enabling	   scanning	   the	   in-­‐gel	   fluorescence	   with	   the	   VersaDoc	   Imaging	   system.	   The	   main	  
drawback	   of	   this	   technique	   is	   slight	  modification	   of	  migration	   behavior,	   it	   brings	   about,	   of	   partially	  
folded	  proteins	  which	  makes	  it	  sometimes	  hard	  to	  predict	  the	  position	  of	  the	  protein,	  when	  subjected	  
to	  biochemical	  analysis.	  
2.2.2.10.2 Blue-­‐native	  PAGE	  
Samples	  were	  mixed	  with	  varying	  concentrations	  of	  SDS	  (0	  –	  2.5	  %)	  and	  loaded	  with	  a	  10x	  blue-­‐native	  
loading	  buffer	  onto	  a	  4	  –	  16	  %	  Gradient	  Gel.	  The	  gel	  was	  run	  overnight	  at	  4	  °C	  with	  constant	  current	  of	  
1	  -­‐	  2	  mA	  (usually	  16	  h).	  Following	  this,	  the	  gel	  was	  fixed	  for	  one	  hour	  in	  methanol	  containing	  fixation	  
solution	   and	   subsequently	   destained	   with	   10	   %	   acetic	   acid	   (additional	   Coomassie	   staining	   was	   not	  
necessary	  due	  to	  the	  Coomassie	  containing	  buffer).	  
2.2.2.10.3 Western	  blot	  analysis	  
Samples	  were	   run	  on	  a	   semi-­‐denaturing	  SDS-­‐PAGE	  as	  described	  above.	   Following	   the	  SDS-­‐PAGE	   the	  
gel	  was	  transferred	  into	  the	  western	  chamber,	  above	  a	  nitrocellulose	  membrane	  and	  sandwiched	  in-­‐
between	  the	  Whatman	  filter	  papers.	  The	  western	  blot	  was	  run	  for	  1h	  at	  a	  constant	  current	  of	  50	  mA.	  
Prior	  to	  this,	  membrane	  was	  activated	  by	  incubation	  in	  methanol	  for	  1	  min	  and	  Whatman	  filter	  papers	  
were	  equilibrated	  in	  transfer	  buffer.	  Pre-­‐stained	  protein	  marker	  served	  as	  an	  indicator	  for	  a	  successful	  
transfer	   (alternatively,	   western	   blot	   marker	   was	   used	   at	   times).	   Subsequently,	   the	   membrane	   was	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incubated	  with	  blocking	  solution	  for	  1	  h	  to	  prevent	  or	  minimize	  unspecific	  binding	  of	  the	  antibodies.	  
After	  washing	  with	  TBS,	  the	  membrane	  was	  incubated	  with	  primary	  antibody	  solution	  for	  1	  h	  at	  RT	  (or	  
overnight	  at	  4	  °C).	  Following	  this,	  the	  membrane	  was	  rinsed	  twice	  with	  TBS-­‐TT	  and	  once	  with	  TBS,	  and	  
incubated	  with	  the	  secondary	  AB	  for	  1	  h.	  After	  the	  incubation	  of	  membrane	  with	  secondary	  antibody,	  
it	  was	  rinsed	  four	  times	  with	  TBS-­‐TT	  and	  twice	  with	  TBS.	  All	  the	  washing	  steps	  were	  carried	  out	  for	  10	  
minutes	  (rocking).	  Finally	  to	  visualize	  the	  bands	  2	  mL	  BCIP/NBT	  solution	  was	  added.	  The	  colorimetric	  
reaction	  initiated	  in	  the	  previous	  step	  was	  stopped	  by	  addition	  of	  water.	  The	  blot	  was	  scanned	  with	  a	  
flatbed-­‐scanner.	  	  
2.2.2.10.4 Estimation	  of	  the	  concentration	  of	  the	  protein	  
Protein	  concentrations	  were	  estimated	  with	  the	  Bradford	  Assay.	  Briefly,	  1	  µL	  of	  protein	  solution	  was	  
mixed	  with	   49	   µL	   of	   ddH2O	   and	   150	   µL	   Bradford	   solution	   to	   a	   final	   volume	   of	   200	   µL	   in	   a	   96-­‐well	  
microtiter	   plate.	   Buffer	  without	  protein	   served	  as	   a	  blank.	   Samples	  were	   thoroughly	  mixed	  and	   the	  
absorbance	   at	   595	   nm	   was	   measured	   on	   a	   Polarstar	   Omega	   Multititer	   Plate	   Reader.	   The	   final	  
concentration	  of	  the	  protein	  was	  estimated	  by	  back-­‐calculation	  from	  a	  calibration	  curve	  plotted	  using	  
bovine	  serum	  albumin	  (BSA)	  as	  standard.	  
2.2.2.11 HPLC-­‐MS	  analysis	  of	  Cln3p	  
Characteristic	  protein	  bands	  were	  excised	  using	  a	  scalpel	  and	  chopped	   into	  small	  pieces.	  After,	  brief	  
incubation	  in	  50	  µL	  acetonitrile	  for	  10	  min,	  acetonitrile	  was	  removed	  and	  gel	  pieces	  were	  re-­‐hydrated	  
in	  50	  µL	  of	  0.1	  M	  NH4HCO3	  for	  5	  min.	  50	  µL	  of	  acetonitrile	  was	  added	  again	  and	  pieces	  incubated	  for	  
15	  min.	  The	  supernatant	  was	  discarded	  and	  gel	  pieces	  dried	  in	  the	  SpeedVac	  for	  30	  min.	  50	  µL	  of	  10	  
mM	  DTT/0.1	  M	  NH4HCO3	  was	  added	  to	  the	  reaction	  tube	  and	  incubated	  at	  56	  °C	  for	  45	  min,	  followed	  
by	  subsequent	  cooling	  of	  the	  mixture	  to	  RT.	  Gel	  pieces	  were	  treated	  again	  with	  50	  µL	  acetonitrile	  for	  5	  
min	  and	  after	  removal	  of	  supernatant,	  50	  µL	  of	  55	  mM	  iodoacteamide/0.1	  M	  NH4HCO3	  was	  added	  and	  
the	   tubes	   incubated	   in	   the	   dark	   for	   15	   min.	   Following	   steps	   were	   repeated	   again:	   Removal	   of	  
supernatant,	   treatment	   with	   50	   µL	   acetonitrile	   (5	   min),	   removal	   of	   supernatant	   and	   drying	   of	   gel	  
pieces	  in	  the	  SpeedVac	  for	  30	  min.	  202	  µL	  digestion	  buffer	  was	  added	  to	  the	  dried	  pieces.	  After	  45	  min	  
incubation	  on	   ice,	   the	  supernatant	  was	  removed	  and	  200	  µL	  of	  digestion	  buffer	  without	  trypsin	  was	  
added	  and	  further	  incubated	  overnight	  at	  37	  °C.	  	  
On	  the	  following	  day,	  reaction	  tubes	  were	  centrifuged	  for	  1	  min	  at	  13,000	  rpm,	  and	  the	  supernatant	  
transferred	   into	   a	   fresh	   tube	   followed	   by	   addition	   of	   20	   µL	   0.1	   M	   NH4HCO3	   and	   a	   15	   min-­‐long	  
incubation.	  Another	  20	  µL	  0.1	  M	  NH4HCO3	  was	  added	  followed	  by	  additional	  15	  min	  incubation.	  After	  
drying	  of	  the	  isolated	  peptides	  for	  60	  min	  in	  SpeedVac,	  they	  were	  stored	  in	  a	  freezer,	  till	  further	  use.	  
Peptides	  were	  re-­‐suspended	   in	  100	  µL	  0.1	  %	  formic	  acid	  and	  30	  µL	  was	  transferred	  to	  a	  HPLC	  micro	  
vial	   for	   HPLC-­‐MS	   analysis,	   which	   was	   performed	   by	   Dr.	   Petra	   Janning	   (Department	   of	   Chemical	  
Biology,	  MPI).	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2.2.2.12 PNGase	  assay	  
To	  check	  for	  protein	  glycosylation	  (which	  may	  interfere	  in	  various	  structural	  studies,	  at	  times)	  and	  to	  
obtain	   a	   homogenous	   protein	   population,	   the	   asparagine	   aminase	   PNGase	   F	   is	   commonly	   used.	  
Protocol	   as	   specified	   by	   the	   manufacturer	   was	   followed.	   The	   results	   were	   analyzed	   on	   a	   semi-­‐
denaturing	  SDS-­‐PAGE.	  
2.2.2.13 γ-­‐phosphatase	  assay	  
Briefly,	  for	  100	  µg	  of	  protein	  60	  µL	  of	  γ-­‐phosphatase	  solution	  was	  used.	  Reactions	  were	  set	  up	  and	  the	  
products	  separated	  via	  semi-­‐denaturing	  SDS-­‐PAGE.	  Subsequently,	  the	  gel	  was	  incubated	  with	  100	  mL	  
of	   freshly	  prepared	   fixation	  solution	   for	  1	  h	  at	  RT.	  This	  step	  was	  repeated	   followed	  by	  rinsing	  thrice	  
with	  ddH2O	  (10	  min).	  The	  gel	  was	  stained	  for	  90	  min	  in	  20	  mL	  Pro-­‐Q	  Diamond	  phosphostain	  solution	  in	  
the	  dark	  followed	  by	  incubation	  with	  100	  mL	  destaining	  solution	  for	  30	  min	  in	  the	  dark,	  for	  destaining.	  
The	   destaining	   step	  was	   repeated	   twice	   followed	   by	   wash	  with	   5	  min	   ddH2O.	   The	   gel	   was	   imaged	  
under	  the	  Typhoon	  Scanner.	  An	  excitation	  wavelength	  of	  532	  nm,	  an	  emission	  wavelength	  of	  580	  nm	  
and	  a	   scan	  width	  of	  50	  µm	  with	  a	   sensitivity	  of	  300	  or	  600	  were	  used.	  Coomassie	   staining	   followed	  
imaging.	  
Table	  2.16	  γ-­‐phosphatase	  reaction	  
	   Cleaved	   Uncleaved	   BSA	  
	   conc.:	  0.8	  mg/mL	   conc.:	  0.8	  mg/mL	   conc.:	  10	  mg/mL	  
	   +	   -­‐	   +	   -­‐	   +	   -­‐	  
protein	   50	   50	   12,5	   12,5	   1	   1	  
Reaction	  buffer	  10x	   10	   10	   10	   10	   10	   10	  
MnCl2	  (100	  mM)	   10	   10	   10	   10	   10	   10	  
γ-­‐phosphatase	   24	   0	   6	   0	   6	   0	  
ddH20	   6	   30	   61.5	   67.5	   73	   79	  
	   100	  µL	   100	  µL	   100	  µL	   100	  µL	   100	  µL	   100	  µL	  
2.2.2.14 2D	  crystallization	  trials	  
Two-­‐dimensional	   crystallization	   trials	   were	   set-­‐up	   with	   a	   protein	   concentration	   of	   1	   mg/mL.	   Lipid	  
stocks	  were	  prepared	  at	  10	  mg/mL	  and	  dialysis	  membranes	  (Spectra/Por®	  4	  -­‐	  MWCO	  12	  000	  -­‐14	  000)	  
were	  cut	   to	  appropriate	   size.	  The	   lipid	   (dissolved	   in	  chloroform)	  was	   transferred	   to	  a	  clean	   reaction	  
tube	  and	  slowly	  dried	  under	  a	  stream	  of	  argon	  to	  get	  rid	  of	  all	  the	  chloroform.	  This	  was	  followed	  by	  
addition	  of	  protein	  (always	  60	  µL,	  1	  mg/mL	  as	  final	  volume)	  mixing	  it	  gingerly.	  Protein	  and	  lipids	  were	  
mixed	  in	  ratios	  (w/w),	  designated	  as	  Lipid-­‐Protein-­‐Ratios	  (LPR).	  LPRs	  ranging	  from	  0.1	  –	  1	  were	  used.	  
After	  1h,	  of	   incubation	   in	   the	  dark,	   the	  protein-­‐lipid	  mixture	  was	  carefully	   transferred	   into	  a	  dialysis	  
button	   and	   sealed	  with	   a	   square	   piece	   of	  membrane	   (for	   good	   dialysis,	   it	   is	   important	   to	   avoid	   air	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bubbles).	  The	  buttons	  were	  placed	  in	  a	  dialysis	  buffer	  that	  lacked	  detergent	  and	  were	  dialyzed	  for	  1-­‐2	  
weeks.	  Sodium	  azide	  was	  added	  to	  all	  the	  dialysis	  buffers	  to	  prevent	  bacterial	  growth.	  
The	   samples	   were	   prepared	   and	   analyzed	   by	   negative	   stain	   electron	   microscopy	   as	   described	   in	  
section	  2.2.1.7.1.	  
2.2.2.15 3D	  crystallization	  trials	  
Various	  crystallization	  suites	  (also	  called	  screens)	  from	  the	  manufacturer	  Qiagen	  were	  used:	  JCSG	  Core	  
I-­‐IV,	  JCSG+,	  MbClass	  I,	  MbClass	  II,	  pHclear	  I,	  pHclear	  II,	  Classics	  I,	  Classics	  II,	  PEGs,	  PEGs	  II,	  PACT.	  All	  the	  
screens	  were	  set	  up	  in	  96	  well	  crystallization	  plates	  (Corning	  3550).	  The	  compositions	  of	  these	  suites	  
rely	  on	  statistical	  analysis,	  aimed	  at	  achieving	  the	  highest	  probability	  of	  nucleation	  and	  crystal	  growth	  
by	   interweaving	   various	   pH	   values,	   salts,	   precipitants	   and	   additives	   in	   varying	   concentrations.	   The	  
precipitant	  solution	  (70	  µL)	  was	  transferred	  into	  the	  wells	  semi-­‐automatically,	  followed	  by	  automated	  
pipetting	   of100	   nL	   of	   the	   protein	   solution	   (centrifuged	   to	   remove	   aggregates,	   dispensed	   using	  
Mosquito	   robot).	   100	   nL	   of	   the	   reservoir	   solution	   was	   also	   pipetted	   automatically	   into	   the	   wells	  
containing	   protein	   solution.	   Subsequently,	   the	   plate	   was	   sealed	   to	   prevent	   evaporation	   and	   to	  
maintain	  a	  closed	  system	  establishing	  equilibrium	  between	  fluid	  and	  gas	  phases,	  crucial	  for	  nucleation.	  
The	   sealed	   plates	   were	   transferred	   in	   an	   automated	   imaging	   system	   (Formulatrix)	   and	   were	  
monitored	  for	  crystal	  growth	  at	  preset	   time	   intervals.	  Trials	  were	  also	  setup	   in	  different	  Formulatrix	  
systems	  operating	  at	  different	   temperatures:	  One	  at	  4	   °C,	   the	  other	  at	  20	   °C.	  Protein	  concentration	  
(ranging	  between	  1	  and	  10	  mg/mL)	  was	  used.	  
2.2.2.16 Fluorescence	  microscopy	  
2.2.2.16.1 Cell	  culture	  
For	  all	  experiments	  Neuronal-­‐N2a	  (generous	  gift	  from	  Dr.	  Leif	  Dehmelt)	  cells	  were	  used.	  The	  cells	  were	  
cultured	   in	   the	  standard	  mammalian	  cell	  growth	  medium	  at	  37°C	   in	  a	  humidified	   incubator	  with	  5%	  
(v/v)	  CO2	  saturation.	  In	  order	  to	  maintain	  the	  cells	  in	  culture,	  they	  were	  kept	  in	  a	  75	  cm²	  cell	  culture	  
flask	   (BD	  Falcon)	   till	   they	   reached	  90%	  confluence.	  At	   this	  density,	   the	  cells	  were	  passaged.	  The	  old	  
growth	  medium	  was	  removed	  from	  the	  flask	  and	  the	  cell	  layer	  was	  briefly	  rinsed	  in	  sterile	  1x	  PBS	  (pH	  
7.5).	   In	  order	   to	  detach	   the	  cells	   from	  the	  surface	  2	  mL	  of	   trypsin/EDTA	  solution	   (PAN	  Biotech)	  was	  
added	  and	  the	  cell	  suspension	  was	  incubated	  for	  1-­‐2	  minutes	  at	  room	  temperature.	  Adding	  10	  mL	  of	  
complete	   growth	  medium	   containing	   10%	   FCS	   inactivated	   the	   trypsin.	   The	   resulting	   cell	   suspension	  
was	  gently	  pipetted	  up	  and	  down	  several	  times	  such	  that	  no	  cell	  clusters	  remained	  in	  the	  suspension.	  
1	  mL	  of	   the	  suspension	  was	   transferred	  to	  a	  new	  flask	  containing	  12	  mL	   fresh	  standard	  mammalian	  
cell	   growth	   medium.	   Following	   this	   protocol	   a	   90%	   confluence	   was	   reached	   every	   2-­‐3	   days.	   Cells	  
growing	   at	   that	   speed	   are	   generally	   considered	   healthy	   for	   experiments.	   Cells	   beyond	   passage	   20	  
were	  generally	  not	  used	  any	  further.	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2.2.2.16.2 Fluorescence	  imaging	  
For	  fluorescence	  imaging,	  cells	  were	  seeded	  into	  a	  6-­‐well	  cell	  culture	  insert	  companion	  plate	  with	  lid	  
(BD	   Falcon)	   containing	   cover	   slips.	   In	   each	   well,	   2	   mL	   of	   standard	   growth	   medium	   was	   added	  
containing	  0.5x106	  N2a-­‐cells.	  The	  cells	  were	  incubated	  for	  24	  h	  to	  attach	  to	  the	  glass	  cover	  slip.	  After	  
attachment	  to	  the	  surface,	   transfection	  was	  carried	  out	  using	  FuGene	  (Roche).	  The	  transfection	  was	  
done	   according	   the	   manufacturer’s	   protocol	   using	   a	   1µL	   FuGene/0.5	   µg	   DNA	   ratio.	   Prior	   to	  
transfection	   the	  media	  was	   removed	  and	  1	  mL	  of	   fresh	  growth	  medium	  without	  FBS	  and	  antibiotics	  
was	  added.	  	  
The	   cells	   were	   fixed	   using	   2	   mL	   of	   a	   3.6%	   PFA	   (w/v)	   solution	   for	   each	   well	   and	   incubated	   for	   20	  
minutes	   at	   room	   temperature.	   Following	   this,	   cells	   were	   rinsed	   with	   PBS	   and	   the	   glass	   slip	   was	  
mounted	   with	   Fluoromount	   (Serva)	   upside	   down	   onto	   a	   glass	   slide	   (Thermo	   Fisher	   Scientific).	   The	  
slides	  were	  stored	  in	  the	  dark	  at	  4°C	  to	  avoid	  any	  damage	  done	  by	  light	  (photobleaching)	  or	  heat,	  till	  
further	  use.	  
2.2.2.16.3 Microscopy	  and	  analysis	  
Leica	  SP2	  Confocal	  System	  (Leica)	  was	  used	  to	  visualize	  the	  fluorescence	  of	  transfected	  N2a	  cells.	  The	  
63×	   Plan-­‐Apochromat	   (numerical	   aperture,	   1.4)	   oil	   immersion	   lens	   objective	   was	   used.	   GFP	   was	  
imaged	  with	  488	  nm	  wavelength	  laser	  excitation	  and	  505~530	  nm	  band	  pass	  emission	  filter.	  RFP	  was	  
imaged	  with	   558	   nm	   laser	   excitation	   and	   580~650	   nm	   filter.	   A	   z-­‐stack	   of	   the	   cells	  was	   acquired	   by	  
moving	  the	  focal	  plane	  from	  the	  bottom	  to	  the	  top	  of	  the	  images	  cells.	  The	  pinhole	  was	  set	  to	  1	  airy	  to	  
ensure	  that	  the	  acquired	  image	  shows	  a	  thin	  plane	  of	  the	  specimen.	  	  
For	  the	  processing	  of	  images	  the	  software	  ImageJ	  was	  used.	  	  
2.2.2.17 Synthesis	  of	  N-­‐acetyl	  palmitoyl	  cysteine	  
500	  mg	   of	   N-­‐acetyl	   cysteine	  was	  weighed	   and	   added	   to	   a	   two-­‐necked	   round-­‐bottomed	   flask	   (RBF)	  
under	   constant	   argon	   pressure.	   25	  mL	   of	   distilled	  Dichloromethane	  was	   added	   to	   RBF,	   followed	  by	  
addition	   of	   Trimethylsilyl	   Chloride	   (TmsCl,	   428	   µL)	   and	   the	   reaction	   heated	   to	   reflux	   for	   2	   h.	   The	  
reaction	  was	  cooled	  to	  RT	  and	  Palmitoyl	  Chloride	  was	  added	  to	  the	  RBF,	  following	  this	  Tri-­‐ethylamine	  
(TEA)	  was	  added	  drop	  wise	  for	  about	  2h	  and	  the	  reaction	  stirred	  for	  another	  hour.	  The	  products	  were	  
analyzed	  by	  TLC	  (Methanol:DCM,	  1:19)	  and	  separated	  by	  flash	  chromatography	  and	  verified	  by	  NMR	  
and	  mass-­‐spectrometry	  analysis.	  
2.2.2.18 Desaturase	  assay	  
15	   nmol	   of	   the	   substrate	   (Palmitoyl	   chloride/Palmitoylated	   cysteine)	   was	   dissolved	   in	  
Chloroform:Methanol	  (2:1,	  v/v),	  dried	  under	  a	  stream	  of	  nitrogen	  and	  re-­‐dissolved	  in	  10	  µL	  of	  ethanol.	  
30	   nmoles	   of	   Bovine	   serum	   albumin	   (BSA,	   free	   from	   fatty	   acids,	   SIGMA)	   is	   dissolved	   in	   90	   µL	   of	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phosphate	   buffer	   (pH	   7.4,	   100	  mM)	   and	   added	   to	   the	   substrate	   (in	   ethanol)	   under	   gentle	   stirring.	  
Solubilized	  membrane	   (isolated	   from	   insect	   cells,	  expressing	  Cln3p)	  was	  added	   to	   the	   substrate	  and	  
thoroughly	  vortexed	  (total	  volume	  of	  the	  reaction	  was	  300	  µL,	  protein	  used	  was	  300	  μg).	  After	  5	  min	  
of	  pre-­‐incubation	  at	  37°C	  the	  reaction	  was	  started	  by	  addition	  of	  1	  μmol	  of	  NADH	  (dissolved	  in	  30	  µL	  
of	  phosphate	  buffer).	  The	  reaction	  was	  carried	  out	  at	  37°C	  for	  1h	  with	  gentle	  agitation.	  100	  µL	  of	  5M	  
Sodium	  Hydroxide	  (NaOH)	  was	  added	  and	  the	  reaction	  terminated	  by	  heating	  for	  30	  min	  at	  65°C.	  	  
The	  products	  were	  extracted	  into	  an	  organic	  phase,	  by	  addition	  of	  300	  µL	  of	  chloroform.	  The	  internal	  
standard	  (1	  nM)	  was	  also	  added	  at	  this	  point.	  Samples	  were	  vortexed	  for	  1min	  and	  centrifuged	  for	  5	  
min,	   14000	   g.	   The	   organic	   phase	   was	   extracted	   and	   the	   aqueous	   phase	   washed	   with	   250	   µL	   of	  
chloroform.	  Both	  the	  chloroform	  phases	  were	  evaporated	  under	  nitrogen	  and	  the	  residue	  derivatized	  
with	   Bis-­‐(trimethylsilyl)trifluoroacetamide	   (BMSTFA)	   for	   1h	   at	   RT.	   25	   µL	   of	   Ethyl	   Acetate	   (EA)	   was	  
added	  and	  samples	  were	  ready	  for	  GC-­‐MS	  analysis.	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3 Results	  and	  discussion	  
3.1 Structure	  of	  the	  ROD-­‐Zw10-­‐Zwilch	  (RZZ)	  complex	  
3.1.1 Negative	  staining	  and	  2D	  alignment	  and	  classification	  
ROD,	   Zw10,	   and	   Zwilch	   are	   proteins	   that	   co-­‐localize	   at	   the	   kinetochore	   during	   mitosis.	   They	   were	  
identified	   and	   shown	   to	   associate	   as	   a	   complex	   with	   molecular	   weight	   of	   approximately	   800	   kDa	  
(twice	  the	  combined	  size	  of	  each	  monomer),	   leading	  to	  the	  speculation	  that	  they	  occur	  and	  function	  
as	  a	  dimer	  [81].	  Re-­‐constitution	  of	  the	  complex,	  in	  vitro,	  was	  deemed	  impossible	  for	  a	  long	  time	  due	  to	  
inaccessibility	   of	   purified	   ROD.	   This	   problem	   was	   tackled	   by	   simultaneous	   co-­‐infection	   of	   all	   the	  
baculovirus	  for	  insect	  cell	  expression	  (all	  the	  purification	  protocols	  were	  established	  and	  carried	  out	  by	  
Anika	   Altenfeld	   or	   Sabine	   Wohlgemuth	   from	   the	   department	   of	   mechanistic	   cell	   biology,	   MPI	  
Dortmund).	  I	  monitored	  the	  end	  product	  after	  each	  round	  of	  purification	  using	  negative	  stain	  electron	  
microscopy	  (EM),	  where	  the	  sample	  is	  stained	  by	  a	  heavy	  metal	  salt	  and	  viewed	  under	  a	  transmission	  
electron	  microscope.	  Ultimately,	  the	  complex	  was	  purified	  to	  near	  homogeneity,	  size-­‐exclusion	  profile	  
of	  which	  is	  shown	  in	  Figure	  3.1,	  a	  and	  the	  corresponding	  SDS-­‐PAGE	  profile	  in	  Figure	  3.1,	  b.	  Negative	  
stain	   EM	   reveals	   RZZ	   complex	   as	   an	   elongated,	   slender,	   ‘worm-­‐like’	   particle	   as	   shown	   in	   the	   raw	  
micrograph	   area	   in	   Figure	   3.1,	   c.	   I	   collected	   micrographs	   under	   low-­‐dose	   conditions	   and	   selected	  
single	  particles	  (using	  the	  ‘Boxer’	  tool	  in	  EMAN).	  I	  then	  performed	  2D	  reference	  free	  alignment	  and	  k-­‐
means	  classification	  on	  a	  dataset	  consisting	  of	  4000	  such	  RZZ	  particles,	  representative	  classes	  of	  which	  
are	   shown	   in	  Figure	   3.1,	   d.	   The	  RZZ	  complex	   is	   approximately	  40	  nm	   long	  and	  10	  nm	  wide	  with	  an	  
inherent	  two-­‐fold	  axis	  of	  symmetry.	  k-­‐means	  classification	  procedure	  gave	  classes	  with	  predominant	  
side	  views.	  To	  authenticate	  the	  averages	  from	  k-­‐means	  I	  also	  performed	  Iterative	  stable	  alignment	  and	  
clustering	   (ISAC)	   analysis	   on	   the	   same	   dataset.	   ISAC	   is	   an	   alternative	   to	   k-­‐means	   clustering	   and	  
generally	   helps	   in	   isolating	   a	   homogeneous	   subset	   of	   images	   [162].	   The	   results	   obtained	   from	   ISAC	  
analysis	  corroborated	  that	  of	  k-­‐means	  classification	  (shown	  in	  Figure	  3.1,	  e).	   In	  essence,	  2D	  negative	  
stain	  analysis	  of	  RZZ	  complex	  reveals	  it	  to	  be	  a	  rigid,	  elongated	  and	  symmetrical	  molecule.	  	  
3.1.2 Generation	  of	  initial	  model-­‐RCT	  
The	   images	   obtained	   from	   the	   transmission	   electron	   microscope	   are	   2D	   projections,	   of	   the	  
object/specimen,	  on	  the	  image	  plane.	  If	  the	  Euler	  angles	  of	  each	  projection	  are	  known,	  then	  one	  can	  
generate	   the	   3D	   reconstruction,	   invoking	   the	   central	   section	   theorem	   (alternatively	   known	   as	   the	  
projection	   slice	   theorem[161]).	   There	   are	   two	  different	  ways	   to	   identify	   the	   Euler	   angles:	   common-­‐
lines	   based	   approach,	   which	   requires	   the	   sample	   to	   take	   all	   orientations	   on	   the	   grid	   and	   the	   tilt	  
approach,	  usually	  applicable	  for	  samples	  with	  preferred	  orientations.	  Random	  conical	  tilt	  method	  falls	  
into	  the	  latter	  of	  the	  categories	  described	  above,	  where	  two	  single	  exposure	  images	  are	  collected	  at	  
low-­‐dose	  at	  two	  different	  angles.	  The	  3D	  reconstruction	  is	  generated	  by	  filtered	  back-­‐projection[163].	  
	  





Figure	  3.1:	  Purification	  and	  negative	  stain	  analysis	  of	  RZZ	  complex	  (a)	  Elution	  profile	  of	  RZZ	  complex	  from	  size	  
exclusion	   chromatography	   Superose	  6	  10/300	   column.	   The	   complex	  elutes	   around	  10	  mL	  as	   a	  mono	  disperse	  
peak.	  (b)	  SDS-­‐PAGE	  profile	  of	  the	  fractions	  encompassed	  by	  the	  peak	  in	  (a).	  Three	  bands	  corresponding	  exactly	  
to	  the	  theoretical	  size	  of	  ROD	  (240	  kDa),	  Zw10	  (84	  kDa)	  and	  Zwilch	  (70	  kDa)	  are	  seen.	  (c)	  Raw	  micrograph	  area	  of	  
negatively	  stained	  RZZ	  complex	  showing	  thin	  and	  elongated	  particles.	  Scale	  bar,	  100	  nm.	  (d)	  Representative	  class	  
averages	  of	  negatively	  stained	  RZZ	  complex	  obtained	  from	  reference	  free	  alignment	  and	  k-­‐means	  classification.	  
The	  complex	  has	  a	  clear	  two-­‐fold	  symmetry	  with	  a	  center	  of	  inversion.	  Scale	  bar,	  10	  nm.	  (e)	  Representative	  class	  
averages	   of	   negatively	   stained	   RZZ	   complex	   when	   processed	   using	   iterative	   stable	   alignment	   and	   clustering	  
(ISAC).	  Scale	  bar,	  10	  nm.	  The	  same	  dataset	  was	  used,	  both	  for	  k-­‐means	  and	  ISAC	  classification	  methods.	  Source	  
(a)	  and	  (b):	  Anika	  Altenfeld.	  
	  
I	   collected	   images	   at	   angles	   of	   55°	   and	   0°	   and	   selected	   1700	   particle	   pairs	   using	   the	   e2RCTboxer	  
program	  embedded	   in	   the	  EMAN2	  suite.	   I	   used	   the	  0°	  particle	  dataset	   for	   reference	   free	  alignment	  
and	  k-­‐means	  classification	  (generated	  around	  8	  classes).	   I	  chose	  the	  class	  average	  with	  best	  features	  
and	   generated	   a	   3D	   reconstruction	   by	   filtered	   back	   projection	   (using	   SPARX)	   of	   particles	  
corresponding	  to	  the	  same	  class	  from	  the	  tilt	  (55°)	  dataset.	  Once	  I	  had	  the	  back	  projection	  I	  refined	  it	  
against	   the	   un-­‐tilted,	   0°,	   dataset.	   The	   back-­‐projection	   refinement	  was	   performed	  without	   imposing	  
any	  symmetry	  restrictions	  and	  the	  reconstruction	  showed	  a	  clear	  two-­‐fold	  symmetry,	  cementing	  the	  
fact	  that	  RZZ	  has	  C2	  symmetry	  (Figure	  S1).	  I	  further	  performed	  refinement	  runs	  imposing	  C2	  symmetry	  
and	  this	  yielded	  us	  a	  low-­‐resolution	  3D	  structure.	  The	  resolution	  was	  estimated	  by	  the	  FSC0.5	  criterion	  
to	  be	  28	  Å.	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3.1.3 Cryo-­‐positive	  stain	  
Negative	   stain	   EM	   is	   limited	   in	   structure	   determination	  on	   the	  basis	   of	   the	   resolution	   that	   one	   can	  
achieve.	   The	   stain	   solution,	   which	   forms	   a	   thin	   layer	   over	   the	   specimen	   on	   the	   grid,	   limits	   the	  
resolution	   of	   the	   reconstructions	   to	   20	   Å.	   One	   generally	   turns	   to	   cryo-­‐EM	   for	   high-­‐resolution	  
information.	  Initial	  attempts	  to	  visualize	  RZZ	  in	  cryo	  conditions	  using	  holey	  carbon	  grids	  suffered	  from	  
major	  setbacks,	  as	  the	  RZZ	  complex	  would	  prefer	  to	  clump	  on	  the	  carbon	  rather	  than	  being	  in	  the	  ice	  
(data	  not	  shown).	  An	  alternative	  to	  such	  situations	  is	  to	  use	  holey	  carbon	  grids	  that	  are	  coated	  with	  an	  
additional	  layer	  of	  carbon[164].	  Cryo-­‐negative	  staining	  is	  in	  essence	  a	  thin	  film	  vitrification	  technique	  
where	   the	   biological	   sample	   comes	   in	   contact	   with	   the	   stain	   for	   a	   very	   short	   time.	   This	   results	   in	  
exceptionally	   brilliant	   contrast	   of	   the	   sample	   (very	   high	   signal	   to	   noise	   ratio).	   I	   tweaked	   the	  
conventional	   cryo-­‐negative	   staining	   procedure	   in	   an	   effort	   to	   counter	   the	   technically	   challenging	  
procedure	  of	  deposition	  of	  an	  additional	  carbon	  layer	  on	  the	  grid.	  Briefly,	  I	  incubated	  the	  sample	  with	  
stain	   solution	  and	  manually	  blotted	   it	  before	   the	  grid	  was	  plunged	   into	   liquid	  ethane.	   I	  was	  able	   to	  
record	  images	  where	  individual	  particles	  had	  remarkable	  contrast.	  Fascinated	  by	  the	  quality	  of	  images	  
I	  performed	  preliminary	  2D	  analysis	  on	  a	  dataset	  consisting	  of	  4880	  particles.	  Representative	  averages	  
from	  reference	  free	  alignment	  and	  classification	  (k-­‐means)	  are	  highlighted	  in	  the	  figure	  below	  (Figure	  





Figure	  3.2:	  Cryo-­‐positive	  stain	  (a)	  Averages	  
from	  reference	  free	  alignment	  and	  k-­‐means	  
classification.	   Scale	   bar,	   10	   nm.	   (b)	  
Variances	   of	   the	   averages	   in	   figure	   (a)	  
highlighting	   significant	   density	   around	   the	  
averages,	   generally	   arising	   due	   to	  
inefficiency	   in	   averaging	   procedures.	   The	  
reason	  for	  such	  an	  effect	  can	  be	  explained	  
invoking	   the	   concept	   of	   positive	   staining,	  
where	  it	   is	  not	  uniformly	  distributed	  in	  the	  
sample	   and	   therefore	   leads	   to	   blurred	  
averages.	  
	  
The	   averages	   look	   significantly	   blurred	   and	   featureless.	   I	   repeated	   the	   analysis	   couple	   of	   times	   to	  
avoid	   systematic	   errors.	   The	   results	   of	   2D	   alignment	   and	   classification	  were	   disheartening.	   A	   closer	  
look	  at	  the	  variances	  from	  the	  k-­‐means	  procedure	  (Figure	  3.2,	  b)	  led	  to	  speculation	  that	  the	  stain	  was	  
not	  uniformly	  distributed	  on	   the	   specimen	   (negative	   stain	  by	  definition),	  but	  was	  absorbed	   into	   the	  
sample	   and	   distributed	   randomly	   leading	   to	   cloudy	   averages.	   In	   essence,	  my	   attempt	   to	   devise	   an	  
alternative	  to	  the	  classical	  cryo-­‐negative	  stain	   led	  to	  cryo-­‐positive	  stain	   instead.	  Since	  averages	  were	  
deemed	  useless,	  I	  did	  not	  venture	  any	  further	  with	  this	  method.	  	  
	   	  




3.1.4.1 2D	  analysis	  
I	   channelized	   efforts	   to	   optimize	   the	   ice	   conditions	   for	   imaging	   RZZ.	   During	   the	   course	   of	   this	  
optimization	  I	  realized	  that	  detergent	  was	  absolutely	  essential	  to	  avoid	  aggregation	  of	  RZZ,	  hinting	  at	  
the	  fact	  that	  some	  regions	  of	  the	  structure	  may	  be	  highly	  hydrophobic.	  The	  use	  of	  detergent	  (0.02%	  
Triton	  X-­‐100	   in	   this	   case)	   also	   ensures	   uniform	   thickness	   of	   ice	   on	   the	   grid.	   I	   also	   found	   that	  much	  
higher	  concentration	  of	  the	  complex	  was	  necessary	  (approximately	  3	  mg/mL)	  as	  opposed	  to	  standard	  
use	  of	  0.1	  mg/mL.	  Another	  parameter	   that	  needed	  calibration	  was	   the	   ice	   thickness.	  Since	   the	   JEOL	  
3200FSC	  is	  equipped	  with	  an	  energy	  filter,	   I	  was	  able	  to	  calculate	  the	  thickness	  of	  ice	  and	  choose	  an	  
optimum	  value	  for	  imaging	  RZZ.	  
I	  recorded	  images	  of	  RZZ	  at	  a	  fixed	  defocus	  (3	  μm)	  and	  in	  holes	  with	  varying	  thickness	  of	  vitreous	  ice	  
(12-­‐80	  nm).	  I	  estimated	  that	  ice	  with	  a	  thickness	  of	  40-­‐50	  nm	  is	  best	  suited	  for	  visualizing	  RZZ	  complex.	  
Having	  set	  all	   the	  parameters	   for	  data	  collection	  right	   I	  collected	  a	  test	  dataset	  of	  780	   images,	   from	  
which	   I	   manually	   selected	   5997	   particles	   and	   subjected	   them	   to	   2D	   alignment	   and	   classification	  
procedures.	  k-­‐means	  classification	  gave	  class	  averages	  with	  distinct	   features.	   I	  also	  found	  RZZ	  taking	  
all	  orientations	  in	  ice.	  	  
	  
Figure	  3.3:	  Cryo-­‐EM	  on	  RZZ	  complex	  
(a)	   Representative	   micrograph	   area	  
of	  RZZ	  on	  holey-­‐carbon	  grids	  imaged	  
in	   cryo	   conditions.	   White	  
arrowheads	   highlight	   particles.	   The	  
image	   was	   acquired	   with	   a	  
JEOL3200FSC	   microscope	   equipped	  
with	   TVIPS	   8k	   x	   8k	   CMOS	   camera.	  
The	   sample	   contained	   0.02%	   Triton	  
X-­‐100	   for	  uniform	   ice	   thickness	   and	  
to	   prevent	   RZZ	   from	   aggregating.	  
Scale	   bar,	   100	   nm.	   (b)	  
Representative	   class	   averages	   as	  
obtained	   from	   reference	   free	  
alignment	  and	  k-­‐means	  classification	  
procedures	   of	   particles	   obtained	  
from	  5997	  cryo-­‐EM	  images.	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Encouraged	  by	  the	  initial	  results	  I	  collected	  3300	  images	  with	  defocus	  value	  varying	  between	  2	  and	  3	  
μm.	  A	  representative	  micrograph	  area	  of	  RZZ	   imaged	  in	  cryo	  conditions	  (Figure	  3.3,	  a)	  and	  averages	  
that	  were	  outcome	  of	  2D	  analysis	  are	  shown	  (Figure	  3.3,	  b).	  	  
Correct	  3D	  structure	  determination	  relies	  on	  the	  precise	  estimation	  and	  the	  correction	  of	  the	  contrast	  
transfer	   function	   (CTF).	   The	   contrast	   transfer	   function	   is	   defined	   as	   Fourier	   transform	   of	   the	   point	  
spread	  function	  (PSF),	  which	  the	  electron	  microscope	  (or	  any	  optical	   imaging	  device)	  associates	  with	  
the	   object	   during	   image	   formation.	   CTF	   depends	   on	   factors	   like	   defocus,	   spherical	   aberration	  
coefficient	   and	   the	   wavelength	   of	   incident	   electrons	   (which	   depends	   on	   the	   voltage	   at	   which	   the	  
microscope	   is	   operated).	   In	   CTF	   correction,	   one	   tries	   to	   retrieve	  undistorted	  object	   from	   the	   image	  
and	   this	   process	   is	   absolutely	   crucial	   for	   determination	   of	   high-­‐resolution	   structures	   by	   cryo-­‐EM.	   I	  
used	   customized	   graphical	   user	   interface,	   built	   for	   a	   program	   which	   parallels	   CTFFIND3	   [165],	  
designed	   in	   the	   lab	   (by	   Dr.	   Rouslan	   Efremov	   and	   Dr.	   Christos	   Gatsogiannis)	   to	   estimate	   the	   CTF	  
parameters.	  The	  program	  generates	  a	  1-­‐dimensional	  fit	  of	  the	  CTF	  as	  a	  function	  of	  spatial	  frequency	  as	  
shown	  in	  Figure	  3.4.	  I	  discarded	  images	  where	  the	  estimation	  of	  CTF	  was	  not	  accurate	  and	  also	  images	  
with	   drift	   and	   astigmatism.	   Particles	   were	   not	   boxed	   out	   from	   such	   images.	   I	   selected,	   manually,	  
35404	  particles	  from	  4000	  8k	  x	  8k	  images.	  	  
	  
	  
Figure	  3.4.	  CTF	   fit	  (a)	  Plot	  of	  the	  radial	  average	  of	  the	  average	  background-­‐subtracted	  power	  spectrum	  (green	  
line)	   and	   the	   fit	   CTF	   (blue	   line).	   B	   factor	   is	   a	   coefficient	   in	   the	   Gaussian	   function	   describing	   CTF	   decay	   with	  
resolution	  as	  exp	  (-­‐B*q^2),	  where	  q	  is	  a	  spatial	  frequency.	  Higher	  B	  corresponds	  to	  faster	  decay	  and	  your	  high	  
resolution	  vanishing	   faster.	  CTF	   fitted	  =	  CTF*exp	   (-­‐B*q^2).	   (b)	   The	  diagnostic	  output	   image	   for	   image	  number	  
268,	  showing	  the	  average	  background-­‐subtracted	  power	  spectrum	  on	  the	  right,	  and	  with	  the	  fit	  CTF	  on	  the	  left.	  
3.1.4.2 3D	  analysis	  
High-­‐resolution	  structure	  determination	  requires	  very	  careful	  and	  precise	  analysis	  of	  cryo-­‐EM	  data.	   I	  
followed	  the	  common	  practice	  of	  using	  the	  3D	  structure	  obtained	  from	  RCT,	  as	  an	  initial	  reference	  for	  
the	   subsequent	   refinement	   runs	   using	   the	   cryo-­‐EM	   data.	   Since,	   experimental	   cryo-­‐EM	   images	   are	  
extremely	   noisy,	   structures	   determined	   by	   such	   data	   may	   be	   prone	   to	   overfitting,	   which	   in	  
mathematical	   terms	   is	   an	   ‘ill-­‐posed’	   problem.	   One	   way	   to	   prevent	   overfitting	   of	   cryo-­‐EM	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reconstructions	   is	   imposing	   smoothness	  by	  using	   filtering	  procedures.	   I	   applied	  a	   low-­‐pass	  Gaussian	  
filter	  (70	  Å)	  to	  the	  negative	  stain	  reconstruction	  and	  used	  it	  as	  the	  starting	  reference.	  In	  brief,	  I	  used	  
the	  projection-­‐matching	  algorithm	  implemented	  in	  SPARX	  [166]	  for	  3D	  refinement	  runs	  in	  an	  iterative	  
approach	   to	   center	   and	   orient	   individual	   particles	   against	   the	   reference	   density	   map.	   For	   the	   first	  
round,	   I	   started	  with	  a	  small	  dataset	  of	  approximately	  6000	  particles	  and	  with	   large	  pixel	  values	   for	  
the	  translational	  search	  parameters	  along	  X	  and	  Y	  directions.	  Also,	  relatively	  large	  angular	  step	  value,	  
delta,	  was	  used.	  The	   resulting	  3D	  density	  map	  was	  used	   to	  generate	  a	  mask	  and	  as	  a	   reference	   for	  
subsequent	   iterations.	   I	   added	   more	   particles	   with	   each	   iteration	   and	   fine-­‐tuned	   the	   alignment	  




Figure	  3.5:	  Representative	  views	  of	  the	  3D	  structure	  of	  the	  RZZ	  complex.	  Scale	  bar,	  10	  nm.	  
	  
RZZ	  appears	  as	  a	  long,	  hollow	  and	  symmetrical	  rigid	  structure	  with	  a	  center	  of	  inversion	  (Figure	  3.5).	  
End	   to	   end	   length	   of	   the	   complex	   is	   42	   nm	   and	   the	  width	   is	   10	   nm.	   The	   high-­‐resolution	   structure,	  
confirms	  the	  biochemical	  finding	  that	  RZZ	  is	  a	  dimer.	  At	  this	  point	  I	  was	  perplexed,	  as	  I	  did	  not	  know	  
the	  organization	  of	  proteins	  in	  the	  complex	  and	  hence,	  the	  nature	  of	  dimerization.	  The	  3D	  structure	  of	  
RZZ	  depicted	  above	  could	  be	  an	  outcome	  of	  dimerization,	  of	  ROD-­‐Zw10-­‐Zwilch,	  in	  one	  of	  the	  following	  
two	   ways:	   as	   a	   longitudinal	   monomer,	   where	   ROD-­‐Zw10-­‐Zwilch	   interact	   along	   the	   length	   of	   RZZ	  
complex	  and	  the	  complex	  would	  therefore	  be	  an	  antiparallel	  dimer,	  or	  as	  a	   lateral	  monomer,	  where	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the	   interactions	   between	   the	   two	   monomers	   is	   predominantly	   along	   the	   lateral	   axis.	   Both	   the	  
possibilities	  are	  highlighted	  in	  Figure	  3.7,	  a	  and	  b.	  A	  detailed	  explanation	  on	  the	  nature	  of	  dimerization	  
follows	  later.	  
Since	   the	   resolution	   of	   the	   cryo-­‐EM	   reconstruction	   is	   inversely	   related	   to	   the	   defocus,	   images	  
recorded	  close	  to	  focus	  are	  expected	  to	  contribute	  towards	  better	  resolution.	  However,	  images	  close	  
to	   focus	   are	   deprived	   of	   contrast	   whatsoever.	   To	   circumvent	   this	   problem	   I	   recorded	   a	   ‘focal-­‐pair’	  
dataset,	  wherein	  two	  images	  of	  the	  same	  area	  are	  recorded,	  the	  first	  close	  to	  focus	  and	  the	  latter	  far	  
away	   from	   focus.	   I	   used	   the	   images	   far	   away	   from	   focus	   (higher	  defocus	   values)	   for	  boxing	  out	   the	  
particles	  and	  used	  these	  co-­‐ordinates	  to	  box	  out	  the	  particles	  from	  ‘close	  to	  focus’	   images.	   I	  did	  not	  
see	   any	   significant	   improvement	   in	   the	   resolution	   of	   the	   structure,	   as	   reflected	   by	   FSC,	   during	  
subsequent	  refinement	  runs	  with	  addition	  of	  close	  to	  focus	  particles	  to	  the	  dataset.	  The	  resolution	  of	  
the	  final	  3D	  reconstruction	  estimated	  by	  FSC0.5	  criteria	  is	  13.4	  Å	  (Figure	  3.6).	  	  
	  
	  
Figure	   3.6:	   Fourier	   shell	  
correlation.	   Resolution	   of	  
reconstructions	   from	   electron	  
microscopy	   is	   estimated	   from	  
the	   Fourier	   shell	   correlation	  
(FSC)	   curves,	   where	   FSC	   is	  
plotted	   as	   a	   function	   of	   spatial	  
frequency.	   The	   most	   widely	  
accepted	   criterion	   is	   the	   FSC0.5.	  
The	   structure	   by	   the	   same	  








Figure	  3.7:	  Two	  possible	  ways	  of	  dimerization	  (a)	  The	  C2	  symmetry	  axis	  is	  highlighted	  in	  dotted	  red	  lines.	  RZZ	  
complex	  can	  be	  a	  longitudinal	  dimer	  or	  a	  lateral	  dimer,	  depending	  on	  how	  the	  interface	  is	  formed.	  (b)	  The	  two	  
possible	  monomers	  are	  highlighted	  in	  gray	  with	  the	  complete	  RZZ	  density	  superimposed	  as	  blue	  mesh.	  Scale	  bar,	  
10	  nm.	  
3.1.4.3 Cross-­‐correlation	  between	  projections	  and	  re-­‐projections	  
To	  verify	  the	  structure	  at	  hand,	  I	  calculated	  cross-­‐correlation	  between	  2D	  projections	  (class	  averages	  
from	  k-­‐means)	  and	  the	  re-­‐projections	  of	  the	  density.	  I	  find	  a	  high	  cross-­‐correlation	  value	  of	  about	  73%	  
(very	  good	  value).	  Representative	  projections	  and	  re-­‐projections,	  befitting	  the	  views	  of	   the	  depicted	  
structure	  in	  Figure	  3.5,	  are	  highlighted	  in	  Figure	  3.8.	  	  
	  	  
	  
Figure	  3.8:	  Representative	  projections	  (left),	  re-­‐projections	  (right)	  pairs.	  The	  re-­‐projections	  were	  generated	  using	  
the	   orientation	   parameters	   from	   the	   projections.	   Therefore	   this	   is	   not	   a	   perfect	   method	   for	   validating	   the	  
structure.	   Nevertheless,	   the	   cross-­‐correlation	   gives	   a	   good	   estimate	   of	   how	   good	   the	   structure	   is.	   The	   views	  
represented	  here	  are	  similar	  to	  the	  views	  of	  the	  structure	  in	  Figure	  3.5.	  Scale	  bar,	  10	  nm.	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3.1.5 Topology	  of	  RZZ	  
3.1.5.1 Antibody	  labeling	  
I	  addressed	  the	  issue	  of	  the	  organization	  of	  proteins	  in	  the	  complex	  by	  interweaving	  biochemical	  and	  
microscopy	   methods.	   First,	   I	   targeted	   localization	   of	   ROD	   by	   using	   a	   polyclonal	   antibody	   directed	  
towards	  its	  N-­‐terminus	  where	  I	  followed	  a	  quick	  and	  dirty	  procedure	  of	  incubating	  the	  antibody	  with	  
the	  complex	  and	  immediately	  subjecting	  to	  negative	  stain	  EM.	  I	  found	  very	  few	  antibody	  labeled	  RZZ	  
molecules.	  One	  would	  expect	  two	  antibodies	  per	  RZZ	  dimer,	  but	  such	  complexes	  were	  seldom	  found.	  
Also,	   since	   the	   antibody	   could	   adopt	   various	   orientations,	   alignment	   and	   classification	   was	   of	   not	  
much	  use.	  It	  was	  to	  my	  great	  advantage	  that	  I	  could	  spot	  the	  antibody	  labeled	  RZZ	  in	  raw	  micrograph	  
(Figure	  3.9,	  c).	  	  
	  
	  
Figure	  3.9:	  Antibody	  labeling	  studies	  on	  the	  RZZ	  complex.	  Each	  of	  the	  panels	  in	  a,	  b,	  c,	  d	  consist	  of	  raw	  particle	  
(top	  left),	  a	  cartoon	  of	  the	  raw	  particle	  (top	  right),	  representative	  average	  from	  k-­‐means	  classification	  (bottom	  
left)	   and	   the	   corresponding	   variance	   (bottom	   right).	   (a)	   RZZ	   complex	   (b)	   R-­‐Z(cGFP)-­‐Z,	   complex	  where	   Zw10	   is	  
expressed	  as	   fusion	  protein	  with	  GFP	  at	   its	  C-­‐terminus	   (c)	  RZZ	   in	  complex	  with	  a	  polyclonal	  antibody	  directed	  
towards	  the	  N-­‐terminus	  of	  the	  ROD.	   (d)	  R-­‐(nGFP)Z-­‐Z,	  complex	  where	  Zw10	   is	  expressed	  as	  fusion	  protein	  with	  
GFP	   at	   its	   N-­‐terminus.	   (e)	   The	   loci,	   as	   understood	   from	   the	   analysis,	  mapped	   onto	   the	   RZZ	   structure.	   Green	  
arrowheads	  represent	  Zw10	  and	  the	  dark	  gray	  arrowhead	  represents	  ROD.	  Scale	  bars,	  10	  nm.	  
	  
Next,	   I	  used	   fusion	  proteins	   (generated	  and	  purified	  by	  Sabine	  Wohlgemuth,	  AG	  Musacchio)	  of	  RZZ,	  
where	   GFP	   was	   fused	   either	   to	   the	   N-­‐	   or	   the	   C-­‐	   terminus	   of	   Zw10	   (R-­‐(nGFP)Z-­‐Z	   or	   R-­‐Z(cGFP)-­‐Z).	   I	  
analyzed	  these	  complexes	  by	  negative	  stain	  electron	  microscopy.	  I	  ran	  into	  a	  similar	  problem	  as	  that	  of	  
antibody	   labeled	   RZZ.	   Though	   clearly	   evident	   from	   raw	   images,	   where	   the	   GFP	   was	   located,	   2D	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alignment	   and	   classification	   did	   not	   give	   spectacular	   results.	   The	  main	   reason	  might	   be	   that	   since	   I	  
used	  polyclonal	  antibodies	  and	  since	  their	  binding	  is	  not	  absolutely	  specific,	  the	  averaging	  procedure	  
did	  not	  yield	   sufficiently	  good	   results.	   I	  mapped	   the	  additional	  electron	  density,	  however,	   from	  raw	  
images	   and	   variances.	   I	   found	   that	   Zw10	   localizes	   centrally	   in	   the	   complex,	   with	   N-­‐terminus	   being	  
farther	  away	  from	  the	  center	  of	  the	  complex	  (Figure	  3.9,	  d).	  The	  density	  corresponding	  to	  GFP	  in	  R-­‐
Z(cGFP)-­‐Z	   is	  more	   central	   (Figure	   3.9,	   b).	   I	   also	   found	   that	   the	  N-­‐termini	  of	  ROD	  and	  N-­‐terminus	  of	  
Zw10	  are	  proximal	  in	  space	  (Figure	  3.9,	  e).	  
3.1.5.2 hZw10	  
During	  the	  course	  of	   investigating	  the	  structure	  of	  RZZ,	   I	  was	  able	  to	  get	  some	  human	  Zw10	  protein	  
(purified	   to	   near	   homogeneity	   by	   baculovirus	   expression	   from	   insect	   cells	   by	   Anika	   Altenfeld,	   AG	  
Musacchio).	  I	  performed	  negative	  stain	  EM	  analysis	  on	  the	  purified	  Zw10.	  The	  averages	  from	  k-­‐means	  
classification	  did	  not	  have	  any	  characteristic	  shape	  and	  were	  not	  well	   resolved	   (Figure	  3.10,	   a).	  This	  
was	   also	   evident	   from	   a	   look	   at	   the	   variances	   of	   the	   corresponding	   averages,	   which	   revealed	   the	  
presence	   of	   extra	   density	   not	   seen	   in	   the	   2D	   averages	   (Figure	   3.10,	   b).	   I	   therefore,	   performed	   an	  
Iterative	  stable	  alignment	  and	  clustering	  (ISAC)	  analysis	  on	  the	  same	  dataset.	  I	  discovered	  that	  hZw10	  
comprises	  of	  two	  distinct	  densities,	  which	  hinge	  upon	  their	  interface	  leading	  to	  various	  conformations	  
in	   solution	   as	   reflected	   from	   the	   averages	   in	   (Figure	   3.10,	   c).	   Structural	   prediction	   confirms	   an	  
unstructured	  region	  nearly	  at	  the	  center	  of	  protein	  (refer	  Figure	  S9).	   Invoking	  the	  GFP-­‐fusion	  labeling	  
studies,	   I	   postulate	   that	   Zw10	   adopts	   a	   variety	   of	   conformations	   when	   in	   solution,	   but	   selectively	  
adopts	  a	  particular	  conformation	  as	  a	  part	  of	  RZZ	  complex.	  I	  believe	  that	  Zw10	  acts	  as	  a	  belt	  that	  holds	  
the	   two	  anti-­‐parallel	  ROD	  molecules	   together.	  These	   results	  provide	   first	   structural	   insights	   into	   the	  
structure	  of	  human	  Zw10.	  
	  
	  
Figure	  3.10:	  Negative	  stain	  analysis	  of	  Zw10.	  (a)	  Representative	  averages	  of	  Zw10	  as	  obtained	  from	  the	  k-­‐means	  
classification	   procedure.	   The	   complex	   appeared	   to	   be	   of	   different	   sizes	   in	   the	   first	   look,	   but	   the	   variances	  
highlighted	   in	   (b)	   revealed	   it	   as	   a	   problem	   surfacing	   from	   the	   k-­‐means	   classification.	   (c)	   Representative	   class	  
averages	  from	  the	  ISAC	  procedure,	  revealing	  the	  inherent	  flexibility	  of	  the	  Zw10	  complex.	  Scale	  bar,	  10	  nm.	  
3.1.5.3 Crosslinking	  and	  Mass	  spectrometry	  
Chemical	   cross-­‐linking	  coupled	  with	  mass	   spectrometry	   (XL-­‐MS)	  presents	  a	   low-­‐resolution	   structural	  
technique	  for	  determination	  of	   topology	  of	  multi-­‐protein	  complexes	   [167,	  168].	  XL-­‐MS	  taps	  spatially	  
close	   lysine	   residues,	   which	   get	   covalently	  modified	   by	   a	   bi-­‐functional	   cross-­‐linking	   reagent	   (Figure	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3.11).	  With	  the	  structure	  of	  RZZ	   in	  hand	  this	  approach	  was	  used	  to	   identify	   the	  subunit	   interactions	  
and	  the	  architecture	  of	  the	  complex.	  These	  experiments	  were	  performed	  in	  the	  laboratory	  of	  Dr.	  Franz	  
Herzog	  at	  the	  LMU,	  Munich.	  
	   	  
	  
Figure	  3.11:	  
The	  cross	  linking	  reagent	  used	  for	  XL-­‐MS	  studies	  was	  
disuccinimidyl	   suberate	   (DSS),	   which	   has	   a	   spacer	  
length	  (8	  atoms)	  of	  11.4	  Å.	  
	  
The	  analysis	  identified	  106	  unique	  cross-­‐links,	  which	  I	  categorized	  into	  two	  classes:	  inter	  (ROD-­‐Zwilch,	  
ROD-­‐Zw10)	  and	  intra	  cross-­‐links	  (Zw10-­‐Zw10	  and	  ROD-­‐ROD).	  All	  the	  cross-­‐links	  are	  listed	  in	  Tables	  5.1	  
and	   5.2.	   Essential	   cross-­‐links	   are	   depicted	   in	   Figure	   3.12.	   The	   very	   first	   conclusion	   from	   the	   XL-­‐MS	  
analysis	   is	   that	   Zw10	   and	   Zwilch	   are	   not	   spatially	   proximal.	   There	   are	   no	   cross-­‐links	   whatsoever	  
amongst	  these	  proteins.	  	  
The	  ROD-­‐Zwilch	  cross-­‐links	  validate	  previous	  biochemical	  experiments,	  where	  the	  N-­‐terminus	  of	  ROD	  
was	  shown	  to	  interact	  with	  Zwilch	  [84].	  The	  XL-­‐MS	  also	  highlights	  the	  fact	  that	  both	  N-­‐	  and	  C-­‐termini	  
of	  ROD	  interact	  with	  Zwilch	  (Figure	  3.12,	  a).	  
The	  second	  set	  of	   inter	  cross-­‐links	  are	  between	  proteins	  ROD	  and	  Zw10.	   I	   find	  that	  Zw10	   is	  spatially	  
proximal	   and	   interacts	  with	   the	   central	   region	  of	   ROD	   (850-­‐1670	   aa).	   I	   also	   find	   that	   certain	   amino	  
acids	  on	  Zw10	  (130,	  for	  example)	  cross-­‐links	  with	  amino	  acids	  859	  and	  1665	  on	  ROD	  (Figure	  3.12,	  b).	  
This	  could	  mean	  either	  ROD	  wraps	  around	  Zw10	  or,	  alternatively,	  Zw10	  remains	  sandwiched	  between	  
two	  anti-­‐parallel	  ROD	  molecules.	  Since,	  prediction	  programs	  model	  the	  stretch	  of	  ROD	  (encompassing	  
amino	   acids	   850-­‐1670)	   as	  α-­‐solenoid	  which	   are	   not	   known	   to	   adopt	   curved	   structures,	   I	   argue	   that	  
Zw10	  is	  most	   likely	  sandwiched	  between	  the	  two	  ROD	  monomers.	  By	  the	  same	  logic	   I	  also	  conclude	  
that	  the	  intra	  ROD	  cross-­‐links	  are	  not	  from	  a	  single	  polypeptide	  chain,	  as	   it	  would	  require	  significant	  
torsional	   strain,	   but	   from	   two	  molecules	   of	   ROD	  which	   are	   anti-­‐parallel	   in	   the	   RZZ	   complex	   (Figure	  
3.12,	  d).	  I,	  however,	  could	  not	  extrapolate	  any	  significant	  information	  from	  the	  intra	  Zw10	  cross-­‐links.	  
The	   analysis	   of	   the	   cross-­‐links	   was	   done	   together	   with	   Anika	   Altenfeld	   and	   Dr.	   Jenny	   Keller	   (AG	  
Musacchio).	  
	   	  




Figure	  3.12:	  Cross-­‐linking	  mass	  spectrometry	   (XL-­‐MS)	  analysis	  of	   the	  RZZ	  complex.	  Representative	  cross-­‐links	  
between	   ROD-­‐ROD,	   ROD-­‐Zw10	   and	   ROD-­‐Zwilch	   highlighted.	   XL-­‐MS	   is	   a	   low-­‐resolution	   technique	   used	   for	  
understanding	  the	  spatial	  organization	  of	  the	  proteins	  in	  a	  complex.	  (a)	  ROD	  (cartoon	  in	  gray)-­‐Zwilch	  (in	  orange)	  
crosslinks.	  (b)	  ROD-­‐Zw10	  (in	  green)	  crosslinks.	  (c)	  Cartoon	  representation	  on	  the	  organization	  of	  sub-­‐units	  in	  the	  
RZZ	  complex	  (d)	  ROD-­‐ROD	  intra	  crosslinks.	  A	  detailed	  list	  of	  all	  the	  cross-­‐links	  is	  in	  the	  Tables	  5.1	  and	  5.2.	  
	  
3.1.6 Rigid	  body	  fitting	  
ROD	  is	  the	  largest	  subunit	  of	  the	  RZZ	  complex	  (2209	  residues).	  The	  first	  350	  residues	  are	  predicted	  to	  
have	  a	   secondary	  beta-­‐propeller	   structure	  organized	   in	  putative	  WD40	  beta	  propellers	  whereas	   the	  
rest	  of	  the	  molecule	  is	  predicted	  to	  have	  secondary	  alpha-­‐helical	  structure	  and	  contains	  3	  regions:	  an	  
NRH	   (Nag-­‐ROD	   homology)	   domain,	   a	   Sec39-­‐like	   domain	   followed	   by	   an	   additional	   1000	   residue	  
segment.	  Protein	  homology/analogy	  recognition	  engine	  (Phyre2)	  was	  used	  to	  generate	  models	  of	  the	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WD40	  beta-­‐propeller	  and	  the	  Sec39-­‐like	  domains	  (Dr.	   Jenny	  Keller	  generated	  the	  models	   for	  various	  
fragments	  of	  ROD).	  Models	  satisfying	  the	  intra-­‐molecular	  crosslinks	  were	  selected.	  De	  novo	  modeling	  
programs	  (I-­‐Tasser,	  CABS-­‐fold,	  Modweb	  server)	  were	  used	  to	  generate	  models	  of	  the	  NRH	  and	  the	  C-­‐
terminal	  domains	  [169-­‐171].	  Dsl1	  has	  been	  suggested	  to	  be	  the	  yeast	  homologue	  of	  Zw10.	  The	  crystal	  
structures	  of	  Dsl1p	  are	  known	  (PDB	  IDs:	  3K8P,	  3ETU).	  I	  used	  these	  models	  for	  fitting	  into	  the	  cryo-­‐EM	  
structure.	   The	   crystal	   structure	   of	   Zwilch	   (PDB	   ID:	   3IF8),	   as	   aforementioned,	   has	   been	   known	   for	   a	  
while.	   A	   gallery	   of	   all	   the	  models	   used	   for	   fit	   is	   highlighted	   in	   Figure	   S5.	   The	   distance	   restraints	   as	  
imposed	  by	  cross-­‐linking	  were	  applied	  and	  I	  fit	  the	  models	  (by	  rigid	  body	  fitting	  procedures)	  predicted	  
for	  various	  segments	  of	  ROD	  and	  the	  structures	  of	  Zw10	  and	  Zwilch.	  It	  led	  to	  the	  architecture	  that	  is	  
depicted	  in	  the	  Figure	  3.13.	  	  
	  	  
	  
Figure	   3.13:	   Predicted	   structural	   models	   of	   ROD	   (see	   Figure	   S5),	   along	   with	   the	   structures	   of	   Zw10	   (used	  
structure	  of	   its	  yeast	  homologue	  Dsl1p,	  3ETU	  and	  3K8P	  chain	  C)	  and	  Zwilch	   (3IF8)	   fit	   into	  the	  electron	  density	  
map	  of	  RZZ.	  Distant	  restraints	  were	  applied,	  as	  inferred	  from	  XL-­‐MS	  analysis	  resulting	  in	  the	  fit,	  views	  of	  which	  
are	  shown.	  The	  volume	  of	  RZZ	   is	   segmented	   into	  colors	  corresponding	  different	  proteins	  using	   the	  color	  zone	  
tool	  in	  Chimera.	  ROD	  in	  gray,	  Zw10	  in	  green	  and	  Zwilch	  in	  orange.	  Scale	  bar,	  10	  nm.	  
	  
3.1.7 Why	  longitudinal	  dimer?	  
I	  propose	  that	  RZZ	  is	  a	  longitudinal	  dimer	  due	  to	  the	  following	  reasons:	  First,	  the	  structural	  prediction	  
of	   ROD	   highlights	   that	   it	   extends	   as	   α-­‐solenoid	   through	  most	   of	   its	   central	   region.	   A	   Lateral	   dimer	  
would	  require	  a	  ROD	  molecule	  to	  bend	  over	  in	  a	  fashion	  such	  that	  the	  N	  and	  C-­‐terminus	  of	  the	  same	  
polypeptide	   interact,	  which	   I	  believe	   is	  energetically	  unfavorable.	  Across	   literature	   there	  are	  seldom	  
examples	   of	   α-­‐solenoids	   adopting	   a	   bent	   conformation.	   Second,	   since	   antibody-­‐labeling	   studies	  
suggest	  that	  Zw10	   is	  predominantly	   localized	  to	  the	  center,	  a	   lateral	  dimer	  would	  mean	  most	  of	  the	  
dimerization	   occurs	   via	   the	   Zw10	  molecules,	   which	   I	   believe	   is	   not	   the	   case	   (I	   do	   not	   observe	   any	  
dimers	   of	   Zw10	   in	   negative	   stain	   electron	  microscopy	   analysis).	   This	   is	   also	   reflected	  when	   Zw10	   is	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expressed	  as	  C-­‐terminal	  GFP	  fusion	  protein.	  I	  often	  find	  complexes	  as	  shown	  in	  Figure	  3.14,	  where	  the	  




Figure	  3.14:	  Class	  average	  as	  a	  result	  of	  reference	  free	  alignment	  and	  k-­‐means	  
classification	  procedures.	  Complex	  is	  assembled	  where	  the	  Zw10	  is	  generated	  
as	   a	   fusion	   protein	   with	   GFP	   at	   its	   C-­‐terminus	   (R-­‐Z(cGFP)-­‐Z).	   Particles	   that	  
cluster	  into	  this	  class	  are	  very	  few	  in	  number.	  Such	  classes	  are	  obtained	  along	  
with	   classes	   which	   appear	   predominantly	   as	   highlighted	   in	   Figure	   3.9,b.	  
Density	   for	   the	   GFP	   can	   not	   be	   attributed	   in	   this.	   However	   I	   see	   that	   the	  
complex	  breathes	  out	  making	  the	  two	  anti-­‐parallel	  ROD	  strands	  evident.	  Scale	  
bar,	  10	  nm.	  
3.1.8 Validation	  of	  structure	  
3.1.8.1 Mini-­‐RZZ	  
To	  validate	  the	  architecture	  as	  described	  above	  complexes	  with	  truncations	   in	  ROD	  were	  generated.	  
One	   such	   complex	   susceptible	   to	   purification	   and	   further	   structural	   analysis	   was	   the	   ROD1-­‐1250ZZ	  
(hereafter	   referred	   to	   as	   mini-­‐RZZ,	   generated	   by	   Anika	   Altenfeld,	   AG	   Musacchio).	   I	   argued	   that	   if	  
proposed	   architecture	   is	   right	   then	   deletion	   of	   C-­‐terminus	   of	   ROD	   should	   lead	   to	   a	   collapse	   in	   the	  
dimerization	   of	   the	   complex,	   as	   it	   is	   necessary	   for	   the	   stability	   of	   the	   complex,	   evident	   from	   the	  
crosslinking	  experiments.	   It	  turns	  out	  that	   I	  was	  right!	  Mini-­‐RZZ	  is	  difficult	  to	  purify,	   lacks	  stability,	   is	  
characteristically	   shorter	   and	   the	   averages	   (generated	   from	   reference	   free	   alignment	   and	   k-­‐means	  
classification)	  do	  not	  indicate	  any	  element	  of	  symmetry	  (Figure	  3.15).	  	  
	  
	  
Figure	   3.15:	  Representative	  negative	  stain	  class	  averages	  of	  mini-­‐RZZ	  as	  obtained	  by	  reference	   free	  alignment	  
and	  k-­‐means	  classification	  procedures.	  Scale	  bar,	  10	  nm.	  	  
	  
To	  get	  an	  overview	  of	  the	  3D	  structure	  of	  mini-­‐RZZ	  I	  resorted	  to	  RCT	  approach.	  I	  recorded	  images	  at	  
55°	  and	  0°	  tilt	  and	  boxed	  particle	  pairs.	  The	  3D	  structure	  was	  generated	  by	  back	  projection	  and	  back-­‐
projection	   refinement,	  as	  described	  earlier	   (for	  RZZ,	   refer	  section	   3.1.2).	  The	   resolution	  of	   structure	  
was	  24.6	  Å	  (FSC0.5	  criterion,	  Figure	  S10,	  d).	   It	  was	  clearly	  evident,	   that	  mini-­‐RZZ	  does	  not	  exhibit	   the	  











Figure	   3.16:	   Views	   of	  mini-­‐RZZ.	   Structure	   obtained	   by	   back-­‐projection	   (RCT)	   and	   back-­‐projection	   refinement.	  
Length	  of	  the	  complex	  is	  26	  nm.	  Scale	  bar,	  10	  nm.	  
	  
I	  was	  not	  able	  to	  generate	  difference	  maps	  between	  RZZ	  and	  mini-­‐RZZ,	  mainly	  because	  of	  the	  fact	  that	  
the	  densities	  were	  obtained	  by	   two	  different	  methodologies	   (cryo	  vs.	   stain)	  and	   the	  difference	  map	  
between	  the	  negative	  stain	  reconstructions	  was	  not	  particularly	  useful.	  However,	   I	   fit	   the	  density	  of	  
mini-­‐RZZ	   into	  a	  filtered	  density	  of	  RZZ.	  This	  fit	  does	  not	  clearly	  attribute	  the	  missing	  density	   in	  mini-­‐
RZZ	  to	  the	  C-­‐terminus	  of	  ROD	  (data	  not	  shown).	  
3.1.9 Salient	  features	  of	  the	  fitting	  and	  proposed	  architecture	  
13.4	   Å	   is	   an	   intermediate	   resolution	   where	   scouting	   for	   secondary	   structural	   elements	   is	   not	   only	  
tough	   but	   can	   be	   misleading.	   The	   main	   limitation	   with	   understanding	   the	   architecture	   is	   that	   the	  
crystal	  structures	  of	  ROD	  and	  Zw10	  are	  not	  known.	  Albeit	  very	  powerful,	  the	  prediction	  programs	  may	  
generate	   models	   that	   are	   far	   from	   accurate.	   However,	   antibody	   labeling	   and	   cross-­‐linking	   studies	  
place	  this	  analysis	  on	  a	  firm	  footing,	  where	  I	  can	  safely	  highlight	  the	  following	  features.	  
1.	   The	  N-­‐terminus	  of	  ROD	   is	   predicted	   to	  be	   folding	   into	  a	  β-­‐propeller	   (Figure	   3.17,	   a).	   The	  density	  
corresponding	   to	   toroid	   stands	   out	   and	   can	   be	   clearly	  marked.	   The	   predicted	  model	   (Figure	   S5,	   a)	  
clearly	  fits	  into	  the	  density.	  	  
2.	  Zw10	  adopts	  various	  conformations	  in	  solution	  (also	  reflected	  by	  the	  inertia	  to	  crystallize)	  but	  gets	  
locked	  into	  one	  conformation	  in	  the	  RZZ	  complex	  and	  serves	  as	  a	  latch	  between	  the	  ROD	  monomers.	  
The	  density	  corresponding	  to	  Zw10	  can	  also	  be	  clearly	  marked	  out	  and	  it	  is	  in	  reasonable	  agreement	  
to	  the	  known	  structural	  homologue,	  Dsl1p	  (Figure	  3.17,	  b).	  
3.	   Zwilch	   is	   terminal	  anchor	  point	   in	   the	  RZZ	  complex,	  and	   that	  both	  N-­‐	  and	   the	  C-­‐terminus	  of	  ROD	  
interact	  with	  Zwilch	  (Figure	  3.17,	  c).	  
4.	   Most	   of	   the	   ROD	   protein	   has	   a	   secondary	   α-­‐helical	   structure	   and	   it	   adopts	   an	   extended	  
conformation	  in	  the	  complex	  give	  the	  distinct	  shape	  to	  the	  RZZ	  complex.	  The	  two	  monomers	  of	  ROD	  
protein	  run	  in	  an	  anti-­‐parallel	  fashion	  (Figure	  3.17,	  d).	  	  
	   	  






Figure	   3.17:	   Salient	   features	   of	   the	   structure.	   (a)	  
The	   N-­‐terminus	   of	   ROD	   is	   predicted	   to	   be	   a	   β-­‐
propeller.	   Density	   corresponding	   to	   this	   can	   be	  
clearly	   visualized	   in	   the	   structure.	   In	   fact	   the	  
architecture	  of	   the	  RZZ	   complex	  was	  built	   starting	  
from	  this	  hint.	   (b)	  Density	  corresponding	   to	  Zw10.	  
The	   crystal	   structures	   of	   Dsl1p	   (in	   green)	   fit	   very	  
well	   into	   the	   density,	   which	   clearly	   seem	   to	  
correlate	   with	   antibody	   labeling.	   The	   two	   Zw10	  
molecules	   lie	   in	  an	  anti-­‐parallel	   fashion	  acting	  as	  a	  
bridge	  between	  the	  ROD	  monomers	   (c)	  Zwilch	  not	  
only	  interacts	  with	  the	  N-­‐terminus	  of	  ROD,	  but	  also	  
the	  C-­‐terminus	  of	  the	  second	  ROD	  molecule.	  Zwilch	  
seems	   to	  be	   the	   terminal	   anchor	  point	  of	   the	  RZZ	  
complex	   (crystal	   structure,	   3IF8	   in	   orange).	   The	  
fitting	   is	   not	   the	   best,	   as	   there	   seem	   to	   be	   of	  
clashes	  between	  ROD	  and	  Zwilch	  molecules.	   In	  my	  
defense,	  the	  models	  of	  ROD	  fit	  are	  from	  prediction	  
programs	   that	   may	   not	   be	   very	   accurate.	   A	   high-­‐
resolution	   cryo-­‐EM	   structure	   will	   facilitate	   better	  
understanding	  of	   the	  precise	   interactions.	   (d)	  ROD	  
molecules	  make	   up	  most	   of	   the	   RZZ	   complex.	   Dr.	  
Jenny	   Keller	   generated	   all	   the	   structures	   of	   ROD.	  
Various	   elements	   that	   were	   predicted	   are	  
highlighted	  in	  Figure	  S7.	  The	  images	  were	  rendered	  
using	  UCSF	  Chimera.	  
	   	  
	  
3.1.10 Why	  dimerize?	  
Why	   is	   RZZ	   a	   dimer?	   Why	   should	   the	   cell	   work	   its	   machinery	   in	   producing	   a	   dimer	   without	   any	  
functional	  consequence?	  Recent	  reports	   indicate	  the	  role	  of	   the	  RZZ	  complex	   in	   formation	  of	   lateral	  
attachments	  while	  keeping	  NDC80C	  inhibited	  and	  then	  promoting	  those	  to	  end-­‐on	  attachments	  [85].	  
In	   the	   study,	   the	   authors	   show	   that	   ROD1-­‐400:	   Zwilch	   (RZ)	   is	   sufficient	   to	   interact	   with	   the	   NDC80	  
complex,	  raising	  questions	  about	  the	  necessity	  of	  the	  dimer.	  Dimerization	  may	  be	  due	  to	  one	  of	  the	  
two	  following	  reasons:	  first,	  RZZ	  might	  be	  acting	  as	  a	  functional	  dimer,	  for	  example	  as	  a	  receptor	  for	  
binding	  the	  Mad2	  dimer	  or	  second,	  dimerization	  may	  be	  the	  mechanism	  to	  inhibit	  the	  activity	  of	  RZZ,	  
by	   blocking	   the	   WD40	   repeats	   of	   the	   ROD	   and	   hence	   preventing	   it	   from	   interacting	   with	   other	  
proteins.	  Although	  the	  surface	  of	  the	  β-­‐propeller	  region	  is	  not	  masked	  out	  much	  due	  to	  dimerization	  it	  














Figure	  3.18:	  β-­‐propeller/α-­‐solenoid	  domains	   tend	   to	  arrange	   into	  higher	  order	   structures.	   (a)	  The	  NPC	   is	  
complex	  multilayered	  hierarchical	  assembly	  of	  proteins	  known	  as	   the	  nucleoporins	   (Nup).	   It	   facilitates	  and	  
mediates	   transport	   between	   the	  nucleus	   and	   cytoplasm	  of	   eukaryotic	   cells	   (for	   sake	  of	   simplicity	   only	   the	  
architecture	   of	   outer	   ring	   of	   NPC	   is	   shown).	   The	   Y-­‐shaped	   heptameric	   complex	   (composed	   of	   Nup85,	  
Nup120,	  Sec13,	  Nup145,	  Nup84,	  Nup107	  and	  Nup133)	   interacts	   in	  a	  head	  to	  tail	   fashion	  to	  form	  the	  outer	  
ring.	  The	  key	  interaction	  here	  is	  the	  interaction	  of	  Nup133	  with	  Nup120.	  β-­‐propellers	  occur	  in	  almost	  all	  the	  
layers	  of	  NPC	  making	  them	  indispensible	  for	  its	  architecture[172].	  (b)	  COPII	  is	  a	  vesicle	  coat	  complex	  made	  up	  
of	   four	   proteins	   (Sec23p,	   Sec24p,	   Sec13p	   and	   Sec31p)	   and	   is	   absolutely	   essential	   for	   the	   anterograde	  
transport	   between	   the	   endoplasmic	   reticulum	   and	   the	   Golgi.	   Again	   the	   interactions	   between	   the	   WD40	  
domains	  are	  absolutely	  essential	  for	  the	  formation	  of	  cages.	  	  
	  
The	  latter	  aspect	  needs	  to	  be	  reflected	  upon	  in	  detail.	  ROD	  is	  the	  largest	  protein	  in	  the	  RZZ	  complex.	  It	  
is	  predicted	  to	  have	  an	  N-­‐terminal	  β-­‐propeller	  followed	  by	  an	  all	  α-­‐helical	  secondary	  structure.	  I	  could	  
define	  and	  outline	  the	  density	  corresponding	  to	  ROD	  in	  the	  structure.	  I	  show	  that	  it	  exists	  as	  an	  anti-­‐
parallel	  dimer	  providing	   the	  chassis	   for	   the	  structure	  of	  RZZ	  complex	  held	   together	  by	  Zw10.	  The	  β-­‐
propeller/α-­‐solenoid	  is	  a	  key	  combination	  occurring	  recurrently	  in	  cellular	  macromolecular	  complexes,	  
where	  proteins	  engage	  in	  forming	  lattices	  primarily	  via	  interactions	  mediated	  by	  WD40	  domains.	  Two	  
examples	   of	   such	   complexes	   are	   the	   nuclear	   pore	   complex	   (NPC)	   and	   the	   COPII	   vesicle	   coat	   [173]	  
(Figure	   3.18).	   The	   β-­‐propellers	   (WD40	   domains)	   are	   far	   apart	   in	   the	   RZZ	   complex,	   and	   are	   partly	  
shielded	  by	  the	  C-­‐terminus	  of	  the	  ROD.	  This	  may	  be	  a	  possible	  reason	  why	  higher	  order	  structures	  are	  
not	  seen	  in	  these	  studies.	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Figure	  3.19:	  Overlay	  of	  the	  predicted	  structure	  of	  
the	   N-­‐terminus	   of	   ROD	   (6-­‐1165,	   in	   yellow)	   with	  
that	   of	   Nup120	   (yeast	   homologue	   of	   Nup160,	   in	  
green).	   The	  β-­‐propellers	   are	   alike	   (aligned	   in	   this	  
figure)	  followed	  by	  a	  linker	  domain	  in	  Nup120	  and	  
NRH	  domain	  in	  ROD,	  which	  define	  the	  orientation	  
of	   the	   α-­‐solenoid.	   Image	   rendered	   by	   Dr.	   Jenny	  
Keller	  using	  PyMOL.	  
	  
The	  oligomeric	  structures	  of	  the	  NPC	  and	  COPII	  complexes	  are	  built	  up	  on	  the	  β-­‐propeller/α-­‐solenoid	  
framework.	   In	   case	   of	   the	   outer	   ring	   of	   NPC,	   the	   Y-­‐shaped	   complex	   (made	   up	   of	   Nup120,	   Nup85,	  
Sec13,	  Nup145,	  Nup84,	  Nup107,	  Nup133)	   interacts	   in	  a	  head	  to	   tail	   fashion	   through	  the	  β-­‐propeller	  
domain.	  Similarly	  in	  the	  COPII	  complex	  (coat	  made	  up	  of	  Sec13/Sec31,	  shown	  in	  Figure	  3.18)	  the	  cage	  
is	  built	  on	   the	   interactions	  mediated	  by	   the	  β-­‐propeller	   regions	  of	  either	  Sec13	  or	  Sec31.	   Structural	  
predictions	   hint	   at	   ROD	   adopting	   a	   similar	   structure	   as	   that	   of	   the	   nucleoporins	   (an	   overlay	   of	  
predicted	   ROD	   structure	   and	   that	   of	   the	   Nup120	   is	   highlighted	   in	   Figure	   3.20).	   Multiple	   sequence	  
alignment	  between	  ROD,	  Sec31	  and	  Nup160,	  however	  show	   little	  conservation	   (Figure	   S12	  and	  13).	  
This	   can	  be	   attributed	   also	   to	   the	  WD40	  domain,	  which	   is	   notoriously	   known	   for	   low	   conservation.	  
Moreover,	  it	  is	  known	  for	  a	  wide	  range	  of	  proteins	  that	  sequence	  similarity	  does	  not	  parallel	  structural	  
similarity.	  
RZZ	   is	   cytosolic	   prior	   to	   prophase	   and	   little	   is	   known	   about	   the	   state	   of	   its	   oligomerization	   during	  
various	  phases	  of	  the	  cell	  cycle.	  Taking	  into	  consideration	  the	  fact	  that	  components	  of	  COPII	  coat	  are	  
cytosolic	  and	  those	  of	  NPC	  are	  cytosol	  bound	  during	  certain	  stages	  of	  cell-­‐cycle;	  it	  is	  possible	  that	  the	  
components	  of	  RZZ,	  NPC	  and	  COPII	  coat	  share	  similar	  ancestry	  but	  have	  diverged	  over	  the	  course	  of	  
evolution.	  	  
Along	  this	  line	  I	  would	  expect	  the	  RZZ	  to	  form	  higher	  order	  complexes.	  Sec13/Sec31	  protein	  complex	  
was	   long	   known	   not	   to	   form	   coats	   without	   adaptor	   proteins.	   However,	   an	   entirely	   serendipitous	  
experiment	  led	  to	  finding	  that	  they	  self-­‐assemble	  to	  form	  minimal	  coats.	  RZZ	  complex,	  however,	  does	  
not	   assemble	   into	  higher	  order	   structures	  when	   treated	  under	   similar	   conditions	   (Figure	   S8).	   It	   can	  
only	   be	   speculated	   at	   this	   juncture	   that	   an	   adaptor	   protein	   or	   possibly	   a	   modification	   on	   RZZ	   is	  
missing.	  A	  promising	  hint	  towards	  this	  aspect	   is	  shift	   in	  size-­‐exclusion	  chromatography	  profile	  of	  RZZ	  
upon	  phosphorylation	  by	  kinase	  Mps1	  (Figure	  3.20).	  Expecting	  RZZ	  to	  form	  higher	  order	  structures	  is	  
not	   entirely	   naïve.	   This	   could	   possibly	   explain	   its	   role	   in	   recruitment	   and	   transport	   of	   kinetochore	  
components	   like	  Mad2.	   One	   can	   only	   speculate	   the	   role	   and	   necessity	   of	   dimerization	   but	   precise	  










Figure	   3.20:	   Size	  exclusion	   chromatography	  profile	  of	  RZZ	   complex	   (blue	  peak)	   and	  of	   RZZ	  phosphorylated	  by	  
Mps1.	   A	   clear	   shift	   is	   seen	   as	   pointed	   out	   by	   the	   arrow.	   Possible	   interaction	   of	   RZZ	   could	   be	   explained	   by	  
electrostatics,	  where	  the	  negative	  charge	   introduced	  due	  to	  the	  phosphate	  moiety	  may	  facilitate	   it	   to	   interact	  
with	  positive	  tail	  of	  the	  NDC80	  complex.	  Source:	  Anika	  Altenfeld.	  
3.1.11 Structure	  in	  the	  context	  of	  kinetochore	  
The	  complexes	   in	  kinetochore	  are	  heavily	   interdependent	  on	  each	  other	   for	  proper	  recruitment	  and	  
localization	   (refer	   to	   section	   1.1.3).	   For	   example,	   for	   the	   SAC,	   the	   Mad1-­‐Mad2	   pathway	   is	  
indispensible.	   This	   relies	   primarily	   on	   the	   RZZ	   complex	   for	   recruitment	   of	   Mad2	   and	   on	   dynein-­‐
dynactin	  complex	  for	  removal	  of	  the	  components	  once	  the	  checkpoint	   is	  quenched.	  The	  recruitment	  
of	  dynein	  depends	  on	  RZZ	  and	  that	  of	  RZZ	  on	  Zwint-­‐1,	  which	  in	  turn	  requires	  Knl1	  for	  its	  recruitment	  
[174].	   In	   essence,	   these	   proteins	   interact	   with	   each	   other,	   directly	   or	   indirectly,	   validity	   of	   which	  
remains	   to	   established	   biochemically.	   Understanding	   the	   spatial	   and	   temporal	   localization	   of	   a	  
protein/proteins	  in	  a	  complex	  in	  vivo	  is	  also	  essential.	  Efforts	  directed	  to	  understand	  the	  positioning	  of	  
proteins	   localizing	   at	   the	   kinetochore,	   along	   the	   kinetochore-­‐microtubule	   axis,	   led	   to	   the	   first	  
nanometer-­‐scale	  map	  as	  depicted	   in	  Figure	   1.3.	   In	   recent	  developments	   this	  analysis	   (K-­‐SHREC)	  was	  
extended	   to	   proteins	   involved	   in	   the	   Mad1-­‐Mad2	   checkpoint	   pathway	   [174].	   The	   essence	   of	   this	  
analysis	  is	  depicted	  pictorially	  in	  (Figure	  3.21,	  a)	  and	  can	  be	  summarized	  as	  follows:	  RZZ	  subunits	  are	  
spatially	  proximal	  to	  the	  N	  terminus	  of	  Knl1	  and	  Hec1.	  Mad2-­‐binding	  domain	  of	  Mad1	  is	  close	  to	  the	  C-­‐
terminus	   of	   Zw10	   and	   Spindly	   extends	   from	   RZZ	   complex	   into	   the	   outer	   kinetochore.	   Of	   particular	  
interest	   is	   the	   position	   of	   the	   epitopes	   of	   RZZ	   subunits	   determined	   from	   this	   analysis,	   according	   to	  
which	  the	  N-­‐terminus	  of	  ROD	  and	  N-­‐terminus	  of	  Zw10	  are	  close	  to	  each	  other	  (within	  3	  nm)	  and	  that	  
Zwilch	   is	   proximal	   to	   N-­‐terminus	   of	   ROD.	   This	   analysis	   resonates	   precisely	  with	   the	   architecture	   as	  
understood	   from	   the	   structural	   determined,	   implying	   that	   the	   protein	   organization	   is	   similar	   in	   the	  
cellular	  context	  as	  in	  vitro.	  I	  find	  that	  the	  structure	  is	  in	  remarkable	  agreement	  with	  the	  Delta	  analysis	  
(refer	   section	   1.1.2).	   I	   compare	   the	   inter	   sub-­‐unit	   distances	   as	   deciphered	   from	  my	   structure	  with	  











Figure	  3.21:	  Structure	  in	  the	  context	  of	  kinetochore.	  (a)	  The	  positions	  of	  proteins/epitopes	  obtained	  from	  mean	  
values	  of	  Delta	  measurements.	   Scale	  on	   the	   left	   side	   is	   set	   to	  0	   at	   the	  position	  of	  CENP-­‐I;	   positive	   values	   are	  
outward	   (toward	   the	   spindle	   microtubules),	   whereas	   negative	   values	   are	   inward	   (toward	   the	   centromeric	  
chromatin).	   Color-­‐coded	   boxes	   indicate	   complexes	   and	   large	   proteins.	   Black	   dots	   indicate	   the	   average	   Delta	  
values	   that	   have	   been	   corrected	   for	   tilt.	   The	   vertical	   lines	   indicate	   the	  minimum	   and	  maximum	  Delta	   values	  
measured	  across	  the	  variation	  in	  centromere	  stretch	  [174].	  (b)	  Segmented	  view	  of	  RZZ	  density.	  Zwilch	  (orange),	  
Zw10	   (in	   green)	   and	   ROD	   (gray)	   are	   represented.	   The	   inter-­‐subunit	   distance	   with	   reference	   to	   Zwilch	   are	  
highlighted	   on	   the	   right.	   The	   distances	   were	   calculated	   from	   the	   mean	   position	   of	   Zwilch.	   The	   approximate	  
values	  from	  the	  K-­‐SHREC	  are	  listed	  in	  parenthesis	  below.	  	  
	  
The	  scenario	  becomes	  a	  little	  bit	  more	  complicated	  in	  the	  context	  of	  RZZ	  as	  a	  dimer.	  Firstly,	  as	  I	  argued	  
earlier,	  the	  functional	  RZZ	  complex	  at	  the	  kinetochore	  may	  not	  be	  a	  dimer	  but	  this	  still	  remains	  to	  be	  
established.	   Secondly,	   the	   Delta	   measurements	   rely	   heavily	   on	   the	   accessibility	   of	   the	   polypeptide	  
chain	   of	   interest	   by	   polyclonal	   antibodies	   (during	   immunofluorescence)	   leading	   to	   high	   values	   of	  
standard	  deviations	  and	  a	  compromise	  in	  accuracy.	  For	  example,	  the	  Delta	  value	  for	  the	  C-­‐terminus	  of	  
Zw10	   is	   36	   (+/-­‐17)	   nm.	   Thirdly,	   estimating	   the	   position	   of	   C-­‐terminus	   of	   ROD	   would	   be	   key	   in	  
understanding	   the	   placement	   of	   complex	   in	   the	   context	   of	   kinetochore.	   It	   would	   give	   a	   complete	  
picture	  as	   to	  how	  RZZ	  complex	   is	  positioned	   in	   the	  kinetochore.	   In	  essence,	   I	  believe	   that	   the	   inter-­‐
protein	   distances	   along	   the	   kinetochore-­‐microtubule	   axis,	   as	   determined	   by	   the	   k-­‐SHREC,	   are	  
comfortably	  placed	  with	  the	  structure,	  but	  the	  scenario	  gets	  a	  tad	  bit	  complicated	  taking	  dimerization	  
into	  account.	  
3.1.12 Road	  to	  high-­‐resolution	  structure	  
Structure	   determination	   by	   cryo-­‐EM	   is	   riding	   a	   new	   high,	   with	   near	   atomic	   resolution	   structures	  
feasible	   for	   asymmetric	   and	   smaller	   protein	   complexes	   [175,	   176].	   The	   advent	   of	   direct	   electron	  
detectors	   has	   catapulted	   cryo-­‐EM	   into	   spotlight.	   The	   power	   of	   single	   particle	   cryo-­‐EM	   is	   limited	   by	  
Results	  &	  Discussion	  -­‐	  I	   	  
	  
91	  
three	  factors:	  lack	  of	  contrast	  in	  the	  images,	  introduction	  of	  noise	  and	  drift.	  Though	  there	  are	  several	  
other	   factors,	   the	   loss	   of	   contrast	   is	   primarily	   a	   consequence	   of	   beam-­‐induced	  motion	   of	   particles	  
(drift)	  and	   less	  efficient	  detectors	   (as	  estimated	  by	  the	  detective	  quantum	  efficiency).	  Thanks	  to	  the	  
advancement	   in	  technology,	  the	  new	  breed	  of	  detectors	  facilitate	  the	  detection	  of	  electrons	  directly	  
rather	   than	  converting	   them	   in	  photons	   for	   recording	   the	   signal	   (like	  most	  of	   the	  CCD’s	   in	  use)	  and	  
hence	  have	  a	  two-­‐fold	  advantage.	  The	  images	  recorded	  have	  a	  high	  signal	  to	  noise	  ratio	  as	  there	  is	  a	  
considerable	  reduction	  of	  back-­‐scattered	  electrons	  and	  secondly,	  because	  of	  the	  high	  DQE	  the	  images	  
contain	  information	  up	  to	  high	  spatial	  frequencies.	  The	  new	  detectors	  also	  facilitate	  recording	  images	  
as	  frames/movies,	  which	  can	  be	  used	  for	  correction	  of	  drift	  or	  beam	  induced	  motion	  of	  particles	  in	  ice.	  
The	  cryo-­‐EM	  images,	  which	  led	  to	  the	  structure	  presented	  here,	  were	  collected	  on	  an	  8k	  x	  8k	  CMOS	  
camera.	   The	   structure,	   although	   novel,	   is	   on	   the	   borderline	   where	   detection	   of	   the	   secondary	  
structural	   elements	   with	   authority	   is	   challenging.	   I	   therefore	   decided	   to	   invoke	   the	   recent	  
advancement	   in	   the	   detectors	   to	   try	   and	   achieve	   sub-­‐nanometer	   resolution.	   I	   collected	   data	   on	   a	  
TITAN	  Krios,	  equipped	  with	  a	  back-­‐thinned	  falcon	  II	  (direct	  detector)	  at	  the	  NeCEN,	  Leiden.	  The	  initial	  
results	   are	   very	   promising	   (Figure	   3.22)	   and	   I	   am	   confident	   that	   I	   can	   get	   past	   the	   sub-­‐nanometer	  
resolution	  barrier.	  
	  	  	  
	  
Figure	  3.22:	  Representative	  cryo-­‐EM	  class	  averages	  of	  RZZ	  complex	  obtained	  from	  reference	  free	  alignment	  and	  
k-­‐means	  classification.	  The	  complex	  was	   imaged	  on	  TITAN	  Krios,	  equipped	  with	  a	  Falcon	   II	  at	   the	  Netherlands	  
center	  for	  Electron	  Nanoscopy	  (NeCEN),	  Leiden.	  The	  averages	  are	  from	  a	  dataset	  of	  5000	  particles.	  Scale	  bar,	  10	  
nm.	  
	  
The	   fit	   of	   various	  predicted	   structures	   in	   the	  density	   is	   a	  bit	   coarse	   and	  not	   ideal.	   Clashes	  between	  
residues	   are	   evident	   especially	   at	   the	   ROD-­‐Zw10	   and	   ROD-­‐Zwilch	   interface.	   Working	   towards	   a	  
structure	   with	   better	   resolution	   (sub-­‐nanometer)	   is	   essential	   at	   this	   stage,	   as	   it	   will	   facilitate	  
identification	  of	  secondary	  structure	  elements	  and	  proper	  fitting	  of	  the	  predicted	  structures	  of	  ROD,	  
Zw10	   and	   the	   structure	   of	   Zwilch	   by	   flexible	   fitting	   methods.	   A	   high-­‐resolution	   structure	   of	   the	  
complex	   is	   an	   urgent	   necessity,	   as	   it	   would	   open	   the	   window	   to	   explore	   and	   understand	   various	  
functional	   aspects	   of	   the	   complex	   in	   the	   cell	   (in	   vivo	   studies	   based	   on	   the	   structure).	   Ultimately,	   I	  
intend	  to	  understand	  the	  molecular	  basis	  of	  RZZ	  function	  by	  targeting	  various	  interfaces	  and	  domains,	  
as	  inferred	  from	  the	  structure,	  and	  their	  consequence	  on	  the	  spindle	  assembly	  checkpoint.	  	  
Finally,	  one	  aspect	  not	  highlighted	  in	  detail	  is	  the	  presence	  of	  the	  RZZ	  complex	  and	  its	  role	  in	  spindle	  
assembly	   checkpoint	   (SAC)	   and	   lateral	   attachment	   of	   microtubules	   only	   in	   higher	   eukaryotes.	  
Kinetochores	   of	   higher	   eukaryotic	   organisms	   bind	   more	   than	   one	   microtubule	   (Figure	   3.23,	   a),	  
requiring	   additional	   proteins	   and	   complexes	   to	   ensure	   the	   fidelity	   of	   chromosome	   segregation.	   The	  
signaling	  in	  SAC	  arises	  because	  of	  unattached	  kinetochores.	  What	  signals	  from	  the	  kinetochore	  ensure	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which	  microtubules	  to	  bind	  and	  which	  to	  avoid?	  How	  is	  the	  whole	  process	  coordinated?	  The	  corona	  of	  
microtubules	   is	  mesh-­‐like	  unstructured	  region	  predominantly	  made	  up	  of	  proteins,	  which	  constitute	  
the	  SAC.	  Studies	  show	  that	  RZZ	  can,	  in	  a	  phosphorylation	  dependent	  manner	  due	  to	  activity	  of	  Mps1	  
kinase,	   form	  higher	   order	   structures/aggregates	   (unpublished	   data).	   This	  may	   be	   a	   hint	   at	   how	   the	  
kinetochore	   coordinates	  multiple	  microtubules	   dynamics	   and	  why	   the	   corona	   of	   the	   kinetochore	   is	  
mesh-­‐like.	   I	   believe	   that	   phosphorylation,	   and	   that	   it	   is	   reversible,	   brings	   about	   a	   conformational	  
change	   in	   the	   RZZ	   complex,	  making	   it	   susceptible	   for	   oligomerization.	   This	   could	   be	   also	   a	   possible	  
explanation	  why	  despite	  tremendous	  efforts;	  reconstitution	  of	  interactions	  of	  the	  RZZ	  complex	  in	  vitro	  
was	   not	   possible	   (Figure	   3.23,	   b).	   The	   role	   of	   phosphorylation	   in	   the	   context	   of	   kinetochore-­‐
microtubule	  interaction	  is	  not	  new	  [177].	  The	  nature	  of	  change	  induced	  upon	  phosphorylation	  and	  the	  
nature	  of	  the	  large	  aggregates	  remain	  to	  be	  investigated.	  What	  triggers	  the	  phosphorylation	  of	  RZZ	  in	  
the	  cell?	  What	  are	  the	  binding	  interfaces	  on	  the	  RZZ	  complex?	  What	  is	  the	  structural	  basis	  for	  removal	  
of	  RZZ	  from	  kinetochores?	  How	  does	  RZZ	  interact	  with	  other	  proteins	  and	  protein	  complexes?	  What	  is	  
the	   structural	   basis	   for	   such	   interactions?	   Finally,	   amidst	   all	   the	   chaos,	   what	   triggers	   the	   shift	   of	  
microtubules	   from	   lateral	   to	   end-­‐on	   attachment?	   These	   are	   very	   few	   questions	   that	   need	   to	   be	  




Figure	   3.23:	   Understanding	   the	   function	   of	   RZZ	   based	   on	   structure.	   (a)	   Kinetochores	   that	  are	  unattached	   to	  
microtubules	   recruit	   additional	  proteins	   to	   facilitate	  microtubule	   interactions	  and	   signal	   cell-­‐cycle	  arrest.	  How	  
RZZ	  coordinates	  multiple	  microtubules	  that	  bind	  kinetochores	   (	  by	   lateral	  capture	  and	  then	  transfer	   to	  NDC80	  
complex)	   in	   a	   dynamic	   fashion	   remains	   to	   be	   understood.	   The	   higher	   eukaryotic	   kinetochores	   present	   an	  
extremely	   complex	   network	   of	   proteins	   interactions	   and	   structures	   of	   which	   remain	   poorly	   understood.	   The	  
structure	   of	   RZZ	   may	   help	   in	   the	   understanding	   various	   aspects	   of	   SAC	   and	   the	   kinetochore-­‐microtubule	  
interactions	  in	  an	  indirect	  fashion.	  Source:	  [26]	  (b)	  Various	  interacting	  partners	  of	  RZZ.	  It	  is	  still	  unclear	  how	  RZZ	  
mediates	  these	  interactions.	  The	  molecular	  mechanisms	  of	  these	  interactions	  remain	  to	  be	  established.	  
	  
To	   summarize,	   I	   report	   the	   first	   high-­‐resolution	   structure	   of	   the	   RZZ	   complex.	   I	   show	   that	   RZZ	   is	   a	  
dimer.	   interweaving	  antibody-­‐labeling	  studies	  with	  XL-­‐MS	  analysis	   I	  highlight	   the	  organization	  of	   the	  
RZZ	   complex.	   The	   structure	   is	   just	   the	   tip	   of	   the	   iceberg;	   efforts	   to	   understand	   how	   the	   complex	  
eukaryotic	  spindle	  assembly	  checkpoint	  is	  regulated,	  from	  a	  structural	  perspective,	  are	  well	  underway.	  





3.2.1 Cloning	  and	  bacterial	  expression	  of	  Cln3p	  
The	  first	  and	  inevitable	  step	  in	  understanding	  the	  structure	  of	  any	  protein	  is	  to	  obtain	  a	  relatively	  large	  
and	  pure	  amount	  of	  the	  same.	  cDNA	  of	  cln3	  (human,	  mouse	  and	  rat)	  was	  cloned	  into	  pOPINE	  vectors	  
with	  a	  fluorescent	  reporter	  (EGFP,	   fused	  to	  the	  N-­‐terminus)	  and	  His	   (6x)	  affinity	  tag	  (	  plasmids	  were	  
named	  according	  to	  the	  nomenclature	  of	  the	  AG	  Raunser	  database	  as	  p231,	  p232	  and	  p261	  for	  mouse,	  
human	   and	   rat	   versions	   of	   cln3	   respectively).	   The	   plasmids	   were	   sequenced	   to	   authenticate	   the	  
proper	  placement	  of	  the	  cln3	  gene.	  A	  great	  advantage	  of	  pOPINE	  vectors	  is	  that	  they	  can	  be	  used	  to	  
express	   proteins	   in	   bacterial,	   insect	   as	   well	   as	   mammalian	   expression	   systems.	   Sandra	   Bergbrede	  
devised	  and	  cloned	  the	  fluorescent	  fusion	  constructs.	  
Expression	   of	   the	   protein	   was	   screened	   in	   various	   bacterial	   expression	   strains	   (C41,	   C43	   and	   BL21	  
(DE3))	  under	  a	  variety	  of	  conditions	  (23	  in	  total:	  varying	  in	  media,	  O.D.	  and	  time	  of	  expression,	  listed	  in	  
Table	   2.15,	  materials	   and	  methods).	   Since	  Cln3p	   is	  a	  membrane	  protein,	   I	   adapted	   the	  purification	  
protocols	   to	   target	   the	  membrane	   pool	   of	   the	   cell	   lysate.	   Using	   EGFP	   as	   a	   reporter	   tag	   is	   of	   great	  
advantage.	  The	  crude	  lysates	  can	  be	  tested	  for	  protein	  expression	  by	  scanning	  for	  EGFP	  fluorescence.	  
In-­‐gel	  fluorescence	  image	  of	  crude	  lysate	  spotted	  on	  a	  petri-­‐plate	  is	  shown	  in	  Figure	  3.24,	  a.	  The	  semi-­‐
denaturing	   SDS-­‐PAGE	   profile	   of	   the	   membrane	   fraction	   of	   the	   lysates	   with	   brightest	   intensity	   as	  
revealed	  from	  (Figure	  3.24,	  a)	  is	  shown	  in	  (Figure	  3.24,	  b).	  
	  
	  
Figure	  3.24:	  Over-­‐expression	  of	  Cln3p	  in	  E.	  coli.	  Semi-­‐denaturing	  SDS-­‐PAGE.	  The	  folding	  of	  the	  protein	  remains	  
generally	   intact	   owing	   to	   low	   concentration	   of	   SDS	   in	   loading	   and	   running	   buffers.	   Since,	   the	   proteins	   are	  
expressed	  as	  fusions	  with	  fluorescent	  reporter	  tags	  (EGFP	  in	  case	  of	  p232),	  scanning	  for	  fluorescence	  of	  GFP	  (ex:	  
488,	  em:	  509)	  in	  the	  gels	  leads	  to	  the	  identification	  of	  quality	  and	  nature	  of	  protein	  bands,	  a	  technique	  known	  as	  
in-­‐gel	  fluorescence.	  (a)	  4	  μL	  of	  crude	  lysate	  from	  all	  different	  conditions	  of	  expression	  loaded	  equidistantly	  on	  a	  
petri-­‐plate	   and	   scanned	   for	   GFP	   fluorescence.	   Intense	   white	   spot	   indicates	   the	   expression	   of	   protein	   (EGFP-­‐
hCln3p,	   p232)	   (b)	   An	   in-­‐gel	   fluorescence	   image	   is	   shown	   where	   the	   most	   prominent	   spots	   seen	   in	   (a)	   were	  
solubilized	  in	  solubilization	  buffer	  (1%	  DDM,	  500	  mM	  NaCl	  and	  50	  mM	  Tris-­‐HCl,	  pH	  7.5)	  and	  loaded	  onto	  a	  15%	  
semi-­‐denaturing	  SDS	  PAGE	  and	  scanned	  for	  fluorescence.	  Exposure:	  150	  s.	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The	  membranes	  were	  extracted,	  solubilized	  (1%	  DDM,	  500	  mM	  NaCl	  and	  50	  mM	  Tris-­‐HCl,	  pH	  7.5)	  and	  
analyzed	  by	  Western	  blotting	  using	  antibodies	  directed	  towards	  the	  6x-­‐His	  tag.	  A	  typical	  analysis	  of	  23	  
samples	   of	   expression	   trial	   of	   p232	   is	   shown	   in	   figure	   3.25.	   Unfortunately	   there	   is	   no	   signal	  
corresponding	   to	   the	   protein,	   indicating	   that	   the	   protein	   is	   minimally	   expressed	   in	   bacteria.	   I	  
generated	  various	  other	  plasmids	  harboring	  no	  EGFP	  tag	  but	  10x-­‐His	  tag	  (both	  N-­‐	  and	  C-­‐terminus)	  and	  
screened	  for	  expression,	  but	  without	  any	  favorable	  results.	  Since,	  Cln3p	  is	  relatively	  small	  (46	  kDa)	  and	  
is	  predicted	  to	  have	  very	  short	  luminal	  loops,	  I	  did	  not	  generate	  any	  truncated	  versions	  of	  the	  protein.	  	  
	  
Figure	  3.25:	  Western	  blot	  analysis	  (directed	  towards	  the	  6x-­‐His)	  to	  check	  for	  expression	  of	  p232	  (EGFP-­‐hCln3p)	  
transformed	   in	  C43	  cells.	  Varieties	  of	  conditions	   (Table	  2.15,	  materials	  and	  methods)	  were	  screened	  but	  none	  
lead	  to	  expression	  of	  protein	  even	  at	  minimal	  amounts.	  This	  was	  repeated	  for	  various	  expression	  strains	  such	  as	  
(BL21-­‐DE3	  and	  C41).	  WM,	  Western	  blot	  marker.	  M,	  PAGE	  marker.	  
	  
Overexpression	   of	   protein	   in	   bacterial	   system	   is	   cheap	   and	   effective	   on	   one	   hand	   but	   suffers	   from	  
major	   setbacks	   in	   the	   context	   of	   eukaryotic	   membrane	   proteins.	   It	   simply	   lacks	   the	   machinery	  
required	   for	   the	   proper	   folding	   and	   stability	   of	   eukaryotic	   proteins	   making	   it	   less	   suitable	   for	  
overexpression.	  	  
3.2.2 Insect-­‐cell	  expression	  of	  Cln3p	  
Bacterial	   hosts	   for	   overexpression	   proved	   inept	   for	   production	   of	   Cln3p	   (all	   homologues	   tested).	   I	  
quickly	  shifted	  my	  focus	  onto	  baculovirus	  driven	  insect	  cell	  expression	  system.	  It	  offers	  a	  predominant	  
advantage	   of	   overexpressing	   proteins,	  which	   require	   post-­‐translational	  modifications	   in	   an	   efficient	  
way.	  The	  BACmid	  (carrying	  viral	  genome	  necessary	  for	  the	  production	  of	  virus)	  and	  plasmid	  were	  co-­‐
transfected	   into	  Sf21	   insect	   cells.	   I	   used	  a	   low	  multiplicity	  of	   infection	   (MOI)	   for	   the	  propagation	  of	  
virus	  (0.01-­‐0.1)	  and	  high	  MOI	  for	  protein	  expression	  (1-­‐10).	  Once	  I	  had	  the	  working	  stock	  of	  the	  virus	  I	  
checked	   for	   expression	   by	   infecting	   the	   Sf21	   cells	   in	   a	   virus/cell	   ratio	   of	   1:10,	   1:100,	   1:1000	   and	  
1:10000.	   I	   optimized	   the	   time	   and	   the	   amount	   of	   virus	   required	   for	   efficient	   protein	   expression	   by	  
monitoring	  the	  fluorescence	  of	  the	  reporter	  tag,	  where	  the	  number	  and	  brightness	  of	  the	  cells	  in	  the	  
fluorescence	  channel	  gives	  an	  estimate	  of	  the	  quality	  of	  expression.	  Shown	  below	  are	  the	  DIC	  (Figure	  
3.26,	   a)	   and	   the	   fluorescence	   image	   (Figure	   3.26,	   b)	   of	   Sf21	   cells	   expressing	   EGFP-­‐hCln3p	   (p232).	   I	  
generated	  virus	  and	  studied	  the	  expression	  and	  purification	  of	  all	  the	  homologues	  (mouse	  and	  rat)	  of	  
Cln3p.	  However	  for	  the	  sake	  of	  simplicity	  and	  to	  reduce	  repetition,	  results	  of	  p232	  (EGFP-­‐hCln3p)	  will	  










Figure	  3.26:	  Overexpression	  of	  Cln3p	  in	  Sf21	  cells.	  (a)	  All	  cells	  have	  an	  equal	  size	  and	  round	  shape	  indicating	  
their	   healthy	   state.	   Also,	   they	   do	   not	   showing	   any	   signs	   of	   contamination	  with	   bacteria	   or	   other	   kinds	   of	  
microorganisms	  (e.g.	  elongated	  cells	  or	  a	  large	  number	  of	  apoptotic	  cells).	  (b)	  Fluorescence	  image	  of	  (a).	  Not	  
all	   the	   cells	   are	   fluorescent	   and	   the	   expression	   of	   the	   GFP	   construct	   varies	   amongst	   the	   cell	   population,	  
however	   the	   expression	   level	   in	   general,	   is	   high	   (transfection	   is	   never	   100	   %	   complete).	   Fluorescence	  
intensity	   is	   seen	   nicely	   located	   on	   the	   cell	   boundaries,	   implying	   that	   the	   majority	   of	   the	   overexpressed	  
membrane-­‐resident	   Cln3p	   is	   transported	   to	   the	   plasma	  membrane.	   The	   fact	   that	   there	   is	   a	   fluorescence	  
signal	  is	  already	  a	  first	  hint	  that	  at	  least	  the	  N-­‐terminal	  part	  of	  the	  protein	  is	  folded	  correctly,	  what	  is	  often	  
related	  with	  an	  entirely	  functional	  protein	  (GFP	  as	  a	  marker	  for	  stability).	  
	  
3.2.3 Purification	  of	  Cln3p	  
3.2.3.1 Detergent	  screen	  
Membrane	  proteins	  need	  detergents	  to	  get	  them	  out	  of	  their	  native	  membrane	  and	  into	  the	  solution.	  
There	  are	  a	  variety	  of	  detergents	  on	  the	  market	  and	  it	  becomes	  crucial	  to	  select	  an	  appropriate	  one	  in	  
which	  the	  protein	  is	  rendered	  pure	  and	  functional.	  I	  therefore	  screened	  for	  the	  solubilization	  capacity	  
of	   various	   detergents.	   After	   extraction	   of	   the	   membrane	   from	   the	   insect	   cells	   expressing	   Cln3p	   I	  
subjected	  them	  to	  treatment	  with	  buffers	  containing	  detergents	  of	  interest.	  For	  each	  of	  the	  detergent,	  
I	  used	  them	  well	  above	  their	  critical	  micelle	  concentration	  (CMC)	  and	  screened	  for	  the	  protein	  in	  the	  
supernatant	  (soluble	  fraction)	  before	  and	  after	  solubilization.	  I	  found	  that	  Fos-­‐choline-­‐13	  is	  the	  best-­‐
suited	  detergent	  for	  the	  purification	  of	  Cln3p	  (Figure	  3.27,	  a).	  The	  level	  of	  solubility	  is	  low	  or	  none	  in	  
other	  detergents.	  Since	  Cln3p	  is	  fused	  with	  a	  GFP	  reporter	  tag,	  I	  used	  in-­‐gel	  fluorescence	  to	  detect	  the	  
protein.	   This	   method	   employs	   polyacrylamide	   gel	   electrophoresis	   (PAGE)	   of	   proteins	   in	   semi-­‐
denaturing	  conditions,	  helping	  proteins	  conserve	  their	  folded	  state	  to	  a	  great	  extent.	  Gels	  are	  scanned	  
for	  GFP	  fluorescence	  prior	  to	  Coomassie	  staining.	  Since	  fluorescence	  is	  a	  very	  sensitive	  technique	  one	  
can	   estimate	   the	   quality	   of	   protein	   accurately.	   I	   found	   consistent	   degradation	   of	   protein	   in	   all	   the	  
detergents	   I	   screened	   for.	   I	   also	   found	   that	   addition	   of	   10%	   glycerol	   was	   absolutely	   necessary	   to	  
stabilize	  the	  protein	  and	  reduce	  its	  degradation	  during	  purification	  (Figure	  3.27,	  b).	  I	  therefore,	  used	  
10%	  glycerol	  in	  all	  the	  subsequent	  steps	  after	  the	  lysis	  of	  cells.	  





Figure	   3.27:	   Solubilization	  
Screen.	   (a)	   In-­‐gel	   fluorescence	  
images	   of	   detergent	   screen	  
comparing	   Fos-­‐13	   with	   two	  
most	   commonly	   used	  
detergents	   for	   membrane	  
proteins:	   DDM,	   DM.	   Only	   in	  
Fos-­‐13	   the	   amount	   of	   protein	  
before	   and	   after	  
ultracentrifugation	   (to	  remove	  
insolubilized	   membranes	   BC,	  
AC	   respectively)	   remains	  
same.	   (b)	   In-­‐gel	   fluorescence	  
image	   showing	   the	   necessity	  
of	   glycerol	   in	   the	   buffer.	   A	  
degradation	   pattern	   is	   clearly	  
seen	  in	  buffer	  without	  glycerol	  
(w/o).	  
3.2.3.2 Purification	  of	  Cln3p	  in	  Fos-­‐Choline-­‐13	  (Fos-­‐13)	  
I	  used	  affinity	  chromatography	  for	  the	  purification	  of	  the	  protein	  as	  all	  the	  constructs	  I	  generated	  had	  
a	  6x-­‐His	  tag.	  By	  introducing	  a	  pre-­‐solubilization	  step	  (I	  solubilized	  the	  membranes	  with	  0.5%	  OG	  since	  
Cln3p	  is	  not	  effected	  by	  OG),	  I	  attempted	  to	  get	  rid	  of	  other	  membrane	  proteins	  (membrane	  anchors	  
and	   proteins	   soluble	   in	   OG,	   background)	   and	   boost	   the	   homogeneity	   of	   the	   Cln3p	   pool	   in	   the	  
membrane	  fraction.	  Solubilized	  membranes	  (in	  0.5%	  Fos-­‐13)	  were	  centrifuged	  at	  100,000	  g	  to	  get	  rid	  
of	  the	   insolubilized	  proteins.	  The	  supernatant	  was	  filtered	  (0.2	  μm	  filters)	  to	  prevent	  clogging	  of	  the	  
affinity	  column	  by	  removing	  very	  large	  detergent	  micelles.	  Immobilized	  metal	  affinity	  chromatography	  
(IMAC)	  relies	  heavily	  on	  the	  interaction	  of	  the	  6x-­‐his	  tag	  of	  the	  protein	  with	  the	  metal	  ion	  (usually	  Ni2+	  
or	  Co2+)	  and	   is	  prone	  to	  high	  amount	  of	  non-­‐specific	   interaction	   if	   the	  expression	  amount	  of	  protein	  
concerned	   is	   low	   (membrane	  proteins).	   I	   screened,	   therefore,	   for	   various	   resins	   (NTA,	   IDA,	  TALON®)	  
and	   found	   that	  Co2+	  -­‐	   TALON®	   resin	   is	  best	   suited	   for	  highest	   sample	  purity.	   It	   is	   also	  noteworthy	   to	  
mention	  that	   the	  binding	  affinity	  of	  TALON®	  resin	   is	  considerably	   lower	   than	  that	  of	   the	  Ni-­‐NTA	  and	  
hence	  the	  background	  (non-­‐specific)	  interactions	  are	  also	  very	  less.	  I	  used	  in-­‐gel	  fluorescence	  again	  to	  
optimize	  and	  assess	  the	  purification	  process.	  A	  typical	  purification	  profile	  of	  EGFP-­‐hCln3p	  in	  Fos-­‐13	  as	  











Figure	   3.28:	   Purification	   of	   human	   Cln3p.	   The	  
solubilization	   and	  purification	  of	   EGFP-­‐hCln3p	  was	  
monitored	   by	   in-­‐gel	   fluorescence.	   (a)	   In-­‐gel	  
fluorescence	   image	   of	   the	   semi-­‐denaturing	   SDS-­‐
PAGE	   profile	   of	   purification	   of	   EGFP-­‐hCln3p.	   No	  
degradation	   of	   the	   protein	   is	   seen.	   T,	   total	  
solubilized	   membrane.	   FT,	   flow	   through.	   W	   1-­‐2,	  
wash.	   E	   1-­‐5,	   Eluates.	   The	   Eluted	   fractions	   were	  
pooled	   and	   concentrated	   (using	   amicon	   ultra	  
MWCO:	   50	   kDa)	   and	   loaded	   onto	   a	   Superose	   12	  
10/300	   column.	   Exposure	   5	   s.	   (b)	   SEC	   profile	   of	  
EGFP-­‐hCln3p	   (c)	   Semi-­‐denaturing	   SDS	   PAGE	   (SDS)	  
and	   corresponding	   Western	   blot	   (W,	   towards	   6x-­‐
His).	   Lanes	  1	  and	  2	   represent	  protein	  without	  and	  
with	   heating.	   A	   clear	   shift	   confirms	   the	   fact	   that	  





Once	  the	  solubilized	  protein	  was	  bound	  to	  the	  resin,	  the	  resin	  was	  washed	  with	  buffers	  containing	  low	  
concentrations	  of	   imidazole	  to	  get	  rid	  of	  the	  non-­‐specifically	  binding	  proteins.	  I	  eluted	  the	  protein	  in	  
low	  concentration	  of	  detergent	  (0.1%	  Fos-­‐13,	  CMC-­‐0.027%).	  The	  protein	  was	  	  then	  dialyzed	  overnight	  
(to	   get	   rid	   of	   the	   imidazole),	   concentrated	   and	   loaded	   onto	   a	   Superose-­‐12	   size-­‐exclusion	  
chromatography	   column.	  All	   the	   buffers	   contained	   detergent	   (0.1%	   Fos-­‐13).	   A	   typical	   size-­‐exclusion	  
chromatography	  (Superose	  12	  10/300)	  profile	  for	  hCln3p	  in	  Fos-­‐13	  is	  shown	  in	  Figure	  3.28,	  b.	  A	  strong	  
UV	   peak	   close	   to	   the	   void-­‐volume	   (devoid	   of	   fluorescence)	   suggests	   that	   the	   protein	   may	   have	   a	  
tendency	  to	  oligomerize/aggregate.	  The	  unhealthy	  size-­‐exclusion	  chromatography	  profile	  may	  also	  be	  
due	  to	  non-­‐homogeneous	  nature	  of	  protein-­‐micelles.	  The	  EGFP	  fusion	  protein	   is	  predicted	  to	  have	  a	  
molecular	  weight	  of	  76	  kDa	  but	  since	   it	   is	   folded	   in	   the	  semi-­‐denaturing	  conditions	   runs	  at	   the	  size,	  
slightly	  above	  55	  kDa.	  This	  is	  confirmed	  by	  the	  overlay	  of	  the	  fluorescence	  signal,	  which	  corresponds	  
to	  the	  band	  around	  55	  kDa	  and	  also	  by	  the	  fact	  that	  upon	  heating	  the	  sample	  (classical	  SDS-­‐PAGE)	  the	  
protein	  runs	  at	   the	  size	  corresponding	  to	  predicted	  molecular	  weight	  of	  76	  kDa	  (see	  Figure	  3.28,	   c).	  
Although	  I	  report	  the	  first	  expression	  and	  purification	  of	  hCln3p,	   it	  took	  me	  quite	   long	  to	  render	  the	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protein	   in	   conditions	   favorable	   for	   biochemical	   and	   structural	   analysis.	   To	   avoid	   repetition	   all	   the	  
biochemical	  analysis	  and	  data	  from	  crystallization	  trials	  will	  be	  presented	  at	  the	  end.	  
Presence	  of	  His	  and/or	  GFP	  tags	  hinders	  crystallization	  of	  proteins	  at	  times.	  Therefore,	  getting	  rid	  of	  
the	  tags	  is	  recommended	  before	  any	  such	  attempts	  are	  made.	  I	  ran	  into	  serious	  problems	  while	  trying	  
to	   cleave	   the	   tag.	   Also,	   most	   of	   the	   protein	   was	   eluting	   in	   the	   void-­‐volume.	   Assays	   to	   understand	  
oligomerization	  and	  the	  state	  of	  post-­‐translational	  modifications	  were	  also	  uninformative.	  The	  2D	  and	  
3D	  crystallographic	  trials	  did	  not	  result	  in	  any	  hits.	  I	  believe	  that	  this	  was	  due	  to	  the	  interference	  of	  the	  
detergent.	   Fos-­‐choline-­‐13	   is	   a	   strong	   zwitter	   ionic	   detergent	   and	   seems	   not	   to	   be	   suitable	   for	  
structural	   studies	   as	   is	   reflected	   by	   the	   lack	   of	   membrane	   protein	   structures	   solved	   using	   this	  
detergent	  to	  date.	  Functional	  assays	  also	  require	  detergents	  that	  do	  not	  interfere	  with	  the	  enzymes.	  
Therefore	   it	  was	  necessary	   to	  change	  the	  detergent.	  Since,	   it	  was	  not	  possible	   to	  solubilize	  Cln3p	   in	  
any	   other	   detergent	   I	   tried	   exchanging	   the	   detergent	   once	   Cln3p	   was	   in	   Fos-­‐13	   micelles.	   I	   tried	  
detergent	   exchange	   (to	   Cymal	   5-­‐8,	   LDAO,	   DM,	   OG,	   DDM)	   via	   gel-­‐filtration,	   dialysis,	   on	   the	   affinity	  
column,	   and	  also	  using	  mixed	  micelles	   (DDM	  and	   Fos-­‐13)	   but	   none	  of	   these	  procedures	   resulted	   in	  
pure	   protein.	   Most	   of	   these	   methods	   led	   to	   precipitation	   of	   the	   protein	   and	   therefore	   those	  
experiments	  will	  not	  be	  discussed	  any	  further.	  
Just	   about	   the	   time	   when	   I	   was	   loosing	   hope,	   maltose	   neopentyl-­‐glycol	   (MNG)	   amphiphiles	   were	  
discovered	  and	   implicated	  for	  facilitating	  the	  X-­‐ray	  structure	  of	  G-­‐protein	  and	  the	  G-­‐protein	  coupled	  
receptor	  complex	  [178,	  179].	  	  
3.2.3.3 Purification	  of	  Cln3p	  in	  MNG-­‐3	  
I	   was	   not	   able	   to	   solubilize	   insect	   cell	   membranes	   overexpressing	   hCln3p	   in	   MNG-­‐3	   or	   MNG-­‐
3/cholesterol	   hemi-­‐succinate	   (CHS)	   buffer	   (10:1).	   Therefore,	   I	   resorted	   to	   the	   old	   approach	  where	   I	  
solubilized	  membranes	  using	  Fos-­‐13.	   I	  was	  able	  to	  exchange	  the	  detergent	  on	  the	   IMAC	  column.	  An	  
overview	  of	  the	  purification	  follows	  in	  Figure	  3.29.	  The	  consistent	  problem	  with	  exchanging	  detergent	  
to	  MNG-­‐3	  was	  the	  appearance	  of	  a	  band	  corresponding	  to	  molecular	  weight	  of	  76	  kDa.	  This	  band	  was	  
attributed	  as	  the	  unfolded	  Cln3p	  (I	  ran	  the	  gels	  in	  semi-­‐denaturing	  conditions)	  and	  confirmed	  by	  in-­‐gel	  
fluorescence	  scan	  (Figure	  3.29,	  a	   (right)	  only	  one	  band	  is	  seen	  which	  corresponds	  to	  the	  lower	  band	  
seen	  at	  around	  55	  kDa	  in	  semi-­‐denaturing	  SDS-­‐PAGE)	  and	  heat-­‐denaturing	  analysis.	  	  
	  
	  




Figure	   3.29:	   Detergent	   exchange	   to	   MNG-­‐3.	  
Solubilization	  of	  insect	  cell	  membranes	  was	  carried	  
out	   in	   Fos-­‐13	   with	   subsequent	   loading	   onto	   an	  
IMAC	   column.	   The	   detergent	  was	   then	   exchanged	  
to	   MNG-­‐3	   (0.1%	   for	   elution,	   CMC,	   0.001%)	   while	  
elution.	   (a)	  A	   semi-­‐denaturing	  SDS-­‐PAGE	  profile	  of	  
such	   detergent	   exchange	   elution	   for	   the	   EGFP-­‐
Cln3p	   (construct	   p232,	   left).	   Corresponding	   in-­‐gel	  
flurorescence	   (right).	   (b)	   Size	   exclusion	   profile	   of	  
EGFP-­‐hCln3p	   run	   after	   concentrating	   the	   elution	  
fractions.	   M,	   marker.	   FT,	   flow	   through.	   W,	   wash.	  
E1-­‐6,	  elution.	  
	  
The	   gel-­‐filtration	  profile	  was	  quite	   similar	   to	   that	  of	   Cln3p	   in	   Fos-­‐13.	   This	  may	  be	  due	   formation	  of	  
aggregates.	  The	  solution	  to	  this	  problem	  follows	   later.	  Cln3p	  existing	   in	   two	  different	  populations	   in	  
solution	  (unfolded	  and	  folded,	  as	  seen	  from	  the	  semi-­‐denaturing	  PAGE)	  is	  not	  favorable	  for	  structural	  
analysis.	   I	   therefore	   opted	   for	   ion-­‐exchange	   chromatography	   (IEC)	   to	   separate	   the	   two	   forms.	   I	  
screened	   for	   conditions	   for	   stability	   of	   Cln3p	   in	   low	   salt	   and	   found	   that	   the	   protein	   is	   stable	   in	  
concentrations	  up	  to	  25	  mM	  of	  NaCl	  (data	  not	  shown).	  For	  ion-­‐exchange	  chromatography	  the	  elution	  
fractions	  from	  IMAC	  were	  pooled	  and	  desalted	  using	  a	  PD10	  to	  a	  final	  salt	  concentration	  of	  50	  mM.	  I	  
used	  a	  cation-­‐exchanger	  column	  and	  the	  protein	  was	  eluted	  using	  a	  salt	  gradient	  rising	  up	  to	  1M	  of	  
NaCl.	  The	  IEC	  chromatogram	  revealed	  two	  peaks	  (labeled	  1	  and	  2,	  Figure	  3.30)	  eluting	  approximately	  
at	   around	   450	  mM	   of	   salt.	   Fractions	   corresponding	   to	   both	   the	   IEC	   peaks	   reveal	   a	   band	   on	   semi-­‐
denaturing	  SDS-­‐PAGE	  at	  the	  same	  size	  of	  55	  kDa	  approximately.	  	  
	  
	  
Figure	  3.30:	  Ion-­‐exchange	  chromatography.	  Ion	  exchange	  chromatography	  runs	  were	  performed	  on	  MONO	  
S	   5/50	   cation-­‐exchange	   columns.	   The	   pI	   of	   the	   protein	  was	   estimated	   to	   be	   5.9	   (generally	   for	  membrane	  
proteins	  the	  estimate	  is	  off	  target)	  and	  used	  a	  cation	  exchanger.	  The	  resolution	  of	  the	  peaks	  from	  IE	  column	  
was	  not	  good.	   I	   intended	   to	   separate	   the	  unfolded	  protein	   (runs	  at	  76	  kDa	  on	  semi-­‐denaturing	  SDS	  PAGE)	  
from	  the	  folded	  protein	  (runs	  around	  55kDa).	  Although	  two	  peaks	  were	  observed	  (1,2)	   in	  (a)	  both	  run	  at	  a	  
similar	  size	  in	  (b).	  
	  
A	   plausible	   explanation	   of	   this	   behavior	  may	   be	   that	   hCln3p	   is	   oligomeric	   in	   solution	   and	   different	  
peaks	  correspond	  to	  oligomer	  and	  monomer	  fractions.	  Surprisingly,	  I	  do	  not	  find	  any	  band	  at	  76	  kDa	  in	  
the	   semi-­‐denaturing	   PAGE.	   IEC	   experiments	   to	   optimize	   the	   purity	   of	   Cln3p	   in	   MNG-­‐3	   suffered	   a	  
setback	  as	  I	  was	  not	  able	  resolve	  the	  recurrent	  peaks	  in	  the	  profile.	  I	  also	  realized	  that	  large	  amount	  of	  
the	  protein	  was	  lost	  during	  the	  desalting	  process.	   I	  therefore,	  decided	  to	  discontinue	  IEC	  and	  sought	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other	  ways	  to	  purify	  the	  protein.	  Size-­‐exclusion	  chromatography	  (Superose-­‐12)	  gave	  results	  similar	  to	  
that	  of	  purification	  in	  Fos-­‐13,	  where	  I	  find	  a	  large	  void	  peak	  followed	  by	  a	  broad	  peak	  for	  the	  protein	  
(Figure	  3.29,	  b).	  
6x-­‐His	  and	  GFP	  tags	  can	  be	  detrimental	  in	  crystallization	  trials	  and	  one	  is	  generally	  advised	  to	  get	  rid	  of	  
them.	  Since	  all	  the	  constructs	  cloned	  encode	  for	  a	  PreScission	  protease	  cleavage	  site,	  I	  tried	  to	  cleave	  
the	  tag	  off	  the	  protein	  (after	  elution	  from	  IMAC)	  and	  use	  this	  as	  a	  way	  to	  enhance	  the	  purity	  of	  the	  
protein	  by	  employing	  reverse	  IMAC	  procedure.	  The	  cleavage	  reaction	  was	  carried	  out	  overnight	  at	  4°C	  
via	  dialysis	  using	  12-­‐14	  kDa	  MWCO	  membranes.	  The	  results	  of	  one	  such	  experiment	  are	  highlighted	  in	  
Figure	   S16.	   In	   essence,	   cleavage	   by	   PreScission	   protease,	   although	   essential,	   was	   not	   an	   efficient	  
procedure.	  The	  fault	  was	  with	  the	  cloning	  strategy	  employed;	  I	  reasoned	  that	  the	  accessibility	  of	  the	  
cleavage	  site	  was	  sterically	  hindered,	  and	  perhaps	  the	  protease	  was	  not	  able	  to	  access	  the	  site	  which	  
could	   be	   possibly	   embedded	   in	   MNG-­‐3	   micelles.	   Besides	   this,	   the	   hCln3p	   from	   p232	   expressed	   in	  
insect	   cells	   was	   susceptible	   to	   degradation	   (not	   helpful	   for	   crystallization	   trials)	   and	   the	   quality	   of	  
protein	  varying	   in	  different	  preparations	   (predominantly	  depending	  on	   the	  extent	  of	  passage	  of	   the	  
cells	  used	  for	  expression).	  
To	  circumvent	  these	  problems	  I	  revised	  the	  cloning	  strategy	  and	  generated	  constructs	  with	  linkers	  of	  
varied	  length	  spaced	  between	  the	  protein	  and	  the	  tags	  (refer	  to	  Table	  2.13,	  Materials	  and	  methods).	  
A	  detailed	  analysis	  of	  6x-­‐His-­‐mCherry-­‐LINKER-­‐humanCln3p	  (p509,	  AG	  Raunser	  database)	  follows	  next.	  
The	   fluorescent	   reporter	   tag	   was	   changed	   from	   EGFP	   to	  mCherry	   as	   the	   theoretical	   stability	   index	  
values	   for	   EGFP	   protein	   were	   always	   predicted	   low	   (ProtParam	   tool,	  
http://web.expasy.org/protparam/protparam-­‐doc.html).	   The	   corresponding	   mCherry	   fusion	   protein	  
with	  linker	  was	  predicted	  to	  be	  more	  stable	  and	  therefore	  used.	  Sandra	  Bergbrede	  devised	  the	  cloning	  
strategy	   and	   Dortmund	   Protein	   Facility	   (DPF)	   carried	   out	   cloning.	   Dennis	   Quentin,	   as	   a	   part	   of	   his	  
Masters	  thesis	  under	  my	  supervision,	  carried	  out	  the	  experiments.	  	  
3.2.3.4 mCherry-­‐fusion	  construct	  (p509)	  
The	   virus	   and	   expression	   were	   optimized	   for	   the	   newly	   generated	   constructs	   following	   protocols	  
established	  previously	  for	  EGFP-­‐Cln3p.	  The	  expression	  of	  the	  virus	  was	  monitored,	  as	  aforementioned	  
(section	  3.2.2),	  by	  fluorescence	  microscopy	  (Figure	  S15).	  I	  used	  the	  established	  strategy	  of	  solubilizing	  
the	  membranes	  in	  Fos-­‐13	  and	  exchanging	  the	  detergent	  over	  the	  IMAC	  column.	  Semi-­‐denaturing	  SDS-­‐
PAGE	  and	  the	  corresponding	  in-­‐gel	  fluorescence	  scan	  are	  in	  Figure	  3.31,	  a	  &	  b	  respectively.	  I	  ran	  into	  
problems	  with	  huge	  void-­‐peaks	   in	  previous	  purification	  trials,	  which	   led	  me	  to	  believe	  that	  probably	  
this	  was	  a	  consequence	  of	  reduced	  ionic-­‐strength	  of	  the	  solution	  while	  dialyzing	  away	  the	  imidazole.	  
To	   counteract	   the	   reduction	   of	   ionic-­‐strength	   dialysis	   buffer	   was	   spiked	   with	   additional	   salt	  
(approximately	   200	   mM).	   Also,	   Superose	   6	   10/30	   GL	   column	   was	   used	   for	   SEC.	   The	   size-­‐exclusion	  









Figure	   3.31:	   Purification	   of	   human	   mCherry-­‐hCln3p	   (with	   long	   linker).	   Solubilization	   of	   insect	   cell	  
membranes	  was	   carried	   out	   in	   Fos-­‐13	  with	   subsequent	   loading	   onto	   an	   IMAC	   column.	   The	  detergent	  was	  
then	  exchanged	   to	  MNG-­‐3	   (0.1%	   for	  elution,	  CMC,	  0.001%)	  while	  elution.	   (a)	  A	   semi-­‐denaturing	  SDS-­‐PAGE	  
profile	   of	   such	   detergent	   exchange	   elution	   for	   the	   mCherry-­‐Cln3p.	   (b)	   Corresponding	   in-­‐gel	   fluorescence	  
profile	  of	  the	  elution.	  (c)	  The	  elution	  fractions	  (E1-­‐E5)	  were	  pooled	  and	  loaded	  onto	  a	  Superose	  6	  10/300	  size	  
exclusion	   column.	   Elution	   profile	   of	   one	   such	   run	   is	   shown.	   (d)	   Semi-­‐denaturing	   SDS-­‐PAGE	   profile	   of	   the	  
concentrated	  elution	  pool	  used	  for	  SEC	  and	  the	  protein	  after	  elution	  from	  SEC.	  M,	  marker.	  FT,	  flow	  through.	  
T,	  total	  solubilized	  membrane.	  W1,	  W2-­‐wash	  fractions.	  	  
	  
The	  addition	  of	  the	  long	  linker	  facilitated	  facile	  cleavage	  of	  the	  tag	  by	  the	  protease.	  During	  the	  course	  
of	  optimization,	  reverse	   IMAC	  after	  the	  cleavage	  was	  deemed	  unnecessary.	   Instead	  the	  mixture	  was	  
loaded	  onto	  a	  Superose	  6	  10/300	  column	  directly	   to	  separate	   the	  pure	  Cln3p	   from	  the	  mCherry	   tag	  
and	   the	   protease.	   Although	   this	   method	   worked	   fine	   best	   results	   were	   obtained	   following	   an	  
alternative	  way:	  after	  the	  binding	  of	  the	  solubilized	  membranes	  to	  the	  IMAC,	  followed	  by	  subsequent	  
washing	   steps,	   cleavage	  of	   the	   immobilized	  protein	   is	   carried	  out	  directly	  on	   the	  affinity	   column	  by	  
passing	  the	  protease	  containing	  buffer.	  Concentrating	  the	  flow	  through	  and	  loading	  it	  on	  a	  Superose-­‐6	  
column	  followed	  this	  step.	  The	  SEC	  profile	  in	  Figure	  3.32	  shows	  minimal	  void	  peak	  followed	  by	  a	  slight	  










Figure	   3.32:	   Cleavage	   of	   the	   6x-­‐His-­‐mCherry	   tag.	   (a)	   The	   cleavage	  
reaction	   of	   the	   Cln3p	   fusion	   protein	   was	   carried	   out	   by	   PreScission	  
protease.	   A	   representative	   shift	   (as	   indicated	   by	   red	   arrows	   is	   shown.	  
The	  reaction	  goes	   to	  near	  completion.	  EP,	  elution	  pool.	  M,	  marker	  and	  
AC,	  after	  cleavage.	  The	  protease	  band	  is	  evident	  at	  26	  kDa.	  The	  cleavage	  
reaction	  was	  optimized	  and	  found	  that	   it	  was	  best	  to	  cleave	  the	  tag	  on	  
the	   affinity	   column	   and	   run	   size-­‐exclusion	   chromatography	   of	   the	  
concentrated	   flow	   through.	   One	   such	   typical	   profile	   on	   a	   superpose	   6	  
10/300	  column	   is	  highlighted	   in	   (b).	  A	   tiny	  amount	  of	  mCherry	   leaches	  
off	   the	   column	   and	   is	   represented	   by	   the	   sharp	   fluorescence	   peak	  
indicated	   in	   green.	   The	   corresponding	   semi-­‐denaturing	   SDS-­‐PAGE	  






Western	   blotting	   and	  mass-­‐spectrometry	   analysis	   confirmed	   the	   product	   of	   cleavage	   reaction.	   The	  
expected	  band	  was	  excised,	  the	  protein	  extracted,	  tryptically	  digested	  and	  subsequently	  analyzed	  via	  
HPLC-­‐MS	  to	  unambiguously	   identify	   it	  as	  Cln3p.	  The	   first	   seven	  entries	  were	  keratin	   (Figure	   3.33),	  a	  
fibrous	   structural	   protein	   and	   a	   known	   contaminant	   in	  mass	   spectrometry	   analysis	   (originates	   from	  
contact	   of	   human	   skin	   during	   sample	   preparation).	   However,	   the	   only	   other	   protein	   identified	  was	  
human	   Cln3p	   with	   a	   number	   of	   seven	   significant	   sequences.	   Cln3p	   is	   a	   membrane	   protein	   with	   a	  
number	  of	  extremely	  hydrophobic	  amino	  acid	  stretches	  that	  span	  the	  membrane;	  it	  was	  not	  surprising	  
that	  only	  a	  fraction	  of	  the	  theoretically	  predicted	  peptides	  were	  identified	  via	  HPLC-­‐MS.	  Nevertheless,	  
unbiased	  search	  confirms	  Cln3p	  as	  the	  target	  protein.	  Other	  peptides	  that	  were	  identified	  during	  the	  
analysis	  could	  be	  traced	  to	  BSA	  and	  trypsin.	  BSA	  is	  a	  common	  contamination	  (traces	  can	  be	  found	  in	  












Figure	   3.33:	   Overview	   of	   the	   tryptic	   digestion	   followed	   by	   HPLC-­‐MS	   analysis	   on	   Cln3p.	   The	   lane	  
corresponding	  to	  Cln3p	  is	  highlighted	  in	  green.	  	  
	  
Other	  proteins	  with	  different	  reporter	  tags	  as	  well	  as	  constructs	  encoding	  only	  His-­‐tag	  are	  also	  being	  
processed.	  As	  mentioned	  earlier	   I	  did	  not	  generate	  any	   constructs	  with	  deletions	   in	   loop	   regions	  or	  
otherwise	  as	  Cln3p	  is	  predicted	  to	  be	  a	  very	  compact	  protein,	  most	  of	  which	  lies	  in	  the	  membrane.	  	  
	  
3.2.4 Biochemical	  characterization	  
All	   the	   results	   in	   this	   section	   are	   very	   preliminary	   and	   therefore	   the	   results	  may	  not	   be	   conclusive.	  
Repetitions	  and	  optimization	  of	  experiments	  are	  underway.	  
3.2.4.1 State	  of	  oligomerization	  –	  Blue	  native	  PAGE	  
The	  state	  and	  nature	  of	  oligomerization	  can	  be	  very	   informative	   regarding	   the	   functional	  aspects	  of	  















Figure	   3.34:	   Blue-­‐native	   PAGE	   analysis	   of	   Cln3p.	   Blue-­‐native	   PAGE	   of	   the	   cleaved	   hCln3p	   in	   (a)	   and	   the	  
mCherry	   fusion	   protein	   in	   (b).	   M:	   specific	   blue	   native	   marker.	   Color	   gradient	   illustrates	   increasing	   SDS	  
concentration	  in	  %.	  In	  both	  the	  cases	  bands	  appear	  at	  weights	  higher	  than	  the	  molecular	  weight	  of	  protein	  
(bands	  are	  indicated	  by	  black	  arrowheads).	  Both	  the	  proteins	  are	  in	  MNG-­‐3	  micelles.	  
	  
Cln3p	  (both	  cleaved	  and	  uncleaved	  versions	  of	  protein)	  has	  a	  tendency	  to	  aggregate	  as	   indicated	  by	  
the	  smear	  and	  the	  protein	  seen	  in	  wells	  of	  blue-­‐native	  PAGE.	  In	  the	  presence	  of	  SDS	  (known	  to	  disrupt	  
the	   formation	   of	   oligomers/aggregates,	   used	   in	   an	   increasing	   amount	   from	   0	   to	   2.5%	   (w/v)	   the	  
intensity	   of	   the	   smear	   is	   lost	   and	   is	   compensated	   by	   the	   intensity	   of	   the	   monomeric	   bands.	  
Representative	  gels	  for	  cleaved	  hCln3p	  and	  mCherry	  fusion	  protein	  can	  be	  seen	  in	  Figure	  3.34,	  a	  and	  b	  
respectively.	  
Although	  not	  completely	  precise	  (due	  to	  the	  smear,	  caused	  most	  likely	  due	  to	  the	  detergent	  micelles)	  
it	  can	  still	  be	  inferred	  that	  Cln3p	  forms	  some	  kind	  of	  higher	  order	  oligomers.	  The	  predicted	  dimer	  size	  
of	   the	   fusion	  protein	   should	  be	  around	  142	  kDa.	  The	  stability	  of	   these	  oligomers	   is	   reflected	  by	   the	  
fact	   that	   even	   at	   high	   SDS	   concentration	   (2.5%),	   a	   certain	   portion	  was	   still	   in	   higher	   oligomers	   are	  
visible.	   The	   nature	   and	   the	   precise	   size	   of	   oligomers	   need	   to	   be	   confirmed	  with	   authority.	   Various	  
bands	  in	  the	  blue-­‐native	  gel	  must	  be	  analyzed	  by	  mass	  spectrometry	  to	  get	  a	  clearer	  estimate	  of	  the	  
size.	  Additional	  information	  may	  be	  inferred	  from	  analytical	  ultracentrifugation	  experiments.	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3.2.4.2 Post-­‐translational	  modifications	  –	  Glycosylation	  
	  
Figure	   3.35:	   Glycosylation	   analysis	  
of	   Cln3p.	   Protocol	   for	   analysis	   of	  
extent	  of	  glycosylation	  differs	  slightly	  
for	   membrane	   proteins.	   The	  
conditions	   are	   generally	   mild.	   Two	  
sets	  of	  reactions	  were	  carried	  out:	  at	  
16°C	  for	  16	  h	  (a)	  and	  37°C	  for	  1	  h	  (b).	  
Semi-­‐denaturing	   SDS-­‐PAGE	   gels	   for	  
both	   the	   reactions	   are	   shown.	   ‘-­‐‘,	  
Without	   PNGase	   and	   ‘+’	   with	  
PNGase	  F.	  M,	  marker.	  P,	  protein	  not	  
subjected	   to	   reaction.	   The	   protein	  
used	   for	   the	   assay	   was	   mCherry-­‐
hCln3p.	  
Post-­‐translational	   modifications	   (PTMs)	   of	   a	   protein	   can	   be	   decisive	   in	   protein	   folding,	   stability,	  
intracellular	   localization	   and	   catalytic	   activity.	   However,	   for	   structural	   studies	   especially	   for	  
crystallization	  glycosylation	  is	  not	  favorable.	  Also,	  products	  of	  glycosylation	  can	  vary	  depending	  on	  the	  
level	   and	   degree	   of	   glycosylation	   leading	   to	   a	   mixed	   protein	   population.	   Therefore	   it	   becomes	  
essential	   to	   know	   the	   state	   of	   glycosylation	   of	   eukaryotic	   proteins.	   PNGase	   F	   (a	   de-­‐glycosylating	  
enzyme)	   to	  address	   this	  question.	  This	  enzyme	  removes	  N-­‐glycosylation	   from	  a	  protein	  with	  a	  post-­‐
translational	   modification.	   The	   protocol	   for	   membrane	   proteins	   was	   modified	   as	   compared	   to	   the	  
conventional	   proteins	   as	   heating	   leads	   to	   aggregation	   of	   these	   proteins	   in	   general.	   The	   results	   are	  
shown	  in	  Figure	  3.35.	  
No	   change	   in	   the	   size	   of	   protein	   upon	   PNGase	   F	   treatment	   was	   seen.	   This	   behavior	   was	   also	  
independent	  of	  the	  temperature	  of	  the	  reaction.	  Analysis	  of	  membrane	  proteins	  for	  glycosylation	  can	  
be	  tricky	  as	  the	  putative	  sites	  may	  be	  masked	  by	  the	  detergent	  micelles	  rendering	  the	  assay	   invalid.	  
Another	   problem	   with	   the	   set-­‐up	   of	   the	   experiment	   is	   that	   there	   is	   no	   positive	   control	   (other	  
membrane	   protein	   that	   undergoes	   glycosylation).	   To	   reaffirm	   that	   Cln3p	   does	   not	   undergo	  
glycosylation	  as	  a	  posttranslational	  modification	  when	  overexpressed	  in	  insect	  cells,	  further	  analysis	  is	  
necessary.	  Experiments	  such	  as,	  use	  of	   lectin	  columns	   to	  separate	  glycosylated	  proteins	   (if	  any)	  and	  
mutating	   the	  glycosylation	  sites	   to	  check	   for	   the	  difference	   in	   size	  of	  protein	  expressed,	  need	   to	  be	  
done.	  A	  final	  approach	  would	  be	  to	  check	  for	  sugar	  modifications	  by	  thin	  layer	  chromatography	  (TLC),	  
where	  one	  can	  use	  spray	  reagents	  to	  identify	  sugar	  modifications	  on	  proteins.	  
3.2.4.3 Post-­‐translational	  modifications	  –	  Phosphorylation	  
Phosphorylation	   is	   another	   very	   important	   and	   interesting	   post-­‐translational	  modification,	  which	   at	  
times	   is	   necessary	   to	   trigger	   the	   activity	   of	   the	   protein.	   The	   cellular	   machinery	   for	   disrupting	  
interactions	   between	   proteins	   or	   complexes	   can,	   at	   times,	   employ	   the	   introduction	   of	   negatively	  
charged	   phosphate	   group.	   Phosphoimaging	   was	   used	   to	   understand	   whether	   Cln3p	   undergoes	  
phosphorylation	   as	   a	   post-­‐translational	   modification.	   This	   technique	   relies	   on	   the	   principle	   of	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recognition	  of	  phosphorylated	  amino	  acids	  by	  a	  specific	  dye.	  The	  protein	  γ-­‐phosphatase	  is	  an	  enzyme	  
capable	   of	   removing	   phosphorylation,	   generally	   used	   to	   confirm	   that	   the	   protein	   has	   indeed	  
undergone	  the	  PTM.	  
	  
	  
Figure	   3.36:	   Phosphorylation	   analysis	   of	   Cln3p.	   Phosphoimaging	  of	  hCln3p	   (left)	   and	   corresponding	   semi-­‐
denaturing	  SDS-­‐PAGE	  on	  the	  right.	  Cln3p	  undergoes	  phosphorylation	  and	  this	  decreases	  in	  the	  presence	  of	  γ-­‐
phosphatase	  (+).	  For	  some	  unknown	  reason	  protein	  is	  not	  visible	  in	  the	  absence	  of	  γ-­‐phosphatase	  in	  the	  case	  
of	   BSA	   (‘-­‐‘	   lane,	   used	   as	   a	   control).	   C,	   cleaved	   protein.	   U,	   mCherry-­‐Cln3p.	   M,	   marker.	   ‘+’,	   Reaction	   γ-­‐
phosphatase	  reflected	  by	  the	  band	  at	  26	  kda	  (right).	  ‘-­‐‘,	  Without	  γ-­‐phosphatase.	  
	  
Cln3p	   is	   phosphorylated.	   This	   is	   evident	   from	   the	   bands	   detected	   in	   the	   phosphoimaging,	   which	  
correspond	  to	  the	  protein	  in	  the	  semi-­‐denaturing	  SDS-­‐PAGE.	  Upon	  the	  use	  of	  γ-­‐phosphatase,	  there	  is	  a	  
significant	   decrease	   of	   the	   intensity	   for	   both	   the	   cleaved	   and	   the	   fusion	   protein.	   The	   failure	   of	   the	  
control	   reaction	   is	  speculative.	  These	  are	  the	  newest	  results	   towards	  characterization	  of	   the	  protein	  
and	   need	   to	   be	   repeated	   properly.	   Removal	   of	   phosphorylation	   can	   used	   as	   a	   strategy	   for	  
crystallization	   of	   the	   protein	   as	   removal	   of	   negative	   charges	   on	   the	   surface	   may	   favor	   protein	  
interactions.	  	  
	  
3.2.5 Electron	  Microscopy	  
3.2.5.1 Single	  particle	  analysis	  
In	   an	   attempt	   to	   visualize	   and	   understand	   the	   structure	   of	   the	   protein,	   I	   performed	   negative	   stain	  
analysis	   on	   EFGP-­‐hCln3p	  purified	   in	   Fos-­‐13	   and	  mCherry-­‐hCln3p	   fusion	  protein	   purified	   in	  MNG-­‐3.	   I	  
was	  not	  able	  to	  see	  characteristic	  particles	  in	  both	  the	  cases.	  In	  the	  case	  of	  Fos-­‐13	  very	  heterogeneous	  
particles	  and	  few	  possible	  aggregates	  were	  seen	  (Figure	  3.37,	  a).	  The	   latter	  case	  of	  MNG-­‐3	  revealed	  
‘ribbon-­‐like’	  filamentous	  particles	  and	  hardly	  any	  single	  particles	  (Figure	  3.37,	  b).	  One	  can	  only	  explain	  









Figure	  3.37:	  Negative	  stain	  analysis	  of	  hCln3p.	  (a)	  Representative	  micrograph	  area	  of	  EGFP-­‐hCln3p	  purified	  
in	  Fos-­‐13.	  Sample	  was	  diluted	  to	  0.01	  mg/mL	  and	  loaded	  on	  to	  a	  carbon-­‐coated	  grid.	  No	  characteristic	  shape	  
and	  size	  of	  particles	   found.	  Possible	  particles	  are	  highlighted	  with	  white	  arrowhead.	  Scale	  bar,	  100	  nm.	   (b)	  
Representative	  micrograph	  area	  of	  mCherry-­‐Cln3p	  purified	  in	  MNG-­‐3.	  Sample	  was	  diluted	  to	  0.01	  mg/mL	  and	  
loaded	  on	  to	  a	  carbon-­‐coated	  grid.	  Long	  filaments,	  possibly	  the	  protein	  in	  linear	  micelles	  in	  MNG-­‐3	  are	  seen.	  
Scale	  bar,	  100	  nm	  
	  
Recent	   advances	   in	   the	   field	   of	   electron	   microscopy	   enables	   one	   to	   determine	   structure	   of	   large	  
membrane	   proteins	   at	   atomic	   resolution	   [176],	   where	   amphipathic	   polymers	   (amphipols)	   are	   used	  
instead	  of	  detergents.	  Exchanging	  Fos-­‐13	  with	  amphipols	  after	  solubilization	  of	  the	  protein	  would	  be	  
ideal	   starting	  point	   for	   future	  efforts.	   Single	  particle	   analysis	  by	   cryo-­‐electron	  microscopy	   (cryo-­‐EM)	  
requires	  the	  protein	  to	  be	  around	  300	  kDa.	  Cln3p	  shows	  a	  tendency	  to	  form	  higher	  order	  structures	  
(the	  nature	  these	  oligomers	  needs	  to	  be	  studied	   in	  detail),	  which	  may	  make	   it	  suitable	   for	  structure	  
determination	  by	  cryo-­‐EM.	  	  
	  
3.2.5.2 Electron	  crystallography	  
Electron	   crystallography	   (2D	   crystallography)	   is	   an	   alternative	   to	   X-­‐ray	   crystallography	   particularly	  
used	   for	   studying	   membrane	   proteins	   that	   can	   organize	   into	   2D	   arrays	   in	   presence	   of	   lipids.	  
Membrane	  proteins	  are	   invariably	  always	  purified	   in	  detergents	   that	  are	  not	   so	   conducive	   for	  X-­‐ray	  
crystallography	  studies.	  In	  2D	  crystallography	  membrane	  proteins	  purified	  in	  detergents	  are	  incubated	  
with	   lipids	   and	   detergents	   are	   gradually	   removed	   over	   a	   period	   of	   time.	   I	   used	   variety	   of	   lipids	   at	  
various	   LPRs	   (lipid	   to	   protein	   ratio)	   and	   set	   up	   trials	   with	   all	   the	   versions	   of	   the	   proteins	   purified.	  
Unfortunately,	  none	  of	  the	  conditions	  reveal	  any	  potential	  crystals.	  A	  snapshot	  of	  one	  such	  screen	  set	  
up	  with	  the	  EGFP-­‐hCln3p	  (p232)	  is	  shown	  in	  Figure	  3.38.	  	  
	   	  







Figure	   3.38:	   2D	  
crystallography	   trials	   on	  
EGFP-­‐hCln3p.	   Purified	  
protein	  at	  a	  concentration	  of	  
1mg/mL	   was	   mixed	   with	  
lipids	   at	   various	   lipid	   to	  
protein	   ratios	   (w/w)	   and	  
dialyzed	   to	   remove	   the	  
detergent	   for	   a	   span	   of	   2-­‐3	  
weeks.	   Results	   of	   one	   such	  
trial	  of	  EGFP-­‐hCln3p	  purified	  
in	  Fos-­‐13.	  LPR	  is	  0.5	  in	  all	  the	  
cases	   (a)	   DOPC	   (b)	   BPL	   (c)	  
EPL	  (d)	  DMPC.	  Scale	  bar,	  100	  
nm.	  
3.2.6 X-­‐ray	  crystallography	  
All	   the	   purifications	   that	   yielded	   protein	   in	   sufficient	   amounts	   were	   used	   to	   set	   up	   X-­‐ray	  
crystallography	  trials	  irrespective	  of	  whether	  the	  tag	  was	  cleaved	  or	  not.	  Various	  suites	  available	  from	  





Figure	   3.39:	   X-­‐ray	   crystallography	   trials	   of	   Cln3p.	  
Representative	  hits	   from	  the	  various	   trials	   set	  up.	  The	  
construct,	  concentration	  of	  protein	  and	  the	  conditions	  
are	   listed.	   (a)	   mCherry-­‐Cln3p;	   suite:	   Classics	   II;	   4	  
mg/mL;	  30%	  Jeffamine	  M-­‐600,	  0.1	  M	  HEPES,	  pH	  =	  7	  (b)	  
EGFP-­‐Cln3p;	  suite:	  pHclear	  II;	  1	  mg/mL;	  1	  M	  LiCl,	  0.1	  M	  
Sodium	  Acetate	  Anhydrous,	  pH	  =	  5	  (c)	  mCherry-­‐Cln3p;	  
suite:	  pHclear	  II:	  11.5	  mg/mL;	  30%	  PEG	  6000,	  1	  M	  LiCl,	  
0,1	  M	  TRIS,	  pH	  =	  8	  (d)	  mCherry-­‐Cln3p;	  suite:	  JCSG	  Core	  
IV;	   4	   mg/mL;	   1	   M	   (NH4)2HPO3,	   0.2	   M	   NaCl	   0.1	   M	  
Imidazole,	  pH	  =	  8	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3.2.7 Localization	  studies	  
Localization	  of	  Cln3p	  has	  been	   studied	  and	  debated	   for	  a	   long	   time.	  The	   localization	  of	  Cln3p	   relies	  
largely	  on	   the	  method	  of	  detection,	   type	  of	   cell	   lines	  and	   the	  nature	  of	   the	  probe.	  The	  human	  cln3	  
gene	   was	   cloned	   into	   the	   pOPINE	   vector	   harboring	   an	   N-­‐terminal	   EGFP.	   Curious	   to	   identify	   the	  
localization,	   since	   Battens	   disease	   affects	   primarily	   the	   neurons,	   I	   studied	   its	   localization	   pattern	   in	  
neuronal	   N2a	   cell-­‐line.	   I	   also	   wanted	   to	   establish	   the	   localization	   pattern	   and	   see	   whether	   it	   gets	  
affected	  in	  some	  of	  the	  disease	  causing	  mutants	  I	   intended	  to	  generate.	  Cln3p	  has	  been	  reported	  to	  
transcend	  a	  variety	  of	  intra-­‐cellular	  organelles,	  primarily	  lysosomes	  and	  the	  Golgi	  apparatus.	  I	  checked	  
for	   localization	   in	   these	  compartments	  using	  appropriate	   sub-­‐cellular	  markers	   (lysosomal	  associated	  
membrane	  protein	  (LAMP)	  as	  the	  lysosomal	  marker,	  GalT	  was	  used	  as	  the	  Golgi	  marker	  and	  peripheral	  
myelin	  protein	  (PMP2)	  as	  the	  peroxisomal	  marker).	  Cells	  were	  co-­‐transfected	  with	  1	  μg	  of	  the	  plasmid	  
using	   lipofectamine.	   Cln3p	   localizes	   primarily	   to	   lysosomal	   compartment	   in	   neuronal	   N2a	   cells.	   No	  
localization	  was	  seen	  in	  the	  Golgi	  or	  the	  peroxisome.	  The	  results	  are	  summarized	  in	  Figure	  3.40.	  
	  
Figure	   3.40:	   Localization	   of	   Cln3p.	   Confocal	   fluorescence	   images	   of	   N2a	   neuronal	   cells	   transiently	  
transfected	   with	   Cln3p	   (EGFP	   shown	   in	   green	   and	   corresponding	   organelle	   marker	   in	   red.	   Lysosome	  
associated	  membrane	  protein	  (LAMP)	  in	  (a)	  The	  Golgi	  marker	  GalT	  in	  (b)	  and	  peroxisomal	  membrane	  protein	  
(PMP2)	  in	  (c).	  An	  overlay	  of	  both	  the	  channels	  is	  represented	  in	  the	  right.	  Transfection	  was	  carried	  out	  with	  
lipofectamine.	  Imaging	  was	  done	  both	  on	  fixed	  and	  live-­‐cells	  to	  obtain	  very	  similar	  results.	  Scale	  bar,	  5	  μm.	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3.2.8 Functional	  studies:	  Establishing	  Desaturase	  assay	  
Cln3p	  has	   been	   implicated	   in	   desaturase	   activity	   of	   palmitoyl	   moieties	   with	   a	   preference	   towards	  
palmitoylated	   N-­‐Ras	   [152].	  With	   purified	   Cln3p,	   reproducible	   and	   in	   sufficient	   amounts,	   I	   aimed	   at	  
reconstituting	   this	   activity	   in	   vitro.	   In	   collaboration	   with	   Dr.	   Gemma	   Triola	   (AG	   Waldmann,	   MPI-­‐
Dortmund)	   I	   started	  with	   synthesis	   of	   the	   simpler	   substrate,	  N-­‐acetyl	   palmitoyl	   cysteine	   (schematic	  




Figure	  3.41:	  Outline	  of	  the	  synthesis	  of	  N-­‐acetyl	  palmitoyl	  cysteine	  (NAPC).	  (A)	  Dichloromethane	  (DCM),	  500	  C,	  
Reflux	   (B)	   Palmitoyl	   Chloride,	   Triethylamine,	   3h,	   RT,	  DCM.	   The	   heptadecanoic	   acid	   derivatives	  were	   prepared	  
along	  similar	  lines.	  Work	  done	  in	  collaboration	  with	  Dr.	  Gemma	  Triola.	  
	  
Establishing	   the	  protocol	  was	  necessary.	  Gas	  chromatography	  coupled	  with	  mass	   spectrometry	   (GC-­‐
MS)	  was	  chosen	  as	  a	  method	  of	  choice	  for	  monitoring	  the	  reaction.	  GC	  is	  a	  common	  analytical	  method	  
for	   separating	  different	   compounds	   in	  a	  mixture	   that	   can	  be	  vaporized	  without	  decomposition.	   The	  
reaction	   is	   carried	   out	   in	   the	   aqueous	   phase	   followed	   by	   the	   extraction	   of	   end	   products	   into	   the	  
organic	  phase	  (chloroform).	  The	  reaction	  is	  terminated	  by	  addition	  of	  NaOH,	  which	  hydrolyses	  the	  end	  
product	   to	   palmitoleic	   acid.	   The	   retention	   volumes	   of	   palmitic,	   palmitoleic	   and	   pentadecanoic	   acid	  
(used	  as	  an	  internal	  standard)	  can	  be	  estimated	  by	  running	  them	  individually	  in	  GC	  and	  area	  under	  the	  
curve	  gives	  us	  the	  concentration	  of	  the	  product.	  Therefore	  one	  can	  estimate,	  in	  principle	  the	  extent	  of	  
reaction	  by	  running	  the	  organic	  phase	  in	  GC.	  Sensitivity	  of	  the	  GC	  was	  calibrated,	  by	  running	  palmitic	  
and	   palmitoleic	   acid	   standards	   varying	   between	   concentrations	   of	   1	   nM	   to	   500	   μM	   and	   it	   was	  
estimated	   that	   the	   detection	   works	   best	   when	   the	   concentration	   is	   in	   the	   range	   of	   10	   μM.	   The	  
samples	  and	  sample	  mixtures	  were	  analyzed	  in	  full	  scan	  MS	  mode.	  The	  most	  abundant	  peaks	  for	  each	  
of	   the	   sample	  m/z	  299	   (pentadecanoic	   acid),	  m/z	  311	   (palmitoleic	   acid)	   and	  m/z	  313	   (palmitic	   acid)	  
were	   determined,	   following	   which	   selected	   ion	   monitoring	   method	   (SIM)	   was	   chosen	   for	   more	  
specificity.	  	  
To	  summarize,	   the	  protocol	   for	  monitoring	  the	  desaturase	  assay	   in	  vitro	  has	  been	  established	   (refer	  
section	   2.2.2.18	   for	   detailed	   description).	   Initial	   substrates	   required	   for	   the	   reaction	   have	   been	  
synthesized	   and	   attempts	   to	   reconstitute	   and	   monitor	   the	   desaturase	   assay	   in	   vitro	   are	   well	  
underway.	  The	  design	  of	  the	  assay,	  however,	  faces	  two	  setbacks.	  One,	   it	   is	  really	  not	  known	  if	  other	  
proteins,	   electron-­‐carriers	   and	   co-­‐factors	   are	   necessary	   for	   the	   function	   of	   Cln3p,	   as	   there	  may	   be	  
missing	  partners	  for	  the	  red-­‐ox	  reaction	  being	  reconstituted.	  Two,	  the	  use	  of	  whole/crude	  membrane	  
from	  insect	  cells	  overexpressing	  Cln3p	  can	  circumvent	  the	  problem	  of	  necessity	  of	  other	  proteins	  but	  
the	   lipids	   from	   the	   membrane	   will	   interfere	   with	   the	   substrate	   and	   therefore	   monitoring	   and	  
quantification	  of	  reaction	  products	  becomes	  difficult.	  To	  circumvent	  these	  problems	  non-­‐natural	  (odd-­‐
Results	  &	  Discussion	  -­‐	  II	   	  
	  
111	  
carbons)	   fatty	   acids	   like	   heptadecanoic	   acid	   could	   be	   used	   as	   substrates	   together	   with	   crude	  
membranes.	  Another	  alternative	  would	  be	  to	  use	  in	  vitro	  redox	  systems	  in	  which	  one	  could	  couple	  the	  
oxidation	   reaction	   carried	   out	   by	   Cln3p	  with	   an	   electron	   recycling	   system	   (for	   example	   glutathione	  
reductase	  kit,	  where	  one	  could	  ideally	  supplement	  the	  NADPH+	  by	  Cln3p	  and	  its	  substrate).	  However,	  
once	   again	   in	   vitro	   systems	   use	   either	   FAD	   (Flavin	   adenine	   dinucleotide)	   or	   NAD	   (Nicotinamide	  
adenine	  dinucleotide)	   as	   substrates	  and	   there	   is	  no	  putative	  binding	   site	   for	   such	  moieties	   in	  Cln3p	  
leading	  to	  a	  large	  speculation	  as	  to	  whether	  desaturase	  activity	  is	  the	  primary	  function	  carried	  out	  by	  
Cln3p	  and	  if	  loss	  of	  this	  activity	  underlies	  the	  Batten’s	  disease.	  	  
3.2.9 Towards	  the	  structure	  of	  Cln3p	  
Integral	  membrane	  protein	  structures	  do	  not	  appear	  every	  day.	  The	  task	  of	  purifying	  these	  proteins	  in	  
an	  environment	  conducive	  for	  structural	  studies	  is	  daunting.	  An	  enormous	  amount	  of	  time	  was	  spent	  
in	   rendering	   Cln3p,	   protein	   implicated	   in	   Batten’s	   disease,	   soluble.	   I	   report	   the	   first	   purification	   of	  
Cln3p	  in	  amphiphiles	  and	  am	  inching	  towards	  determination	  of	  its	  structure.	  Although	  initial	  trials	  to	  
understand	   its	  structure	  have	  failed,	  other	  methods	   (such	  as	   lipid	  cubic	  phase	   (LCP)	  crystallography)	  
are	   yet	   to	   be	   tried.	   Cln3p	   is	   a	   tricky	   protein,	   since	   its	   natural	   substrate	   is	   not	   known.	   Ligands	   or	  
inhibitors	  capable	  of	  stabilizing	  the	  protein	  in	  a	  specific	  conformation	  and	  facilitating	  further	  analysis	  
of	   the	   protein	   must	   be	   screened	   for	   at	   Compound	   Management	   and	   Screening	   Center	   (COMAS,	  
Dortmund).	   The	   glycosylation	   and	   palmitoylation	   sites	   need	   to	   be	   targeted,	   to	   mutate	   them	   to	  
facilitate	   crystallography	   studies.	   Albeit	   labor-­‐intensive,	   antibodies	   and	   antibody	   fragments	  
(nanobodies)	   that	   may	   help	   facilitate	   crystallization	   attempts	   need	   to	   be	   produced.	   In	   antibody-­‐
fragment	   mediated	   crystallization	   the	   available	   hydrophilic	   surface	   area	   is	   enlarged	   to	   form	   an	  
improved	  crystal	  lattice	  by	  promoting	  protein-­‐protein	  contacts	  and	  providing	  space	  for	  the	  detergent	  
micelle.	  Additionally,	  they	  restrict	  flexible	  protein	  parts.	  Alternatively,	  other	  scaffolds	  like	  affibodies	  or	  
DARPins	   (designed	   ankyrin	   repeat	   proteins)	   that	   are	   known	   to	   mask	   residues	   unfavorable	   for	   the	  
formation	  of	  crystal	  contacts	  remain	  to	  be	  tested.	  
Single	   particle	   electron	   microscopy	   (SP-­‐EM)	   is	   emerging	   as	   a	   very	   powerful	   tool	   for	   structure	  
determination.	  Once	  thought	  as	  a	  technique	  suitable	  only	  for	  intermediate	  resolutions	  SP-­‐EM	  is	  now	  
being	   routinely	   used	   to	   generate	   near-­‐atomic	   resolution	   structures.	   Although	   the	   number	   of	  
structures	  is	  still	  low	  in	  contrast	  to	  crystallography,	  the	  potential	  is	  immense.	  Attempts	  to	  reconstitute	  
Cln3p	  in	  amphipols	  (amphipathic	  polymers,	  which	  make	  membrane	  proteins	  suitable	  for	  cryo-­‐electron	  
microscopy)	  are	  well	  underway	  (briefly	  discussed	  in	  section	  3.2.5.1).	  
On	   the	   functional	   front	  we	  are	  well	  placed	  with	   the	  design	  of	  desaturase	  assay.	  The	  assay	  needs	   to	  
tried	  and	  tested.	  Another	  plausible	  role	  of	  Cln3p	  may	  be	  in	  arginine	  transport	  [145]	  a	  possibility	  that	  
has	  not	  been	   investigated	  during	   the	   course	  of	   the	  work.	   This	  needs	   to	  be	   studied	   in	   the	   future	  by	  
radioactive	  isotope	  uptake	  into	  proteoliposomes.	  Alternative	  way	  to	  assay	  this	  would	  be	  by	  microscale	  
thermophoresis,	   where	   change	   of	   the	  hydration	   shell	   of	   biomolecules	   due	   to	   changes	   in	   their	  
structure/conformation	  results	  in	  a	  relative	  change	  of	  movement	  along	  the	  temperature	  gradient	  and	  
is	  used	  to	  determine	  binding	  affinities.	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Finally,	  understanding	  the	  molecular	  mechanism	  of	  the	  disease	  is	  the	  key	  intention.	  We	  have	  come	  a	  
long	   way	   having	   embarked	   upon	   this	   goal,	   but	   obtaining	   the	   structure	   of	   the	   protein	   still	   remains	  
challenging.	  Someday,	  not	   far	  away	   in	   future	  we	   intend	  to	  elucidate,	   the	  structural	  basis	  of	  Batten’s	  
disease.	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Figure	   S1:	   Steps	   in	   the	   generation	   of	  
initial	  model	  of	  RZZ	  by	  Random	  Conical	  
Tilt.	   (a)	   Back-­‐projection	   of	   the	   best	  
average	   from	   the	   tilted	   stack.	  The	  noise	  
and	   dust	   is	   hidden,	   using	   the	   hide	   dust	  
tool	  in	  Chimera.	  (b)	  After	  back	  projection	  
refinement,	   without	   imposing	   any	  
symmetry.	   (c)	   After	   back	   projection	  
refinement	  imposing	  C2	  symmetry.	  Scale	  






Figure	   S2:	   Representative	   cryo-­‐positive	  
electron	   micrograph	   area,	   recorded	   on	  
JEOL	  3200FSC	  equipped	  with	   TVIPS	   8k	   x	  
8k	   camera.	   White	   arrowheads	   highlight	  





















Figure	  S3:	  Stages	  in	  determining	  
cryo-­‐EM	   structure.	   (a)	  
Reference	   from	   negative	   stain	  
(RCT)	   filtered	   to	   70	   Å	   (b)	   Initial	  
refinement	   without	   any	   mask	  
with	   6000	   particles.	   (c)	   Volume	  
in	   (b)	   was	   set	   to	   appropriate	  
threshold	   and	   used	   to	   generate	  
a	  mask.	  Refinement	  using	  mask.	  
(d)	   After	   multiple	   iterations	   of	  
refinement	  procedures,	  the	  final	  
density.	   (e)	   Fourier	   shell	  
correlation	  curves	  of	  b,	  c	  and	  d.	  
Since	  the	  data	  used	   initially	  was	  
4x	   binned	   the	   FSC	   of	   the	   final	  
reconstruction	   reaches	   Nyquist	  






















Figure	  S4:	  Purification	  and	  negative	  stain	  EM	  of	  Zw10.	  (a)	  Size-­‐exclusion	  chromatography	  profile	  of	  Zw10.	  
(b)	   SDS-­‐PAGE	   of	   the	   fractions	   encompassed	   by	   the	   peak	   from	   SEC	   indicating	   highly	   abundant	   and	   pure	  
protein.	  (c)	  Representative	  negative	  stain	  micrograph	  area	  representing	  Zw10	  particles.	  Scale	  bar,	  100	  nm.	  
	  
	   	  




Figure	  S5:	  Structures/models	  of	  components	  of	  RZZ	  complex	  (in	  rainbow	  representation	  N-­‐terminus	  (blue)-­‐
C-­‐terminus	   (red).	   (a)	   Models	   of	   ROD	   generated	   by	   structure	   prediction	   program	   (I-­‐TASSER)	   by	   Dr.	   Jenny	  
Keller.	   (b)	   Structures	   of	   yeast	   homologue	   of	   Zw10	   (Dsl1p).	   N-­‐terminus	   (37-­‐355),	   PDB-­‐ID:	   3ETU	   and	   the	   C-­‐

















Figure	   S7:	   Fitting	   of	   various	  
domains	   of	   ROD	   into	   the	   cryo	  
EM	   structure.	   (a)	   The	   NRH	  
domain,	   amino	   acids	   (371-­‐590).	  
(b)	   The	   C-­‐terminus	   of	   ROD	  
extends	   to	   tip	   of	   the	   structure,	  
amino	   acids	   (1215-­‐1714,	   1770-­‐
2169).	  (c)	  The	  α-­‐solenoid	  in	  ROD,	  
amino	  acids	  (584-­‐1165)	  
	  
	   	  




Figure	   S8:	  Negative	   stain	  micrograph	   area	   representing	  RZZ	   complex	   in	   four	   of	   the	  many	   conditions	   tried	   for	  
spontaneous	  assembly.	  In	  most	  of	  the	  cases	  the	  sample	  loses	  its	  characteristic	  shape.	  Scale	  bar,	  100	  nm.	  (a)	  50	  
mM	  HEPES	  pH	  8.5,	  100mM	  NaCl,	  1mM	  TCEP	  (b)	  50	  mM	  HEPES	  pH	  8.5,	  500mM	  NaCl,	  1mM	  TCEP	  (c)	  50	  mM	  MES	  

















Figure	  S9:	  Secondary	  structure	  prediction	  of	  Zw10.	  Protein	  stretch	  
from	   amino	   acids	   421-­‐600	   is	   highlighted.	   Most	   of	   the	   protein	   is	  
predicted	  to	  have	  secondary	  α-­‐helical	  structure,	  with	  intermittent	  
regions	   of	   disorder.	   The	   largest	   such	   stretch	   with	   a	   very	   high	  
disorder	  confidence	  is	  central	  to	  the	  protein	  (amino	  acids	  428-­‐470,	  
approximately).	   The	   secondary	   structure	   was	   predicted	   using	  
Phyre-­‐2.	   The	   confidence	   in	   prediction	   is	   depicted	   as	   color	  
spectrum	  from	  red	  (high	  confidence)	  to	  blue	  (low	  confidence).	  
	  
	   	  







Figure	  S10:	  Purification	  and	  negative	  stain	  EM	  of	  mini-­‐RZZ.	  (a)	  Size-­‐exclusion	  chromatography	  profile	  of	  mini-­‐
RZZ.	   (b)	   SDS-­‐PAGE	   of	   the	   fractions	   encompassed	   by	   the	   peak	   from	   SEC	   indicating	   instability	   of	   complex,	  
reflected	   from	   the	   degradation.	   (c)	   Representative	   negative	   stain	   micrograph	   area	   representing	   mini-­‐RZZ	  
complex	  particles.	  Scale	  bar,	  100	  nm.	  (d)	  Fourier	  shell	  correlation	  curve	  for	  the	  structure	  of	  mini-­‐RZZ	  complex.	  




















Figure	   S11:	   Purification	   and	   negative	   stain	   EM	   of	   R-­‐(nGFP)-­‐Z	   and	   R-­‐Z(cGFP)-­‐Z	   (a)	   Size-­‐exclusion	  
chromatography	  profile	  of	  R-­‐(nGFP)-­‐Z	  and	  R-­‐Z(cGFP)-­‐Z	   (b)	  and	   (c)	  SDS-­‐PAGE	  of	   the	   fractions	  highlighted	  by	  
the	   blue	   and	   green	   lines	   of	   R-­‐Z(cGFP)-­‐Z	   and	   R-­‐(nGFP)-­‐Z	   (d)	   and	   (e)	   Negative	   stain	   micrograph	   area	  
representing	  R-­‐Z(cGFP)-­‐Z	  and	  R-­‐(nGFP)-­‐Z	  particles	  respectively.	  Scale	  bar,	  100	  nm.	  
	  
	   	  




Figure	  S12:	  Multiple	  sequence	  alignment	  (MSA)	  of	  N-­‐terminus	  of	  ROD	  (1-­‐330)	  with	  the	  N-­‐termini	  of	  Sec31	  and	  
Nup160	  proteins	  generated	  using	  T-­‐Coffee	  online	  MSA	  server.	  All	  the	  three	  proteins	  are	  known	  or	  predicted	  to	  
contain	  an	  N-­‐terminal	  β-­‐propeller.	   The	  alignment	   score	   (27)	   is	  bad	  and	   is	  not	   surprising	  as	  WD40	   repeats	  are	  
known	  for	  low	  sequence	  similarity	  even	  though	  they	  are	  structurally	  similar.	  
	  
	   	  





Figure	  S13:	  MSA	  analysis	  of	  ROD,	  Sec31	  and	  Nup160	  proteins	  similar	  to	  one	  in	  Figure	  S12.	  Alignment	  shown	  





Figure	  S14:	  Representative	  cryo	  electron	  
micrograph	   area	   (an	   average	   of	   seven	  
frames,	   unaligned),	   recorded	   on	   TITAN	  
krios	   equipped	   with	   FALCON	   II	   direct	  
electron	   detector	   camera.	   White	  
arrowheads	  highlight	  particles.	  Scale	  bar,	  
100	  nm.	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Table	  5.1	  Cross-­‐links	  between	  ROD-­‐ROD	  (intra)	  detected	  from	  XL-­‐MS	  
	  	  
ROD	   ROD	  
24	   328	  
24	   404	  
43	   116	  
43	   377	  
52	   527	  
127	   240	  
240	   406	  
328	   377	  
406	   430	  
430	   464	  
503	   2016	  
513	   521	  
513	   1031	  
701	   739	  
701	   1658	  
705	   726	  
739	   1658	  
770	   843	  
829	   1646	  
829	   1648	  
829	   1658	  
829	   1665	  
831	   1648	  
831	   1665	  
838	   859	  
843	   859	  
916	   971	  
946	   957	  
946	   1021	  
946	   1029	  
946	   1031	  
946	   1051	  
957	   1051	  
964	   977	  
971	   1493	  
1021	   1051	  
1021	   1086	  
1021	   1076	  
1029	   1051	  
1029	   1063	  
1029	   1076	  
1029	   1081	  
1029	   1085	  
	  
	  
ROD	   ROD	  
1031	   1051	  
1031	   1063	  
1031	   1076	  
1031	   1081	  
1031	   1085	  
1051	   1081	  
1051	   1086	  
1076	   1101	  
1081	   1086	  
1081	   1092	  
1085	   1092	  
1307	   1316	  
1307	   1318	  
1333	   1367	  
1413	   1493	  
1493	   1560	  
1640	   1648	  
1640	   1731	  
1645	   1653	  
1646	   1653	  
1646	   1665	  
1648	   1653	  
1653	   1665	  
1658	   1756	  
1728	   1737	  
1728	   1738	  
1731	   1738	  
1737	   1768	  
1738	   1768	  
2093	   2135	  
2093	   2136	  
2106	   2145	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Table	  5.2	  Cross-­‐links	  between	  ROD-­‐Zw10	  (left,	  inter)	  and	  ROD	  –Zwilch	  detected	  from	  XL-­‐MS	  
	  
ROD	   Zw10	  
859	   45	  
859	   129	  
859	   130	  
859	   145	  
870	   157	  
916	   777	  
946	   74	  
946	   143	  
946	   149	  
946	   152	  
1029	   624	  
1031	   624	  
1063	   624	  
1081	   528	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Figure	  S15:	  Overexpression	  of	  mCherry-­‐Cln3p	  in	  Sf21	  cells.	  (a)	  DIC	  image	  (b)	  fluorescence	  image.	  
	  
	  
Figure	  S16:	  Cleavage	  of	  tag	  from	  EGFP-­‐Cln3p	  protein	  
(p232	   construct).	   Semi-­‐denaturing	   SDS-­‐PAGE	   (left)	  
and	   corresponding	   Western	   blot	   (right).	   BC,	   before	  
clevage.	  AC,	  after	  cleavage.	  M,	  marker.	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